UNLV Theses, Dissertations, Professional Papers, and Capstones
12-2011

The impact of regulating social science research with biomedical
regulations
Brenda Braxton Durosinmi
University of Nevada, Las Vegas

Follow this and additional works at: https://digitalscholarship.unlv.edu/thesesdissertations
Part of the Ethics in Religion Commons, Higher Education and Teaching Commons, Other Law
Commons, Philosophy Commons, and the Public Policy Commons

Repository Citation
Durosinmi, Brenda Braxton, "The impact of regulating social science research with biomedical
regulations" (2011). UNLV Theses, Dissertations, Professional Papers, and Capstones. 1251.
http://dx.doi.org/10.34917/2821184

This Dissertation is protected by copyright and/or related rights. It has been brought to you by Digital
Scholarship@UNLV with permission from the rights-holder(s). You are free to use this Dissertation in any way that
is permitted by the copyright and related rights legislation that applies to your use. For other uses you need to
obtain permission from the rights-holder(s) directly, unless additional rights are indicated by a Creative Commons
license in the record and/or on the work itself.
This Dissertation has been accepted for inclusion in UNLV Theses, Dissertations, Professional Papers, and
Capstones by an authorized administrator of Digital Scholarship@UNLV. For more information, please contact
digitalscholarship@unlv.edu.

THE IMPACT OF REGULATING SOCIAL SCIENCE RESEARCH
WITH BIOMEDICAL REGULATIONS

By

Brenda Braxton Durosinmi

Bachelor of General Studies
Virginia Commonwealth University, 1989

Master of Public Administration
Trust: Impact for Organizational Team Building
University of Nevada, Las Vegas, 1997

A dissertation submitted in partial fulfillment
of the requirements for the

Doctor of Philosophy in Educational Leadership
College of Education
The Graduate College

University of Nevada, Las Vegas
December 2011

Copyright by Brenda Durosinmi, 2011
All Rights Reserved

THE GRADUATE COLLEGE

We recommend the dissertation prepared under our supervision by

Brenda Durosinmi
entitled

The Impact of Regulating Social Science Research with Biomedical
Regulations
be accepted in partial fulfillment of the requirements for the degree of

Doctor of Philosophy in Higher Educational Leadership
Department of Education

Gerald Kops, Committee Chair
Cecelia Maldonado, Committee Member
Sterling Saddler, Committee Member
Patrick Carlton, Committee Member
LeAnn Putney, Graduate Faculty Representative

Ronald Smith, Ph. D., Vice President for Research and Graduate Studies
and Dean of the Graduate College

December 2011

ii

Abstract

The Impact of Regulating Social Science Research with Biomedical
Regulations: A Qualitative Study
by
Brenda Durosinmi
Gerald C. Kops, J.D., PhD, Committee Chair
Professor of Educational Leadership
University of Nevada, Las Vegas
Since 1974 Federal regulations have governed the use of human subjects
in biomedical and social science research. The regulations are known as the
Federal Policy for the Protection of Human Subjects, and often referred to as the
―Common Rule‖ because 18 Federal agencies follow some form of the policy.
The Common Rule defines basic policies for conducting biomedical and social
science research. Almost from the inception of the Common Rule social
scientists have expressed concerns of the policy‘s medical framework of
regulations having its applicability also to human research in the social sciences.
The purpose of this dissertation was to investigate the impact of regulating social
science research with the framework of biomedical research regulatory
standards.
Qualitative methodology is used to analyze the Office of Human Research
Protection‘s Determination Letters, to facilitate in-depth interviews of human
research protection program administrators, and to evaluate the Common Rule
policy.

iii

The researcher reviewed 763 letters with 43 letters determined to be
associated with social science research projects. The 763 determination letters
represented a time span of 10 years, from 2000 to 2010. The letters were
reviewed for indications of noncompliance or deficiencies to regulations specified
in the Federal Regulations 45 CFR 46, Subpart A, (the Common Rule).
Noncompliance or deficiencies by the IRB and HRPP support staff represented
the majority of determination letter findings.
In-depth interviews were conducted with HRPP administrators. The lack of
flexibility of the Common Rule in its application to social science disciplines was
a common theme in the responses of HRPP administrators. Evaluation of the
Common Rule suggested the policy was effective and efficient for the IRB and its
administrative support staff, but was less effective and not efficient for social
science research projects.
The assessment of the impact of regulating social science with biomedical
regulations highlights the need for additional education and training of IRBs and
their administrative support staff to more effectively apply a biomedical model of
research regulation to the review and approval of social science research activity.
The assessment additionally suggests the need for an ―update‖ of the Common
Rule to address the specificity of new areas of social science research in which
IRBs deliberate scrupulously with no regulatory guidance.
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Chapter 1
Introduction
Human research can be traced as far back as the sixth century B.C.
Sharav (n. d.) details in A Chronology of Human Research (see Appendix A)
vegetable and meat experimentation with young Jewish prisoners.1,2 As
research continued during the Age of Enlightenment, medical human
experimentation sought prisoners as research subjects with routine frequency
(Jones, 1993). Eighteenth century research procedures included offers of free
pardon to inmates who agreed to be inoculated with infectious small pox in
variolation experimentation 3 (Lederer, 1995; Sharav, n.d.). Variolation
experimentation resulted in disease and death for many of those inoculated with
small pox. (Moreno, 2000; Faden & Beauchamp, 1986; Gibelman & Gelman,
2005).4 In most, if not all cases, prisoners were subjected to variolation
experimentation without their consent or offer of free pardon. Vollman & Winau
(1996) puts forward that human research should not put subjects at risk to benefit
others. They further suggest human subjects should receive a quotient of benefit
from their participation in research.
1

No date is mentioned for the compilation of Human Experiments: A Chronology of Human Research
by Vera Hassner Sharav
2
Katz (2008) suggests Sharav is referring to the Book of Daniel, 1:3-5, 8, 11-13 in which the king
requests the presence of some of the Israelites of royal blood and nobility. The king allotted them a daily
portion of food and wine from the royal table…But, Daniel was resolved not to defile himself with the kings
food or wine…Then Daniel said …‖Please test your servants for ten days. Give us vegetables to eat and
water to drink…Then see how we look in comparison with the other young men who ate from the royal
table.‖
3
Variolation is an obsolete method of immunizing humans against smallpox by infecting them with the
pustules of infected humans. The method was popularized in England in 1721-1722. In America, Cotton
Mather (1663-1728) used the method on slaves. During that time variolation continued to be opposed by
religious groups and most physicians, who were not convinced of the safety of the method. It was replaced
by vaccination in 1799. In 1842 an act of Parliament in England made the practice of variolation a felony in
that country.
4
Philip S. Hench Walter Reed Yellow Fever Collection details historical accounts of Walter Reeds
experimentation with small pox research. See: http://yellowfever.lib.virginia.edu/reed/commission.html.

1

Vollman & Winau (1996) suggest that in 1900, as scientific information
expanded so too did questions of unethical medical research practices. In Berlin,
prostitutes were subjected to syphilis serum treatment without their knowledge or
consent. The serum from patients recovering from syphilis was administered to
the prostitutes by way of injection. The procedure was administered with the
belief that the practice was a discovery in the cure for syphilis. An immeasurable
epidemic among prostitutes and their customers resulted from the experimental
procedures. The epidemic laid grounds for public outrage (Vollman & Winau,
1996). The authors suggest that the outraged public demanded action to be
taken to halt unethical experimentation.
Early Human Research Regulatory Codes
Berlin Code
As a result of public outrage for unethical medical syphilis experiments,
the Berlin Code of 1900 (the Code) was developed (see Appendix B). The Berlin
Code was the first and strongest Code of that time to specify the conditions of
ethical experimental procedures while conducting medical research with human
subjects (Vollman & Winau, 1996). The Code required:
 unambiguous consent, after thorough explanation of possible negative
consequences of participation in study;
 the study be conducted or directed by the institute‘s medical
administrator;
 of minors or incompetent subjects be excluded;

2

 documentation of fulfillment of the Code requirements in subjects
medical records; and that
 the research not interfere with standard diagnostics, care and
prophylaxis.
Accounts of unethical human medical experimentation by world famous
and revered doctors continued throughout the 1920s and beyond, forcing the
medical community, courts, and the public to consider additional protections for
human research subjects in addition to those protections stated in the Berlin
Code of 1900. Examples of continued unethical treatment of human research
subjects are documented in the historical events of medical experimentation by
the Nazi regime.5 Nazi regime doctors performed many series of unethical
medical experiments on hundreds of prisoners held in concentration camps6
during World War II (1939-1945).
Annas & Grodin (1992) suggests that camp prisoners were coerced and
forced into participating in the medical research experiments. The experiments
conducted resulted in harmful and often deadly consequences for the subjects
(see Appendix C, Appendix D; Appendix E; Appendix F; and Appendix G). The
harmful and deadly medical experiments were never accompanied by informed

5

The National Socialist German Workers' Party, known in German as the Nationalsozialistische Deutsche
Arbeiterpartei and commonly known in English as the Nazi Party, was a political party in Germany between
1919 and 1945. The party's last leader, Adolf Hitler, was appointed Chancellor of Germany in 1933 and
established a totalitarian regime known as the Third Reich. Nazi ideology stressed the failures of
communism, liberalism, and democracy. They supported the "racial purity of the German people" and that
of other Northwestern Europeans. The Nazis persecuted those they perceived as either race enemies or
those with "life unworthy of living". This included Jews, Slavs, Communists, homosexuals, the mentally and
physically disabled, and others. Source: http://en.wikipedia.org/wiki/Nazi_human_experimentation.
6
The Oxford English Dictionary, 2nd ed. defines concentration camp as: a camp where non-combatants of
a district are accommodated, such as those instituted by Lord Kitchener during the South African war of
1899-1902; one for the internment of political prisoners, foreign nationals, etc., especially as organized by
the Nazi regime in Germany before and during the war of 1939-45.

3

consent.7 Public awareness of the medical research atrocities being performed
in the camps surfaced. Doctors and scientists that had engaged in the human
experiments were put on trial for war crimes, including ―violations of the laws or
customs of war‖ (Annas & Grodin, 1992, p. 95).
Nuremberg Code
In 1946 Nazi doctors and scientists that conducted harmful and fatal
experiments were indicted for war crimes before the International Military
Tribunal in Nuremberg, Germany. Shelton and Cengage (2005, para. 1) state
that:
The trial of the Nazi doctors, known as the United States of
America vs. Karl Brandt et al. the Medical Case, or the Nazi
Doctors Case, was based on the Agreement for the
Prosecution and Punishment of the Major War Criminals of
the European Axis, signed in London on August 8, 1945 by
the United States, the United Kingdom, France, and the
Soviet Union, which created the International Military
Tribunal (IMT). The Nazi doctors were not tried by the IMT,
but rather by a U.S. tribunal acting pursuant to Control
Council Law No. 10, signed on 20 December 1945.
The U.S. tribunal condemned all such harmful and fatal experiments and
classified the experiments as crimes against humanity. These crimes were the
result of Nazi doctors and scientists performing vile and potentially lethal
medical experiments on concentration camp inmates and other living humans.
The trials resulted in the conviction of 16 of the 23 physician defendants. Seven
of those indicted were sentenced to death (Selton & Cengage, 2005).
7

Informed consent represents giving the research subject a clear appreciation and understanding of the
facts of the research, the implications, and any foreseeable future consequences of the research
procedures. In order to give informed consent, the individual concerned must have adequate reasoning
faculties and have all relevant facts at the time consent is given. 45 CFR 46.116 of the Common Rule
addresses informed consent. This term was first used in a 1957 medical malpractice case by Paul G.
Gebhard. See Salgo v. Leland Stanford etc. Bd. Trustees, 154 Cal.App.2d 560 [Civ. No. 17045. First Dist.,
Div. One. Oct. 22, 1957.]

4

Shelton & Cengage further suggest the tribunal resulted in the judgment of
principles that must be observed by medical researchers to satisfy moral, ethical,
and legal concepts of research. The principles, as shown in Table 1, are known
as the Nuremberg Code (see Appendix H). The tribunal espoused ten principles
by which physicians must conform to when carrying out experiments on human
subjects. The Nuremberg Code established additional standards of ethical
medical behavior for the post-World War II human rights era (Annas & Grodin,
1992)
Grodin (1992) suggests that the Nuremberg Code was the cornerstone of
modern human experimentation ethics. Whereas, Rothman (2003) suggest there
were little if any impact of the Nuremburg Trials on medical experimentation in
the U.S. The harmful scientific research performed on humans in Germany had
little, if any, impact on improving medical research practices in the U.S.
(Rothman 2003). Rothman acknowledges that although twenty-three medical
doctors and scientists were indicted for the atrocities, with seven of them being
executed, the majority of American medical researchers did not find the German
doctors‘ engagement in the unethical experimentation of human research
subjects to be unscrupulous.
Annas & Grodin (1992) and Rothman (2003) put forward that German
scientists and research doctors were trusted and revered scientists. Oakes
(2002, p. 444) suggests that:
Americans believed that its physician-researchers
acted in accordance with their Hippocratic ideals and
voluntary consent was unnecessary in a society with a
long and untarnished history of medical research.
5

Table 1
Principles of the Nuremberg Code

1.

Voluntary consent of the human subject is absolutely
essential

2.

The experiment should be such as to yield fruitful
results for the good of society

3.

The experiment should be so designed and based on
the results of animal experimentation

4.

5.

6.

7.

The experiment should be so conducted as to avoid
all unnecessary physical and mental suffering and
injury
No experiment should be conducted where there is
an a priori reason to believe that death or disabling
injury will occur
The degree of risk to be taken should never exceed
that determined by the humanitarian importance of
the problem to be solved by the experiment
Proper preparations should be made and adequate
facilities provided to protect the experimental subject
against even remote possibilities of injury, disability,
or death

8.

The experiment should be conducted only by
scientifically qualified persons

9.

The human subject should be at liberty to bring the
experiment to an end

10.

The scientist in charge must be prepared to
terminate the experiment at any stage

6

American ethicists justified human research without the protections of informed
consent given to subjects as unnecessary due to the need of experimentation for
the persons own therapy; experimentation for the good of humanity in general,
and experimentation to advance science (Oakes, 2002; Moreno, 2000; Vollman
& Winau, 1996).
Unethical Human Research in the United States
Tuskegee Syphilis Study
Jones (1993), Reverby (2009) and Washington (2006) suggest the forty
year Tuskegee Syphilis Study conducted from 1932 until 1972, captures the
unethical medical experimentation with humans in the United States after
regulatory guidance of the Berlin Code and the aftermath of the Nuremberg
Trials and the Nuremberg Code. The authors further suggest that the United
States Public Health Service (PHS) continued to conduct unethical medical
research.
The Tuskegee Syphilis Study included medical research on 399 indigent
men infected with syphilis. The men, black illiterate sharecroppers in Alabama,
were never told by the medical researchers what disease they were suffering
from or the seriousness of the disease. The research subjects became enrolled
in the study without their knowledge or consent (Reverby, 2009; Jones, 1993;
Moreno, 2000; Oakes, 2002; Washington 2006). Medical researchers told the
men they were suffering from ―bad blood‖ instead of the disease of syphilis.
The research doctors had no intention of treating the men for their illnesses
(Jones, 1993; Washington, 2006; Oakes, 2002). Jones, Moreno and
7

Washington suggest that the men were left to expire with their disease in order
that data could be collected from autopsies of their diseased bodies. One of the
medical research team involved in the study explained, referring to the
research subjects, ―As I see it we have no further interest in these patients until
they die‖ (Washington, 2006, p. 164).
The men died a slow and painful death without treatment being
administered for their disease although penicillin had proven to be an effective
treatment for syphilis in 1946 8 (Jones, 1993; Moreno, 2000). Medical research
funding by the U.S. Public Health Office had been greatly increased for human
subject research, although increased protections for subjects had not yet had
been also put in place (LaFollette, 1994; Dubois, 2008).
Increased Funding for Medical Research
Major Federal government financing of medical research appeared during
World War II. Research funding escalated from $4 million to more than $100
million between 1947 and 1957 while the National Institutes of Health (NIH), an
agency of the Public Health Service, had grown from a budget of $8 million to
over $1 billion by 1966 (Schrag, 2009). Under the same legislation that grew
NIH‘s budget, the legislation also authorized the opening of a Clinical Center to
―specifically provide researchers with people, some of them not even sick, on
whom to experiment‖ (Schrag, 2009, p. 5).

8

In 1946, extensive trials with penicillin had demonstrated that the antibiotic was successful in curing
syphilis. Supervising Physicians of the Tuskegee Study made certain that the experimental group were
never to be given penicillin so as not ―to contaminate‖ the study as it was designed to determine the natural
evolution of untreated chronic syphilis.

8

Schrag suggests Institutional Review Boards (IRBs) were formed to
respond to the increased amount of medical research taking place in the United
States. Although, as Schrag further suggests, the NIH had required their studies,
having increased risk to subjects, be approved by their medical review committee
with participating patients to be given written consent to participants in the
studies. The NIH did not require signed informed consent from subjects
participating in minimal risk studies as a condition for research institutions to
receive Federal funding for their medical research projects. A comparable system
of human research protection was recommended to be applied to all programs
financially sponsored by NIH during the 1960s (Schrag, 2009).
In 1966 medical research funded by the Public Health Service was
required to undergo ―prior review‖ by institutional associates to insure research
participants‘ protection of their rights and welfare (Gray, 1978). Pattullo (1985),
Schrag (2009), and Oakes (2002) suggest that prior review was the first Federal
prerequisite placed on institutions conducting research outside of the Federal
government‘s agencies. Currently, all institutions receiving Federal funding are
now required to have an institutional review committee (IRB) review and approve
all medical and social science research projects before implementation of the
research.
Research with Vulnerable Populations in the United States
In the United States biomedical researchers believed they were far
removed from participating in unethical research atrocities as those perpetuated
by Nazi doctors and scientists (Vanderpool, 1996). Vanderpool points out that
9

between 1946 and 1966 U.S. biomedical researchers ―resisted ethical and
regulatory oversight‖ (p. 8). Beecher (1966) brought unprecedented attention to
research practices in the United States involving unethical research practices in
general and more specifically unethical research on children. Criticisms of
unethical medical research practices involving children gained new attention
(Vanderpool, 1996). The Willowbrook State Hospital study, as Rothman &
Rothman (1984) note, is the most widely known unethical study on children. The
Willowbrook Study involved children diagnosed with mental retardation, living at
the Willowbrook State Hospital as patients from 1956 to 1971 (Levine, 1988).
Researchers infected the otherwise healthy children with hepatitis to gauge its
natural history, prevention, and treatment of the disease. A public uncovering of
the Willowbrook Study forced researchers to suspend the hepatitis research.
Other fragile populations continued to be enrolled in unethical research
studies in the U.S. (Faden & Beauchamp, 1986). The Jewish Chronic Disease
Hospital Study, undertaken in 1963 included live cancer cells being injected into
22 senile patients. The purpose of the research was to determine how a
weakened immune system influenced the spread of cancer (Jones, 1993;
Lederer, 1995). Patients were not informed of the research or asked to give their
consent by the researchers about the experimental procedures of receiving live
cancer cells. Researchers also neglected to get approval from the hospital‘s
research committee or the patients‘ physicians or patients‘ legal guardians.
According to Jones (1993) part of the researchers‘ defense was that there
was no need to unnecessarily frighten the patient and their family with the details
10

of the research study. The researchers conducting this study were tried and
found guilty of fraud, deceit, and unprofessional conduct (Jones, 1993; Lederer,
1995; Dubois, 2008). Still, unethical medical research practices continued
(Dubois, 2008, Vanderpool, 1996).
Congressional hearings produced the Kefauver-Harris Bill of 1962 as a
result of pregnant women given birth to deformed infants in the United States,
Canada, and Europe after being given the drug thalidomide. The experimental
drug was given to women without their knowledge or consent. Originally
developed to relieve nausea during pregnancy, the drug‘s birth defects of the
fetus from the drug resulted in more than 12,000 severely deformed infants,
many without limbs (National Center for Juvenile Justice [NCJJ]), n.d.). The
Kefauver-Harris Bill required researchers to inform all subjects about impending
risks and benefits of experimental drugs and to acquire consent from participants
prior to taking part in the study (NCJJ, n.d.). NCJJ notes that this bill was the first
U.S. statute requiring informed consent.
The NCJJ suggest the requirements of the Kefauver-Harris Bill did not
―address the capacity of minors or adults with limited decision-making skills to
make an informed decision‖ (para. 7) to participate in research activity. To
address this issue, the World Medical Association issued the Declaration of
Helsinki ( Appendix 1) in 1964, which required ―surrogate consent when the
participant is incapable of decision-making (para.7). The Declaration of Helsinki
(the Declaration) requires surrogate consent if minors and adults are to be

11

enrolled in a study and, ―lack cognitive ability or emotional maturity to
understand potential risk or harm associated with research participation‖ (para.8).
The 1970s brought about much controversy over unethical medical
research practices in general, and specifically the 40 year Tuskegee Syphilis
Study (Caplan, 1992; Lederer & Grodin, 1994). Negative publicity of the studies
garnered publication in medical journals, major newspapers, and discussions in
Congress (Field & Berman, 2004; Goldman, 1973; Faden & Beauchamp, 1986;
Lederer & Grodin, 1994).
Human Research Regulatory Statutes in the United States
National Research Act
―While the 1947 Nuremberg Code was the world‘s reaction to Nazi war
crimes, the 1974 National Research Act Public Law 93-348 (see Appendix J)
was the response of the United States to the Tuskegee Syphilis Study‖ (NJCC,
para. 8). The National Research Act established the IRB process requiring formal
peer review and approval of all Department of Health and Human Services
(DHHS) research involving human subjects (NCJJ, National Bioethics Advisory
Committee (NBAC), 2001).
NJCC and NBAC suggest that the 1974 National Research Act (Public
Law 93-348) legislation also created the National Commission for the Protection
of Human Subjects of Biomedical and Behavioral Research (National
Commission). The National Institutes of Health
One of the charges to the Commission was to identify the
basic ethical principles that should underlie the conduct
of biomedical and behavioral research involving human
subjects and to develop guidelines which should be
12

followed to assure that such research is conducted in
accordance with those principles. In carrying out the
above, the Commission was directed to consider: (i) the
boundaries between biomedical and behavioral research
and the accepted and routine practice of medicine, (ii) the
role of assessment of risk-benefit criteria in the
determination of the appropriateness of research
involving human subjects, (iii) appropriate guidelines for
the selection of human subjects for participation in such
research and (iv) the nature and definition of informed
consent in various research settings
(http://ohsr.od.nih.gov/guidelines/belmont.html, para. 1).
The Belmont Report
The Belmont Report serves as a statement of basic ethical principles and
guidelines to assist in resolving ethical problems related to the conduct of
research with human subjects. The basic tenets of the Belmont Report (see
Appendix K) include three fundamental principles, respect for persons,
beneficence, and justice.
As a result of the 40 year Tuskegee Syphilis Study by the U.S. Public
Health Service the Belmont Report was developed. The National Commission for
the Protection of Human Subjects of Biomedical and Behavioral Research, 1974
to 1978 revised and expanded 45 CFR 46 Subpart A (see Appendix L) to include
principles of the Belmont Report. The National Commission's Report of ethical
principles and guidelines for the protection of human subjects was published and
was given the name, the Belmont Report for the Belmont Conference Center
where the National Commission met to draft the report. Institutional peer review
became a formal process to ensure compliance with the basic principles of the
Belmont Report.
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However, the Belmont Report did have its critics regarding its applicability
to nonmedical research. Schrag (2010) suggests that Albert Reiss, a prominent
sociologist who participated in the 1976 conference that resulted in the National
Commission‘s creation of the Belmont Report, ignored objections by social
scientists participating in the recommendations to the document. Schrag notes
that although the Belmont Report ―is a notable achievement in the exploration of
the ethical challenges raised by medical research, but which serves as a poor
guide to research in the social sciences and humanities …‖ (para. 2). The impact
of the Belmont Report is discussed further in the section, Protecting Human
Subjects Using Regulatory Standards.
The Common Rule
The National Commission recognized the need for a common Federal
policy by recommending in 1991 that all Federal departments and agencies
adopt a common core of regulations governing research with human subjects
which was to be issued by the Department of Health and Human Services. NCJJ
suggested that the adoption of these ―common‖ regulations by 17 Federal
departments and agencies became known as the Common Rule. The Code of
Federal Regulations, Title 45 Public Welfare Department of Health and Human
Services Part 46, Protection of Human Subjects (45 CFR 46) was adopted by 17
Federal agencies and became known as the Common Rule because the rules
are common to many Federal departments and agencies conducting human
subjects research. Unethical use of human subjects in biomedical research in the
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United States brought intervention from the Federal government that provided
better protection for human research subjects (Pattullo, 1985).
Although historical accounts of medical experimentation with human
subjects identifies a history embedded in horrific pain, disfigurement, and death, 9
Muller (2007) suggests the literature does not bare the same historical unethical
events for human subjects participating in social science research.
Human Research Regulations and the “New Sciences”
Although medical research was the initial focus of human research
protection intervention by the Federal government, the ―new sciences,‖
anthropology, sociology, economics, and political science were also under
scrutiny (Pattullo, p. 527). Tropp (1978) suggests that additional Federal policy to
protect human research subjects emerged in the early 1970‘s regulating not only
medical human research but also research activity of the social sciences. Yet,
Singer & Levine (2002, p. 18) puts forward:
Unlike clinical research, which at times involves the risk
of physical injury and even death as a direct result of a
research intervention, the most severe harms likely to
befall subjects in social science research arise from
potential breaches of the confidentiality of the data
collected. Thus, for example, loss of job, criminal
prosecution, and public humiliation are all potential
consequences of revealing damaging information that a
research subject has disclosed to an investigator.

The authors suggest the kinds of limited harm social science research
engenders is far less detrimental than that of biomedical research. Seemingly

9

Vivien Spitz. (2005). Doctors from Hell: The Horrific Account of Nazi Experiments on Humans. During the Nazi
doctors‘ military tribunals Spitz, then a 22-year-old court reporter recounts the atrocities of 20 doctors and medical
assistants‘ use of prisoners for horrific experimentation in German prisons.
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―over-zealous medical scientist‖ has brought an increased level of scrutiny to
social science research evidenced by governmental regulations (Patullo, 1985, p.
524). Among noted social science unethical research includes:
 The Harvard Drug Study (Weil, 1963)
o Psychedelic drug research with students at Harvard University.
 Tearoom Trade (Humphreys, 1970,)
o Research to investigate who seeks quick, impersonal sexual
gratification and the motives for doing so?
 Stanford Prison Experiment (Zimbardo, 2007)
o Investigation of the psychological effects of becoming a prisoner or
prison guard.
 Stanley Milgram Obedience Study (Milgram, 1974)
o Research of the effect of authority on obedience
The literature suggests the amount of harm experienced by those
participating in social science research has been negligible (Pattullo, 1985,
Gunsalus et.al., 2004). Additionally, it is put forward that the fields of
anthropology, journalism, oral history, ethnography and other social science
fields already had well-established ethical research guidelines for their profession
(Gunsalus et.al., 2004; Haggerty, 2004)).
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Social Scientists’ Concerns of Overregulation
As a result of the 1974 National Research Act, and the establishment of
the National Commission for the Protection of Human Subjects of Biomedical and
Behavioral Research both disciplines (biomedical and the social sciences) were
subject to increased scrutiny. The Code of Federal Regulations, Title 45 Public
Welfare Department of Health and Human Services Part 46, Protection of Human
Subjects, the Common Rule10 (Subpart A of 45 CFR 46) in 1979 formally
proposed that all human research including social science research be regulated
by the same standards as biomedical research practice (Seiler & Murtha, 1980).
The 1979 Federal Register (see Appendix M) proposed guidelines requiring all
Federal funded social science research to receive institutional review board (IRB)
review comparable to that of biomedical research. The Federal Register
suggests that social science be included in the Federal regulations (Oakes 2002,
p. 448; 44 FR 47688).
Although the Federal Register includes social science research in the
human subject research regulations, a number of social scientists saw the
applicability of the federal regulations for the protection of research subjects to
social science as ―being included by mistake‖ because there were no social
scientist involved in the decision-making process to advocate for less restrictive
regulatory standards of minimal and less than minimal research practices of
social science researchers (Seiler & Murtha, 1980, p. 47). Seiler & Murtha
10

The Common Rule which has been adopted by 17 government agencies proposes procedures for
Institutional Review Boards, including the kinds of research which is exempt from their purview, and the
kinds of research that should receive expedited review given there is minimal risk to participants. Felice
Levine of the American Sociological Association pointed out in recent testimony, there are ―growing fault
lines in the system that protects human participants," and a ―gap has developed between law and policy on
the books and in action.
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suggest that there was ambiguity about how social science research became
included for oversight in the federal human subject protection regulations. The
authors note that documentation of discussions held did not address issues
related to the less than minimal risk projects of social science research, including
interviews, surveys, or oral history projects.
The NBAC in 2001 proposed various efforts to strengthen the protection of
humans participating in research regulated by the Common Rule, applying the
tenets of biomedical human research protection to social science research.
Gordon (2003) suggests that while these efforts to provide increased protections
for human research participants reflect a laudable goal, the regulations do not
necessarily apply or translate well to all disciplines of research, particularly social
science research. Gordon further suggests that social science researchers
commonly perceive the current and proposed human subjects regulations as
obstacles to research for social scientists. Anthropologists and other social
scientists typically encounter these obstacles at the point of obtaining IRB review
and approval of their research protocol. As an example, IRBs require that human
subjects research studies comply with the Common Rule by ensuring primarily
that the benefits of participation in research outweigh the risks to subjects, and
that subjects are consented by way of written informed consent in most cases
prior to participation in the research. For anthropological projects and other social
science projects these requirements can present unattainable conditions (White,
2007; Hamberger, 2005).
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Seiler & Murtha (1980) suggests that regulations and interpretations of the
regulations are modeled heavily in the biomedical standards of research. The
authors propose that the biomedical model of human research protection does
not necessarily conform to social science approaches toward research. White
(2007, p. 548) articulates the concerns of social science researchers in stating:
The government‘s continued reliance on monopolistic,
one-size-fits-all institutionalized solutions such as the
IRB process clearly threatens the future of behavioral
science, if not of biomedical science, by overloading the
system with paperwork and by wasting the time, effort
and resources of everyone involved, including
researchers, board members, students, teachers and
government officials.
Social scientists puts forward that the Common Rule may not be fully applicable
to anthropological and other social science research (Mueller, 2007; De Vries;
DeBruin & Goodgame, 2000). They suggest that there is no evidence of
enhanced safety for research participants of social science research when the
one- size-fits-all regulations of the Common Rule are applied to the review and
approval of their research projects.
Mueller (2007) suggests dissatisfaction and frustration with the system of
applying biomedical regulations of research to social scientist research projects.
Much of the frustration he suggest, centers on describing how risk is interpreted
in biomedical terms, thereby making it difficult to apply the Common Rule to
social science research. Social science researchers express high levels of
concern of overregulation and mission creep as a result of applying biomedical
regulations to social science research (White, 2007; Schrag, 2009; Mueller,
2007; De Vries et al., 2004).
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Haggerty (2004) suggests that IRBs are the instruments of a system of
licensing in which scholars, students and other researchers must get permission
to conduct research with human subjects. He suggests that IRBs are far more
dangerous than the research they review and they offer little if any protection for
human subjects. Rothman (1995) suggests that IRB‘s and their staff may not
have adequate education and training in pertinent regulations; therefore
inappropriate burdens may be placed on researchers. Similarly, excessive
documentation procedures rather than providing guidance in the interpretation of
the regulations amount to the overregulation and less protection for research
subjects (Hamilton, 2004; Gunsalus, 2004).
Burris & Welsh (2007) characterize IRBs as a regulatory system that often
distracts from rather than focus on key ethical concerns. Zywicki (2007) suggests
that ―IRBs have become a ubiquitous presence on the landscape of America‘s
higher education system‖ using a system of review of research projects which
suggests a one-size-fits-all approach (p. 861). Zywicki proposes that IRBs have
been extensively criticized as inefficient, obstructionist, and indifferent to the
researchers‘ needs. He suggests that IRBs are ineffective at protecting the safety
and ethical concerns of research participants because of excessive regulations
required in biomedical and behavioral research.
De Vries et al. (2004, October) propose that although the Common Rule at
§46.117(c) state that the IRB may waive the requirement for the investigator to
obtain a signed informed consent for some or all subjects if it finds that either:
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(1) That the only record linking the subject and the research would
be the consent document and the principal risk would be potential
harm resulting from a breach in confidentiality. Each subject will be
asked whether the subject wants documentation linking the subject
with the research, and the subject's wishes will govern; or
(2) That the research presents no more than minimal risk of harm to
subjects and involves no procedures for which written consent is
normally required outside of the research context.
De Vries; Debruin; & Goodgame propose that although the waiver of
signed informed consent included in the regulation is a useful exception,
beneficial to carrying out social science research, the institutions‘ administrative
bureaucracy of legal cover insists that documented written consent be obtained
from participants, even if they cannot write their names. The authors also
suggest that documentation of legal consent is to cover the institution, not to
provide additional protection for the research participant. Similarly, White (2007)
agrees that the waiver is useful to accommodate minimal risk research projects,
as most social behavioral research represent; however, some human research
protection programs are reluctant to utilize such provisions as the waiver of
signed documentation in the protocol review and approval process.
Agreeing with some of the criticisms of social science researchers, the
NBAC in 2001 criticized Institutional Review Boards for being grossly
overwhelmed by tremendous workloads, scarce resources, and by a regulatory
system that routinely distracts from, rather than focuses on more relevant and
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important ethical issues. Criticisms by researchers of the practices of their IRB
have appeared repeatedly in the literature for the last four decades as
documented by the authors cited. The NBAC (2001) suggest that federal
regulators‘ emphasis on procedure and documentation as contributing factors for
the creation of a climate of hostility and noncompliance in which the review of
research becomes an exercise in avoiding sanctions and liability rather than in
maintaining appropriate ethical standards and protecting human research
participants.
De Vries et al. (2004); Gunsalus et al. (2004); and Wax (2000) also
suggests that IRBs may be overly zealous in their interpretation and application
of federal guidelines for conducting research with human subjects, exacerbating
the challenges faced by social science researchers seeking IRB approval for
their research projects. Professor of anthropology, Murray Wax, in his testimony
before President Clinton's National Bioethics Advisory Commission stated:
The gravest ethical problem facing the people
studied by anthropological research is posed by
unknowing and overzealous IRBs and by
governmental regulators attempting to force
qualitative ethnographic studies into a biomedical
mold (NBAC, 2000, p. 95).
White (2007) suggests that patterns of noncompliance and litigation are
not seen in social science research as in biomedical or clinical research. He
suggests that applying similar rules of biomedical research, with no subject being
harmed, amounts to IRB mission creep. White further suggests that mission
creep is due to OHRP‘s oversight based in the need for documented
administrative procedures, not explicit unethical researcher implementation of the
22

research project. Gunsalus et al. (2007) refers to mission creep as detailed in the
Illinois White Paper, Improving the System for Protecting Human Subjects:
Counteracting IRB “Mission Creep” as a crisis being caused by the increased
workload for IRBs and HRPP‘s inability to handle the workload effectively.
Therefore, the emphasis is placed on the less difficult path of focusing more on
procedures and documentation rather than difficult ethical issues presented in
research studies.
Gunsalus et al. suggest that the institutions‘ efforts to comply with federal
requirements, even when research is minimal risk, amounts to exaggerated
precautions to protect against program shutdowns, and efforts to protect the
institution and institutional review boards against lawsuits. The concerns of social
science researchers of overregulation and mission creep, permeates the
literature. These concerns have given impetus to investigate the impact of
regulating social science research with biomedical regulations.
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Research Problem
The literature supports the premise of protecting research participants
from the risks and harms of research. Regulatory policy has provided guidelines
to ensure research risk is minimized, although it is widely perceived that the
system of human research protection needs improvement. The literature has
consistently revealed social scientists‘ concern of regulating social science
research using research standards assembled from for biomedical research
practices. The Common Rule in its application to social science research, social
scientists suggests, result in overregulation and mission creep.
The research problem is to test the critical assessment of the Common
Rule‘s impact of applying biomedical research standards for minimal risk social
science research.
Research Questions
The research questions for this study include the following:
1. What are the findings of deficiencies and findings of
noncompliance indicated in OHRP determination letters (DL) for
social science research projects?
2. What impact does the Common Rule have on social science
research protocol review by human research protection
programs?
3. Has the Common Rule achieved its intended purpose of
protecting human research subjects participating in social
science research?
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Research Method
Data collection and analysis include three research methods
1. Content analysis of public documents (determination letters)
issued by the Office of Human Research Protection;
2. In-depth interviews of human research protection program
administrators; and
3. Policy evaluation of Federal Policy 45 CFR 46, Subpart A, the
Common Rule.
Content Analysis
Gathering and analyzing documents that are produced in the course of
everyday events is what Marshall & Rossman (1999) proposes as unobtrusive
research. Babbie (2004) suggests unobtrusive research is a method of studying
social behavior without affecting it. Bogden & Biken (2003, p. 128) suggests that
external documents like those available to the public are more effective for the
researcher if it is known who produced the documents and for what reason they
were produced. Having this knowledge can better place documents in social
context. Babbie (2004) further suggests that content analysis is used to study
human communication that has been recorded. He provides as an example,
letters. Letters are documents well suited to content analysis, giving the
researcher the ability to answer: "Who says what, to whom, why, how, and with
what effect (p. 314).
Qualitative content analysis method is used to analyze OHRP public
documents (determination letters). The goal of content analysis is to provide
25

knowledge and understanding of the phenomenon (Weber, 1990). Weber
additionally suggests that qualitative content analysis is one of many research
methods used to analyze text data and that it can be used to examine and
classify large amounts of text into efficient number of categories. Qualitative
content analysis is the study of human communications in the forms art, songs,
collections and a host of categories of texts such as newspapers, books, letters,
speeches (Weber 1990).
Cavanagh (1997) suggests that researchers find content analysis a
flexible method for analyzing text data. Conversely, Tesch (1991) suggests that
the flexibility that has made content analysis useful on one hand provides
constraints to a firm definition of procedures resulting in limited application of
content analysis. Whereas, Weber (1990) suggest, the specific type of content
analysis approach used by the researcher depends on the theoretical and
substantive interests and the problem being studied by the researcher.
Additionally, Holsti (1969, p. 608) legitimizes the methods of content analysis as
a ―technique for making inferences by systematically and objectively identifying
special characteristics of messages." Thus, content analysis is reasonable
method for conducting inquiry (Weber, 1990; Babbie, 2004; Holsti, 1969; Lincoln
& Guba, 2000).
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In-Depth Interviews
In-depth interviewing is a qualitative research technique that involves
conducting individual interviews with a small number of respondents to explore
their perspectives on a particular idea, program, or situation (Boyce & Neale,
2006). The authors suggest that in-depth interviews are useful when detailed
information about a person‘s experiences and behaviors are sought (p. 3).
Additionally, Boyce & Neale (2006) and Patton (2002) suggest that in-depth
interviews are used to provide context to other data to assist in providing
additional information to complete the picture of what is happening in a particular
phenomenon. Marshall & Rossman, 1999 suggest that in-depth interviewing
may be the overall research method or one of several methods used in a study
and the researcher must understand the advantages as well as disadvantages to
in-depth interviewing.
The purpose of the in-depth interviews implemented in this study is to
better comprehend HRPP administrators experiences in applying the tenets of
the Common Rule to minimal risk social science research. Marshall and
Rossman suggest that in-depth interviews are like conversations that ―uncover
the participants views but otherwise respects how the participant frames and
structures the responses" (p. 108). Although some systematization may be
necessary to guide the questioning, it is the participant‘s perspective of the
phenomenon of interests that should become apparent as the interview unfolds
(Marshall & Rossman, 1999). In-depth interviews allow the researcher to
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investigate complex topics and allow for ideas to emerge that have not been
predetermined by the researcher (Berg, 2006; Denzin & Lincoln, 2005).
Policy Evaluation
Torgerson (1985) and Shapiro & Schroeder (2008) identify Lasswell as
the founder of the policy science field. Lasswell, defined policy science
orientation utilizing three characteristics (1) a multi- disciplinary approach, (2)
problem oriented focus that is contextual in nature and (3) and explicitly
normative orientation. These characteristics provide the additional framework of
foundation to utilize Fischer‘s interrelated discourses for policy evaluation
In Fischer‘s Four Discourses of Policy Evaluation, Fischer (1995) suggest
that regardless if one seeks to document accomplishments of a policy or criticize
its failures, policy evaluation has emerged as an important component of the
policymaking process in American government. Bryne (1987) and Fischer (1995)
suggest that policy analysis asks the question of whether or not a policy
accomplishes its stated purposes. Fischer (2003) posits that policy evaluation
can also take the form of cost benefit analysis. He suggests that the logic of costbenefit analysis involves a compilation of costs and benefits of a policy to
determine its net value. Although, he suggests that cost-benefit analysis has
been the subject of theoretical and practical disagreement because of its difficulty
in quantifying policy inputs and policy outputs. Fischer (2003) further suggests
that ―the technique systematically underplays social objectives that cannot easily
be measured in quantitative terms‖ (p. 116).
Utilizing Fischer's (1995) framework of practical informal logic of policy
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deliberation (which he uses synonymously with the ‗logic of policy evaluation‘),
this descriptive study is organized around the basic discursive components of
four interrelated discourses being viewed from a qualitative lens.


Technical/Analytic Discourse (Program Verification): does the
program empirically fulfill its stated objectives?



Contextual Discourse (Situational Validation [Objectives]): are the
program objectives relevant to the program situation?



Systems Discourse (Societal Vindication [Goals]): does the policy
goal have instrumental or contributive value for the society as a
whole?



Ideological Discourse (Social Choice [Values]): do the fundamental
ideas (or ideology) that organizes the accepted social order provide
a basis for a legitimate resolution of conflicting judgments?

Title 45 CFR 46, Subpart A, the Common Rule is the focus of policy evaluation
utilizing Fischer's Four Steps of Analysis.
Complementary Analysis Research Method Application (CARMA)
The literature suggest, Putney, Wink & Perkins (2006) originally
implemented Critical Action Research Matrix Application also called CARMA as
an inquiry tool to assess transparency of practices and the implementation of
classroom activities (p. 4). Putney suggest that CARMA can be used to evaluate
programs for their effectiveness as shown in Table 2). Jezierska (2009) in
collaboration with the principal author, Putney (2008) adapted the Critical Action
Research Matrix Application as the Complementary Analysis Research Method
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Application (CARMA) for use in policy assessment. It is Jezierska‘s work in
collaboration with Dr. Putney that lays the foundation for using the
Complementary Analysis Research Method Application tool to assess the
implementation and viability of the qualitative research method of analyzing the
Common Rule.
CARMA is a flexible and natural tool to assist in the analysis process of
the target populations intended to utilize the Common Rule and to assist the
researcher to perceive the tangential impact of the Common Rule on social
science and to identify elements of the Common Rule to support the tenets of
social science research. Using a four tier matrix including; 1) Policy Expectations;
2) Evident Implementation; 3) Results; 4) Recommendations, information is input
into the CARMA Matrix in combination with the framework of Fischer‘s Four
Discourses of Policy Evaluation to be analyzed. Putney (2008) suggests
flexibility of CARMA lends its evaluation technique to components of this
investigation.
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Table 2
Complementary Analysis Research Method Application (CARMA)
1
Determination
Letter
Expectations

2
Evident
Implementation

3
Results

NOTETAKING

NOTE-TAKING

NOTEMAKING

4
Conclusions/
Recommendation
s

NOTEREMAKING
Evaluator
Interpretations

Initiators

Users/
Participants

Compare/
Contrast
expected with
evident

Who is being
served?
Who is
involved?

Who are evident
participants?

Expected vs.
Evident

What are the
implications?
Modify or
maintain
program?

How are
participants to
be served?

How are
participants
using the
service?

Expected vs.
Evident

What are the
implications?
Modify or
maintain
program?

What will be
produced by
participants in
the program?

What was
produced by
participants in
the program?

Expected vs.
Evident

What are the
implications?
Modify or
maintain
program?
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Limitations of the Study
Researcher bias is a threat to the validity of conclusions drawn from the
data of this qualitative study. For nearly 10 years the researcher of this study has
served in the role of HRPP Administrator of a doctoral granting academic
research institution which conducts biomedical and social science research. In
addition the researcher has conducted social science research, having the
projects reviewed and approved by the IRB at a doctoral granting academic
research institution. Miles & Huberman (1994, p. 263) suggests that qualitative
data that fit the existing theory and preconception of the data selected and the
data that ―stand out‖ to the researcher is a threat to qualitative conclusions.
Although the researcher‘s theories, beliefs and perceptual lens can never
be fully eliminated, it is the explanation of the possible biases and how they will
be dealt with nonetheless that should be revealed in the study (Maxwell, 2005).
Berg and Smith (1988) puts forward that qualitative researchers have a
responsibility to science and their research participants which includes
examining and reexamining their studies for their connection with their research
as they ―formulate ideas, collect and interpret data and build theory‖ (p. 11). It is
with these understandings that the researcher pursues this study.
The additional limitations of this study are presented in a three pronged
methodological approach of 1) content analysis of determination letters, 2) indepth interviews of HRPP Administrators and 3) policy, analysis of the Common
Rule.
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Content analysis of determination letters: Tesch (1991) suggests
that the flexibility that has made content analysis useful on one
hand provides constraints to a firm definition of procedures
resulting in limited application of content analysis. Determination
letters most often address ethical violations and deficiencies of
federal agency funded research projects, whether biomedical or
social science research projects. A large portion of social science
research is unfunded. As the intent of the qualitative content
analysis is to identify determination letters applicable to the social
sciences which contain research violations or deficiencies, the
sample may be small and not generalizable.



In-depth Interviews: The limitation created by inclusive bias can
impact the analysis of the data. Inclusive bias occurs when samples
are selected for convenience. This type of bias is often a result of
convenience where samples tend to fit a narrow demographic
range. In this study HRPP Administrators are a narrow
demographic range. Inclusive bias samples do not present concern,
as long as the researcher is aware that the results cannot be
extrapolated to fit the entire population of that demographic.
Therefore the information extrapolated is not generalizable.



Evaluation of the Common Rule policy: Fischer (1995) suggests
that although the policy evaluation process may be narrowed to
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specific facets of the policy no absolute criterion exists to ensure
the position of the evaluation method.
The characteristics which limit and delimit the scope of this research
project and define its boundaries and serve to enhance the overall quality of the
data to be analyzed. These include the practice of OHRP in providing
determination letters to institutions and researchers in many disciplines. OHRP
regularly corresponds with hospitals, pharmaceuticals, medical teaching
institutions, academic institutions and others. Correspondence to academic
institutions from January 2000 to June 2010 is a delimitation to the study, I‘m
ready used to the exclusion of other agencies or institutions OHRP sends
determination letters. With the focus of this study concerned with social science
research projects, these projects can be found in greater numbers at doctoral,
profession dominant institutions (Doc/Prof).
The Carnegie Foundation classifies Doc/Prof institutions as those
institutions that award doctoral degrees in a range of fields such as education,
public policy, and social work. The institutions may also offer professional
education in law, and medicine11. Doc/Prof institutions are a delimitation to this
study. Therefore, some entities are omitted for the reason that they are not
directly relevant to this study. Furthermore, human research administrators are
recruited from academic institutions sent determination letters reviewed in this
study. An additional administrator is recruited from a DOC/Prof institution.

11

Carnegie classifications can be found at:
(http://classifications.carnegiefoundation.org/descriptions/grad_program.php )

34

Six HRPP administrators are selected for the study. All HRPP
administrators have more than five years training and experience in the human
research protections field of work and are considered to have adequate
knowledge of the tenets of the Common Rule. Over a five year period knowledge
gained from professional conferences and workshops, and day to day duties in
the role of HRPP administrator is considered adequate to garner understanding
of the Common Rule in its application to social science research.12 HRPP
administrators are selected due to their knowledge of the Common Rule by way
of their professional training, their consistent contact with social scientists and
social science research projects submitted to their HRPP to be reviewed and
approval by the IRB. HRPP administrators are obligated to pursue a course of
action in creating a culture of research compliance to assist the IRB by
developing institutional human research compliance policies based on the
policies of the Common Rule. HRPP administrators using the Common Rule as
the basis for their institutional policies, could reasonably be a population in which
the results of this study could be generalizable to the specific group.

12

The IRB Forum (at: http://irbforum.org) routinely post job positions for HRPP
Directors/Administrators that require five years or more experience to be considered for the
position. prior experience to be success.
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Definitions
Assurance: A formal written, binding commitment that is submitted to a
federal agency in which an institution agrees to comply with applicable
regulations governing research with human subjects and stipulates the
procedures through which compliance will be achieved, (Office of
Human Research Protection)
Behavioral and social science research: The Office of Behavioral and
Social Science Research13 defines behavioral and social research in
part as an assortment of methodological approaches including:
surveys and questionnaires, interviews, direct observation,
physiological manipulations and recording, descriptive methods,
laboratory and field experiments, standardized tests, economic
analyses, statistical modeling, ethnography, and evaluation. Social
science is used interchangeably with behavioral science.
Belmont Report: A statement of basic ethical principles governing
research involving human subjects, issued in 1978 by the National
Commission for the Protection of Human Subjects of Biomedical and
Behavioral Research.
Biomedical Science: ―the application of the principles of the natural
sciences to medicine‖ (Bankert & Amdur, 2006, p. 87)
Human Subjects: Individuals whose physiologic or behavioral
characteristics and responses are the object of study in a research
13

The Office of Behavioral and Social Sciences Research (OBSSR) established by Congress opened in
1995.
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project. The Federal Regulations define human subjects: living
individual(s) about whom an investigator conducting research obtains:
(1) data through intervention or interaction with the individual; or (2)
identifiable private information.
Informed Consent: A person's voluntary agreement, based on adequate
knowledge and understanding of relevant information, to participate in
research or to undergo a diagnostic, therapeutic, or preventive
procedure. In giving informed consent, subjects may not waive or
appear to waive any of their legal rights, or release or appear to
release the investigator, the sponsor, the institution or agents thereof
from liability for negligence (Amdur & Bankert, 2006).
Institutional Review Board (IRB): A specially constituted, federally
mandated review body established or designated by an entity to
protect the welfare of human subjects recruited to participate in
biomedical or behavioral research (Amdur & Bankert, 2006).
Minimal Risk: The Common Rule describes minimal risk as the probability
and magnitude of harm or discomfort anticipated in the proposed
research are not greater, in and of themselves, than those ordinarily
encountered in daily life or during the performance of routine physical
or psychological examinations or tests. For example, the risk of
drawing a small amount of blood from a healthy individual for research
purposes is no greater than the risk of doing so as part of routine
physical examination.
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Mission Creep: Defined by Gunsalus et al. (2007) as the result of the
workload of IRBs that has expanded ―beyond their ability to handle
effectively.‖ Mission creep they suggest is caused by ―rewarding wrong
behaviors, such as focusing more on procedures and documentation
than difficult ethical questions; unclear definitions, which lead to
unclear responsibilities; efforts to comply with unwieldy federal
requirements even when research is not federally funded; exaggerated
precautions to protect against program shutdowns; and efforts to
protect against lawsuits (p. 2).
Protocol: The formal design or plan of an experiment or research activity;
specifically, the plan submitted to an IRB for review and to an agency
for research support. The protocol includes a description of the
research design or methodology to be employed, the eligibility
requirements for prospective subjects and controls, the treatment
regimen(s), and the proposed methods of analysis that will be
performed on the collected data.
Research: A systematic investigation (i.e., the gathering and analysis of
information) designed to develop or contribute to generalizable
knowledge (the Common Rule).
Risk: The probability of harm or injury (physical, psychological, social, or
economic) occurring as a result of participation in a research study.
Both the probability and magnitude of possible harm may vary from
minimal to significant. Federal Regulations define only "minimal risk."
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Social Science: Branches of social science include anthropology;
economics; education; geography; history; law; linguistics; political
science; public administration; psychology; sociology (Rule, 1997).
Significance of the Study
The significance of the study is to provide increased knowledge of the
impact of the Common Rule for social science research. This study may ground
criticisms of a ―one-size-fits-all‖ regulatory policy (the Common Rule) as well as
determine the merit to the assertion. This study can provide the basis for
additional research to recommend policy changes as a result of the findings of
this study for more adaptable regulatory standards for social science research.
Additionally, the study can provide a foundation for further research in the area of
human research protection policy for federal agencies and academic research
institutions. This research is needed to assess public documents held by the
regulating authority OHRP and associated with their determination and findings
of social science research projects. HRPP Administrative Administrators‘
assessment of utilizing a biomedical human research approach to evaluate the
ethicality of social science research regulatory standards provide insight to the
criticism of overregulation and mission creep. Finally this study can assist in
better clarification of the Common Rule's applicability to and impact on social
science research.
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Summary
The Introduction of this study provides the historical framework of human
subject research and human research protections from 6 B.C. to the present. The
research problem of the study suggests there is a need to test the critical
assessment of the Common Rule in its application to the social science research.
The research questions of 1) what are the findings of deficiencies and findings of
noncompliance indicated in OHRP determination letters (DL) for social science
research projects, 2) what impact does the Common Rule have on social
science research protocol review by human research protection programs,
and 3) has the Common Rule achieved its intended purpose of protecting
human research subjects participating in social science research.
The methods used to address the research questions are, content analysis of
public documents, in-depth interviews of human research protection program
administrators and policy evaluation of Federal Policy 45 CFR 46, Subpart A
using Fischer‘s (1994) Four Discourses of Public Policy Evaluation, and Putney‘s
(2008) Complementary Analysis Research Method Application.
The study includes a small sample size of HRPP directors which is not
generalizable to an entire population but could be generalizable to the specific
population of HRPP Directors, and researcher bias. Researchers suggest having
social science research viewed through the regulatory eyes of biomedical
expectations of risks has implications of unnecessary time barriers and cost to
researchers, high workload for IRBs and their administrative support staff, as well
as offering little if any additional protection for research subjects of behavioral
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research14. The significance of the study is to provide increased knowledge of the
impact of the Common Rule for social science research. Additionally, the study
can provide a foundation for further research in the area of human research
protection policy for federal agencies and academic research institutions.
This research is needed to assess public documents held by the
regulating authority OHRP, as they are related to the determination and findings
of social science research projects. HRPP Administrators‘ assessments of
utilizing a biomedical human research approach to evaluate the ethicality of
social science research regulatory standards are assessed. Finally this study can
assist in better clarification of the Common Rule's applicability to and impact on
social science research.
Although there has been much anecdotal comment in the literature on the
topic of the application of a one-size-fits-all approach to regulating social science
research with biomedical regulations, it is not apparent in the literature that
empirical research has been conducted to substantiate the regulatory premise
that social science research participants are better protected as a result of the
one- size- fits-all Common Rule.

14

The Illinois White Paper out of the Center for Advanced Study at the University of Illinois at UrbanaChampaign resulted in much controversy of IRB‘s and mission creep ,see Gunsalus, 2005.
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Chapter 2
Review of Literature
This Chapter presents a review of the literature related to social scientists‘
concerns of what in the literature is called over-regulation and mission creep in
its application to the Common Rule. The Chapter will document the historical
perspectives of unethical human experimentation as well as the regulatory
standards put in place to protect human subjects. In addition, the Chapter will
discuss prior research related to researcher and institutional human research
compliance while outlining the necessity to investigate the impact of social
science research that is regulated by a medical model of human research
protections.
Gunsalus et al. (2007) puts forward that ―IRBs blizzard of paperwork is
getting in the way of the fundamental mission: to protect the dignity and wellbeing of human subjects‖ (p. 4). Institutional Review Board (IRB) workloads have
expanded beyond their ability to handle, due to focusing much more on
procedures and documentation, unclear definitions, leading to unclear
responsibilities and efforts to comply with the standards of human research
requirements even when research is not federally funded (Schrag, 2009, Lincoln
& Tierney, 2002).
The overzealous responses and exaggerated precautions to protect
against program shutdowns and lawsuits is what Gunsalus et al. have referred to
as mission creep. Shweder (2006) posits that projects that are not federally
funded and ―are not mandated for IRB review are under the federal surveillance
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system‖ by IRBs (p. 507). Moreover, the increased scrutiny indirectly ―generates
a bias favoring overregulation or mission creep‖ (p. 515).
The concerns of social science researchers reflect the premise of
overregulation. Gunsalus et al. suggests that:
Without any systematic data or evidence of a problem, or
even a thoughtful analysis of costs and benefits, the
application of the human participant review system within
universities is overreaching at the same time that some risky
experimentation on humans outside of universities is
unregulated… In too many cases, the focus is on form over
ethical substance: counting what can be counted, rather than
focusing instead on what counts. Some disciplines—oral
history and journalism, for example—simply do not belong
within the scope of institutional review board jurisdiction.
Others, such as survey research, informational interviews,
and informal interactions, call for a shift from centralized
review to more departmentally based (i.e., rooted in
disciplinary ethics) oversight, and clearer guidelines on what
requires advance review as opposed to provision of post hoc
complaint systems.
Fox (1994), Faden & Beauchamp (1986), and Schrag (2009) concur with
Gunsalus (2007) in his interpretation of the concerns related to overregulation.
Although substantial social benefits have been produced by scientific research, it
has also posed troubling ethical issues of noncompliance and deficiencies
(Oakes, 2002; Jones, 1993; Edwards & Mauther, 2002; Dubois, 2008). Medical
research has presented an abundance of physical and ethical risks to human
subjects (Dubois, 2008; Advisory Committee on Human Radiation Experiments,
1995; Ashcroft & Kirchin, 2004). To address the physical and ethical violations
once seen in medical research the regulatory standards by which appointed
Institutional Review Boards review, approve and oversee human research is the
Common Rule (Alvino, 2003; Schrag, 2009).
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Aita & Richer (2005) suggests that the foundations of research ethics has
been a result of the biomedical and social sciences fields, saying that the ―ethical
principles related to human subjects‘ well-being emerged mostly with biomedical
research while issues related to human rights are from the social sciences‖ (p.
120). Although there is little question that those involved in social science
research do not want the human rights of their research participants abdicated
and that there must be protections against unethical research, social scientists
have found that utilizing the current biomedical system of human research
protections result in incongruence of the application of biomedical regulations for
social science research projects (Gunsalus et al., 2004; Braxton & Bayer, 1994;
De Vries et al., 2004).
Social science researchers characterize their concerns as overregulation
and mission creep resulting from the application of a regulatory process created
for medical research being applied to non-invasive and minimal risk social
science research, that usually is unfunded or privately funded (Oakes, 2002;
Gunsalus et al., 2007). The authors suggest the premise of overregulation put
forward by social science researchers, lays foundation for inquiry of regulating
behavioral science research with biomedical science regulatory standards.
Gunsalus et al. (2007) suggest the result human research overregulation
can and do result in unintended consequences for the researcher and their
institution‘s human research protection program (HRPP). Social science
researchers express increased concern of overregulation and mission creep,
putting forth that increased documentation requirements by HRPPs appears to
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have no additional protections for human participants of social science research,
but serve to delay and even deny research projects (Gunsalus et al., 2007;
White, 2007; Candilis et al., 2006; Coleman, 2004).
To better understand the impetus for the emergence of Federal
Regulations to protect human research participants, historical perspectives on
human experimentation are presented. The historical accounts of human
experimentation provide background for additional perspective of the ethical
concerns involved in human experimentation and research regulation in the
United States. The majority of social science researchers‘ concerns focused on
overregulation and mission creep suggests the need to evaluate the impact of
the Common Rule on social science research. The review of literature applicable
to this study include the following topics:


Historical Perspectives on Unethical Human Experimentation



Protecting Human Subjects with Regulatory Standards



Berlin Code



Nuremberg Code



Declaration of Helsinki



Belmont Report



Common Rule



National Commission for the Protection of Human Subjects of
Biomedical and Behavioral Research



National Bioethics Advisory Commission



Office of Human Research Protection (OHRP)
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Determination Letters


Human Research Protection Program (HRPP)
Institutional Review Boards (IRB)
IRB Administrative IRB Support Staff



Social Science Research



Overregulation/ Mission Creep



Intent and Impact of Policy

Historical Perspectives of Unethical Human Experimentation
Throughout the centuries human experimentation has been constant, as
shown in Table 3. Human experimentation in the eighteenth century included
regular offers of free pardon to inmates to participate in human experiments
(Sade, 2003). One such experiment included the inoculation of prisoners with
infectious smallpox in variolation experimentation (Morgan & Parker, 2007).
Variolation was a method of immunizing humans against smallpox by infecting
them with the pustules of infected human subjects. The method was popularized
in England in 1721-1722.
In America, Cotton Mather (1663-1728) used variolation experimental
method on slaves (Washington, 2006, p. 72). Selgelid (2003) suggests that in
1900 as scientific information expanded, questions of unethical medical research
practices emerged with regularity. In Berlin, Germany, the medical practice of
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Table 3
Historical Events in Unethical Human Experimentation
Date
1796
18451849
1900

19191922
19321972

1939-45
1940‘s

19441980

19561980

Event
Edward Jenner injects healthy eight-year-old first with cowpox then three
months later with smallpox and is hailed as discoverer of smallpox vaccine
J. Marion Sims, "the father of gynecology" performed multiple experimental
surgeries on enslaved African women without the benefit of anesthesia. After
suffering unimaginable pain, many lost their lives to infection
Walter Reed injects 22 Spanish immigrant workers in Cuba with the agent for
yellow fever paying them $100 if they survive and $200 if they contract the
disease
Walter Reed injects 22 Spanish immigrant workers in Cuba with the agent for
yellow fever paying them $100 if they survive and $200 if they contract the
disease
The Tuskegee Syphilis Study, sponsored by the U.S. Department of Health.
Studied the effects of untreated syphilis in 400 African American men.
Researchers withheld treatment even when penicillin became widely available.
Researchers did not tell the subjects that they were in an experiment. Most
subjects who attended the Tuskegee clinic thought they were getting treatment
for "bad blood."
German scientists conduct research on concentration camp prisoners.
Chicago doctors infect nearly 400 prisoners with Malaria to develop new drugs
to fight the disease during World War II. I
Inmates given general information that they were helping with the war effort, but
not informed about the nature of the experiment. Nazi doctors on trial at
Nuremberg cited the Chicago studies as precedents to defend their own
research aimed at aiding the German war effort
The U.S. government sponsors secret research on the effects of radiation on
human beings. Subjects were not told that they were participated in the
experiments. Experiments were conducted on cancer patients, pregnant women,
and military personnel
Saul Krugman, Joan Giles and other researchers conduct hepatitis experiments
on mentally disabled children at The Willowbrook State School. They
intentionally infected subjects with the disease and observed its natural
progression. The experiments were approved by the New York Department of
Health
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Table 3
Historical Events in Unethical Human Experimentation (continued)
19501963
1972

1982

1992

1994
1999

1999
2001
2001

2004

The CIA begins a mind control research program, which includes administering
LSD to unwitting subjects.
Stanley Milgram conducts his "electric shock" experiments, which proved that
many people are willing to do things that they consider to be morally wrong
when following the orders of an authority. He publishes Obedience to Authority
in 1974
William Broad and Nicholas Wade publish Betrayers of Truth, claiming that there
is more misconduct in science than researchers want to admit. Their book helps
to launch an era of "fraud busting" in science
National Academy of Science publishes Responsible Science: Ensuring the
Integrity of the Research Process. The book estimates the incidence of
misconduct, discusses some of the causes of misconduct, proposes a definition
of misconduct, and recommends some strategies for preventing misconduct
The Clinton Administration declassifies information about secret human radiation
experiments conducted from the 1940s-1980s and issues an apology
Jessie Gelsinger dies in a human gene therapy experiment at the University of
Pennsylvania. The event triggers heightened scrutiny of conflicts of interest in
human subjects research, including institutional conflicts of interest. Penn settles
with the Gelsinger family for an undisclosed amount of money
Administrator of National Institute of Mental Health suspends 29 clinical trials
that failed to meet either ethical or scientific standards
Ellen Roche, a healthy 27-year old volunteer, dies in study at Johns Hopkins
University in Baltimore, Maryland.
Maryland Court of Appeals renders a landmark decision affirming "best interest
of the individual child" as a standard for medical research involving children. The
Court unequivocally prohibited nontherapeutic experimentation on children.
(Higgins and Grimes v. Kennedy Krieger Institute).The case involved exposure
of babies and small children to lead poisoning in EPA funded experiment.
(http://www.courts.state.md.us/opinions/coa/2001/128a00.pdf)
Liem Scheff authors article on AIDS research project of ―Guinea Pig Kids‖ toxic
drugs given to NY Black, Hispanic and poor orphans. The orphan children
become subjects of drug trials sponsored by National Institute of Allergies and
Infectious Disease, a division of the NIH, the National Institute of Child Health
and Human Development in conjunction with some of the world‘s largest
pharmaceutical companies – GlaxoSmithKline, Pfizer, Genentech,
Chiron/Biocine and others.

Sources: Human Experiments: A Chronology of Human Research by Vera Hassner Sharav
http://www.ahrp.org/history/chronology.php, Research Ethics Timeline (1932-2004) by David B.
Resnik, JD, PhD http://www.niehs.nih.gov/research/resources/bioethics/timeline.cfm. Table does
not represent an exhaustive list of unethical human experimentation.
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injecting prostitutes with serum from patients recovering from syphilis, with the
belief that the protocol was a discovery for the cure of syphilis, laid grounds for
public outrage as an immeasurable epidemic among prostitutes and their
customers and partners surfaced (Gibelman & Gelman, 2001; Vollman & Winau,
1996).
Despite public concern of unethical research practices questionable
research practices continued. The 1920s and 1930s revealed physicians‘ acts of
routinely sterilizing Americans without their consent (Emanuel, 2002). Victoria
Nourse‘s work, In Reckless Hands examines the case of Skinner versus
Oklahoma (2008).15 Nourse details a history of America's experiment with
eugenics16 resulting in thousands of incarcerated men and women having been
sterilized. American ethicists at that time readily justified human research without
the protections of informed consent as unnecessary due to the need of
experimentation for the persons own therapy, experimentation for the good of
humanity in general, and experimentation to advance science (Vollman & Winau,
1996).
American human research practices during the 1920s and 1930s would
prove to be ambiguous in the effort to attain ethical research standards arising
from the uncertainty of using experimental research methods for providing
medical therapy, protecting the rights and welfare of research subjects and
furthering scientific knowledge (Vanderpool, 1996; Moreno, 2000). Questionable
medical research practices continued to proliferate.
15

Skinner v. State of Oklahoma,1942, the United States Supreme Court ruling held that compulsory sterilization
could not be imposed as a punishment for a crime.
16
Eugenics is the study and practice of human selective breeding. The aim is to improve the species.
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The Willowbrook hepatitis studies and the Tuskegee Syphilis study remain
two of the United States most noted human research experiments failing to
―adequately protect human research participants‖ (DuBois, 2008, p. 14). The
Willowbrook hepatitis study carried out at the Willowbrook State Mental facility in
New York City began in 1963 and was halted in 1966 as a result of public uproar
(DuBois, 2008). Although the crowded mental institution had been closed to new
patients, parents that agreed to have their child participate in various medical
research studies were given placement for their child (Levine, 1988). The
experiment, conducted on otherwise healthy children ―deliberately infected with
the hepatitis virus, fed stool from infected individuals … and received injections
from more purified virus preparations‖ (Levine, p. 70). Researchers defended the
studies, suggesting that the children would become infected in the hospital
anyway, and by being in the study the children would have better care in ―wellstaffed‖ units that would protect the children from more harmful infectious
diseases (Beauchamp & Childress, 2001, p. 428).
The 40 year Tuskegee Study of Untreated Syphilis in the Negro Male
(1932-1972) is substantiated as the longest nontherapeutic experiment on
human beings in history (Heintzelman, 2003; Vanderpool, 1996; Washington,
2006). Jones (1981, p. 179) notes that when John Heller , U.S. Public Health
Service Administrator was questioned about the ethical obligation on the part of
the Public Health Service toward the participants in the syphilis study he stated
that ―The men‘s status did not warrant ethical debate. They were subjects, not
patients, clinical material, not sick people.‖
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Washington (2006); Oakes (2002); DuBois (2008); Caplan (1992) suggests
the Tuskegee Study is considered by human scientists as one of the pivotal events
leading to the regulation of human research in the United States. Emanuel (2002)
posits that the Tuskegee Study led directly to the appointment of a National
Commission for the Protection of Human Subjects of Biomedical and Behavioral
Research in 1974. As a result of the work of the Commission, it was required that
all federal funded studies using human subjects to be reviewed by an institutional
review board (Jones, 1993; Iltis, Matsuo, & DeVader, 2008).
In 1997 President Clinton encouraged federal human research protections
programs to be extended to all Americans. The president stated that "science
must respect the dignity of every American. We must never allow our citizens to
be unwitting guinea pigs in scientific experiments" (NBAC, 2001, p. 145).
Protecting Human Subjects Using Regulatory Standards
Early human research regulation focused on medical experimentation.
The Berlin Code of 1900, one of the earliest documents to address the outrage of
medical research and its unethical practices in general and more specifically the
outrage of the Berlin prostitute syphilis research (Harnett, 2004; Annas & Grodin,
1992; Vollman & Winau, 1996). Murders, brutalities, tortures, and other inhuman
acts were carried out daily as a result of Nazi medical experiments on World War
II prisoners, on gypsies, the mentally disabled, and others (Washington, 2006;
Jones, 1993; Baumrind, 1971). Although the Code was in place, continued
accounts of human experimentation by world famous and revered Nazi doctors
forced the medical community, courts, and the public to consider additional
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protections for human subjects (Oakes 2002; Harnett & Neuman, 2009).
Nuremberg Trials
After WW II, the Nuremberg Medical Trials (October, 1946 until August
1947) resulted in twenty-three German physicians and scientists being convicted
of performing vile and potentially lethal medical experiments on concentration
camps inmates and other living human subjects between 1933 and 1945. Due to
the trials, the Nuremberg Code was established as a set of ethical research
principles. The Code includes principles of informed consent and condemns
coercion, as well as it promotes that the study must be a properly formulated
scientific experiment, and must include beneficence toward experiment
participants. The elements of the Nuremberg Code include that: The voluntary
consent of the human subject is absolutely essential.


The experiment should be so designed and based on the results
of animal experimentation and knowledge of the natural history
of the disease or other problem under study that the anticipated
results will justify the performance of the experiment.



The experiment should be so conducted as to avoid all
unnecessary physical and mental suffering and injury.



The degree of risk to be taken should never exceed that
determined by the humanitarian importance of the problem to be
solved by the experiment.



Proper preparations should be made and adequate facilities
provided to protect the experimental subject against even
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remote possibilities of injury, disability, or death.


The experiment should be conducted only by scientifically
qualified persons. The highest degree of skill and care should
be required through all stages of the experiment of those who
conduct or engage in the experiment. A complete list of the
Code is found at Appendix H

Although the legal force of the Nuremberg Code was not established, and
the document was not incorporated directly into either American or German law,
the Nuremberg Code and related Declaration of Helsinki are the basis for the
Code of Federal Regulations, Title 45 Subpart 46 (45 CFR 46). The Federal
Regulations were issued by the United States Department of Health and Human
Services which governs federally funded research in the United States.
Oakes (2002) acknowledges, although forty-two doctors were indicted,
resulting from the Nuremberg Trials, the majority of American medical
researchers did not find the unethical treatment of human subjects appalling
(Rothman, 1995). Oakes points out that during that time Americans believed ―its
physician-researchers acted in accordance with their Hippocratic Oath and that
voluntary consent was unnecessary in a society with a long and untarnished
history of medical research‖ (p. 444). The similar contention was pervasive
among American physician-researchers.

53

Declaration of Helsinki
The Declaration of Helsinki (Declaration) of 1964, revised in 1975, was
developed by the World Medical Association (WMA), as a set of ethical principles
for the medical research community regarding human experimentation. Although
the WMA developed the Declaration for the medical community it encourages
other researchers conducting medical research to adopt the principles. The
Declaration is not a legally binding instrument in international law, instead, draws
its authority from the degree to which it has been codified in, or influenced in
national or regional legislation and regulations (Dubois, 2008). There have been
eight amendments to the Declaration.
Belmont Report: An Ethical Foundation
The National Commission for the Protection of Human Research Subjects
task was to consider:


the boundaries between biomedical and behavioral research
and be accepted and routine practice of medicine;



the role of assessing risks criteria in the determination of the
appropriateness of research involving human subjects;



appropriate guidelines for the selection of human subjects for
dissipation in such research;



the nature and definition of informed consent in various
research setting.

The tasks resulted in the Belmont Report. The statement of basic ethical
principles and guidelines to assist in resolving ethical problems related to the
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conduct of research with human subjects laid another foundation for protection of
research subjects. The tenets of the Belmont report include three fundamental
principles: respect for persons, beneficence, and justice as shown in Table 4.
The Belmont report is the guiding document of ethical framework for
protecting human subjects in the United States (NBAC, 2001).
The Common Rule and Social Science
Williams‘ (2005) Congress of Research Service Report (CRS) suggests
that the Common Rule was designed with a focus on biomedical research, and
submits that most social science researchers have questioned whether the
Common Rule should apply to social science research. ―These regulatory
concerns voiced by those in the social science community have focused primarily
on the impact of the Common Rule‖ (p. 24). CRS suggest that social science
research researchers ―have expressed a desire to have regulations regarding
their research carved out from the Common Rule‖ (p. 24) noting that social
science researcher, Joan S. Sieber‘s presentation ―Social and Behavioral
Research with Human Subjects: Key Issues for SACHRP17 and OHRP to
Consider‖18 represented the sentiments of an overwhelming number of social
science researchers in their concerns of biomedical regulatory standards being
applicable to social science research.

17

In July 2004, Secretary’s Advisory Committee on Human Research Protections (SACHRP) heard a
series of presentations on protecting human subjects in Social Science Research. Presenters raised
concerns for having regulations for social science separate from biomedical research regulations. Joan
Sieber, an esteemed social science researcher, represented the views of her colleagues.
18
Presentation to the U.S. Secretary’s Advisory Committee on Human Research Protections, Washington,
D.C., Aug. 8, 2004.
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Table 4
Key Concepts of the Belmont Report
Principle

Application

Respect for Persons:
Informed consent:
Individuals should be
Subjects, to the degree that they are
treated as autonomous
capable, must be given the opportunity to
agents • Persons with
choose what shall or shall not happen to
diminished autonomy are
them. The consent process must include
entitled to protection
three elements: information,
comprehension, and voluntariness
Beneficence:
Human subjects should
not be harmed.
Research should
maximize possible
benefits and minimize
possible harms

Assessment of risks and benefits:
The nature and scope of risks and benefits
must be assessed in a systematic manner

Justice:
The benefits and risks of
research must be
distributed fairly

Selection of subjects:
There must be fair procedures and
outcomes in the selection of research
subjects
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The CRS suggest that IRBs are assembled with biomedical expertise, and
a review process focused on that research may not be well suited to review
social science research. Social science researchers argue that unnecessary
delays in the review and approval of their protocols are due to lack of familiarity
with social science research (Oakes, 2002, Gunsalus, 2004). The CSR finds that
the IRB review process, in their use of the Common Rule as the standard of
regulatory compliance, often does not place protocols in the category acceptable
in the Common Rule. As an example, protocols exempt from IRB review are
often placed in the expedited category which then does require IRB approval,
costing unnecessary time for the researcher and unnecessary documentation for
the IRB. The report details that protocols are place in a higher category of risk
although the protocol would be ―commensurate with the protocols‘ level‖ and type
of risk described in the Common Rule. Williams (2005) suggest that ―risk may be
physical in biomedical research but is usually limited to the areas of
confidentiality and privacy for social science research‖ (p. 24).
In concurrence with, the CRS Report (2005); Oakes (2002); Bosk (1998);
and Gunsalus (2004) suggest that IRBs‘ requirements for obtaining informed
consent in social science research are overly cumbersome and ineffective due to
the consent process required by the Common Rule. The process of consenting
as illuminated in the Common Rule focuses on ―documenting consent instead of
ensuring informed, voluntary decision making‖ (CRS, p. 24). In spite of long held
concerns of the Common Rule, Federal agencies, many which conduct only
social science research, have adopted Subpart A (see Appendix L).
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The Common Rule, adopted by 16 federal departments and agencies in
1991 is currently the regulatory framework for protecting human subjects for 17
federal agencies. It requires all federally funded research conducted by any of
the 17 federal agencies as shown in Table 5 to be reviewed by an institutional
review board. Although, the Common Rule is not required to be the regulatory
standard of human research protection for nonfederal funded research, human
research protection programs at academic institutions have opted to apply the
Common Rule also to research that is not federally funded (Oakes, 2004,
Gunsalus, 2007, Williams, 2005).
The Common Rule, developed in response to recommendations made by
the President's Commission for the Study of Ethical Problems in Medicine and
Biomedical and Behavioral Research in 1981(Presidents Commission) called for
the adoption by all federal agencies of the Department of Health and Human
Services. Until 1991, federal departments and agencies that conduct, support, or
regulate research used a variety of policies and procedures to protect human
research subjects. To promote uniformity of the rules applicable to human
research subjects, each of the 17 departments and agencies, as shown in Table
5, adopted as regulation, a common Federal Policy for the protection of human
research subjects (NBAC, 2001, p. 5).
Gordon (2003) suggests that significant revisions have been made to the
Common Rule. These revisions have been primarily under the supervision of the
National Bioethics Advisory Commission (NBAC). Gordon posits that the NBAC
(2001) proposed various suggestions to strengthen the protection of humans
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Table 5
Federal Agencies Subject to the Common Rule
1. Social Security Administration
2. Central intelligence agency
3. Consumer Product Safety
4. Department of Agriculture
5. Department of Commerce
6. Department of Defense
7. Department of Education
8. Department of Energy
9. Department of Health and Human Services
10. Department of Housing and Urban Development
11. Department of Justice
12. Department of Transportation
13. Department of Veterans Affairs
14. Environmental Protection Agency
15. National Aeronautics and Space Administration
16. National Science Foundation
17. Office of Science and Technology Policy
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participating in research but the suggestions did not apply or translate well to
social science research. Social science researches commonly perceive the
current and proposed human subjects regulations as impediments to research
(Gordon, 2003).
The Common Rule‘s focus on concerns of risk from a biomedical
viewpoint makes it difficult to apply the rules to social science research, Gordon
suggests. However, the Common Rule does provide revisions for research that
poses minimal risk. As such, the Common Rule states that minimal risks are
those that are ordinarily encountered in daily life. Gunsalus (2006), and Gordon
(2003) are among those who suggest, although minimal risk research is eligible
for exemption according to the Common Rule, the general trend for IRBs is to
incorporate a level of perceived risk. The perceived risk assessment most often
calls for additional explanatory documentation, adding additional time to the
review and approval process for the researchers, IRB's and their administrative
support staff.
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Office of Human Research Protection
The Office for Human Research Protections (OHRP) is an agency of
DHHS, that provides leadership and oversight for the protection of the rights,
welfare, and wellbeing of subjects involved in research conducted or supported
by the United States Department of Health and Human Services (DHHS) (Oakes,
2002, Burris & Welsh, Borror et al., 2003). Prior to 2000 OHRP was called the
Office for the Protection of Research Risk (OPRR), at that time an agency under
The Office Of Extramural Research in the National Institute of Health (NIH).
In 2000 OHRP was relocated from under NIH to the Office of Public
Health and Science within the Office of The Secretary of the Department of
Health and Human Services (DHHS). Amdur & Bankert (2002, p. 27) suggest
that the administrative location of OHRP was changed to eliminate what could be
viewed as a conflict of interest in which the research regulatory office reported to
the administrator of an agency having research duties as their primary mission.
―The status of the OHRP Administrator was upgraded to the Senior Executives
Service, which is the highest level of nonpolitical civil servant‖ (p. 28). OHRP‘s
mission continues to be toward providing clarification and guidance to institutions
and researchers, by maintaining regulatory oversight, providing advice related to
ethical and regulatory issues in biomedical and behavioral research and
developing educational programs and materials.
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The Federalwide Assurance
The OHRP establishes a contract with institutions called Federalwide
Assurance (FWA). The FWA (see Appendix N) establishes the standards by
which institutions are to conduct research. So that institutions may qualify to
receive federal funding for research, the institution must have a Federalwide
Assurance on file with the OHRP (45 CFR 46.103). The assurance requires that:


Each agency provide written assurance satisfactory to the
department or agency head that it will comply with the
requirements set forth in the policy,



The institution must have an approved assurance, and the
research must be approved by an IRB provided for in the
assurance and the research will be subject to continuing review
by the IRB.



Assurances applicable to federally funded support or conducted
research shall at minimum include a statement of principles
attesting to be the institutions responsibilities for protecting the
rights and welfare of human subjects. Despite whether the
research is subject to Federal Regulation designation of one or
more IRB's established within the requirements of 45 CFR 46.



A list of IRB members identified by name, earned degrees,
representative capacity, indications of experience such as board
certifications and licenses etcetera, sufficient to describe each
member's chief anticipated contribution to IRB deliberations.
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Written procedures for which the IRB will follow for conducting
its initial and continuing review of research and for reporting its
findings and actions to the investigator an institution, for
determining which projects require review more often than
annually, and for ensuring prompt reporting to the IRB of
proposed changes in research activity.



Written procedures for ensuring prompt reporting to the IRB, the
appropriate institutional officials, and the department or agency
head of any unanticipated problems involving risk to subjects or
others, or any serious or continuing noncompliance, and any
suspension or termination of IRB approval.



Obtain written informed consent from research participants,
unless the written informed consent is waived by the IRB.



The institutional signatory official, the IRB chair, and the human
protections administrator must have adequate training.



Adequate educational and oversight mechanisms must be in
place for documenting the training of investigators.



The IRB must have adequate knowledge of local research
regulations.

Although an FWA is not required to conduct research that is not funded by
a federal agency, Cohen (2002, p. 313) suggests there are many institutions that
have elected to hold all research, even research that is not federally funded, to
the same standards of the Common Rule. Many social scientists consider this to
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be the impetus for institutional review boards to assert unnecessary regulation of
minimal risk research projects (White, 2007). Some institutions are have recently
revised their FWA to only include research that is federally funded to be
applicable to the Common Rule.
The FWA requires the institution to have a human protections
administrator. The administrator is an employee of the institution and serves as
an agent of the FWA exercising the day-to-day operations of the human research
protections program. In most cases the IRB human protections administrator is
also the Director of the institution‘s human research protection program and
supervisor of the HRPP staff. Cohen (2002) suggests that the human protections
administrator be extremely knowledgeable of the institutions systematic
protections for human subjects. In addition to the human protections
administrator, the FWA must also designate an Institutional Signatory Official
who has the legal authority to represent the institution named in the FWA. The
FWA ―formalizes‖ an institution's commitment to protect human subjects (Cohen,
2002).
The OHRP‘s Division of Compliance Oversight evaluates all written
substantive indications of noncompliance or deficiency of the institution or
researcher related to the Common Rule. OHRP requests the institution involved,
to investigate the allegations and to provide OHRP with a written report of its
investigation. OHRP then determines what, if any, regulatory action needs to be
taken to protect human research subjects19. However, the NBAC suggests that
19

OHRP provides information fact sheets to the public relation to their mission, duties and expectations
at: http://www.hhs.gov/ohrp/about/ohrpfactsheet.htm.
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OHRP takes the lead as a de facto reference point and consensus builder among
federal agencies although; it has no congressional or executive authority to do
so. Additionally, some agency departments have not established offices
comparable to OHRP for interpreting and implementing the regulations.
Oversight activities in most of these cases are the responsibility of a single
individual, therefore, ―the ability to coordinate oversight among the departments
is weak, leaving departments and agencies to interpret the Common Rule
potentially differently‖ (NBAC, 2001, p. 9).
Determination Letters
One of the available indicators of accounts of noncompliance and
deficiencies resulting in increase of risk to research participants, researcher
violation, IRB violations or institution violations is via the publicly available portal
maintained by OHRP. OHRP memorializes its findings of noncompliance and
deficiencies in determination letters sent to the institution for investigation. The
letters outline concerns of OHRP relating to an approved research project. The
project can be biomedical or social science research, and are usually federally
funded. OHRP does not regulate unfunded research unless the institution‘s FWA
document indicates that all research conducted at the institution will be under the
interpretation of the FWA. Many institutions have opted out of the FWA regulating
all research by unchecking the box on the form that previously indicated the FWA
would be subject to all research. Only federally funded research is then regulated
for those institutions.
The determination letters specifically outline what actions must be taken
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by the institution to return to, a compliant state, rectify a deficiency, or resume
research activity. The communication from OHRP to the institution is publicly
available. The letters have been routinely available to the public since 2000 on
the OHRP Internet portal. Sieber (2004) posits that OHRP‘s publicized
determination letters, and the costly sanctions handed down to a few institutions
and the negative publicity to the institution makes it understandable that IRBs
and research administrators have considered it in their self-interest to enact
highly conservative decisions. As an example, IRB‘s have the authority to waive
documentation of informed consent, but often neglect to do so although the
Common Rule offers such flexibility (White, 2007).
The Food and Drug administration (FDA) has a similar mechanism in
place called Warning Letters. The Warning Letter is issued when the FDA has
reason to believe deficiencies and or violations have been committed in an
approved research project. The letters are also considered voluntary action
letters. The voluntary action letters request voluntary correction of minor issue
and deficiencies found by OHRP. The process is usually ended when all
concerns raised in the letter has been addressed. Warning letters can and do
carry sanctions for the institution and the investigator (Chadwick, 2002). The FDA
oversees research involving drugs, biologics, and medical devices and does not
oversee social science research, therefore, only OHRP determination letters are
the focus of this discussion.
The literature of determination letters studies is scarce, although the
literature did reveal three similar research studies, one conducted by Borror et al.
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(2003), Burris and Welsh (2007) and Weil et al.(2010). In each case their
research revealed the numbers of citations of noncompliance (determination
letters) sent to institutions. Borror et al. found 1120 citations of noncompliance
and deficiencies and Burris & Welsh found 648 letters of noncompliance and
deficiencies were sent from OHRP. The research projects did not investigate
which institutions or agencies were involved in the citations of noncompliance nor
did the project delineate the numbers of biomedical or social science citations of
noncompliance or deficiencies. The authors focused on the kinds and numbers of
noncompliance and deficiencies found in determination letters. The focus was
not on the discipline in which those noncompliance and deficiencies were found.
In the studies conducted by Borror et al. (2003) and Burris & Welsh (2007) they
addressed, the percentage of institutions cited by OHRP, problems and remedies
based on review of determination letters, and the regulatory requirements of the
Common Rule.
Borror et al. (2003) explains that over the last several years OHRP has
developed a list of determinations of noncompliance that that include:


Initial and Continuing Review



Expedited Review Procedures



Reporting of Unanticipated Problems



Noncompliance,



Suspension of Protocol Changes



Application Of Exemptions



Informed Consent
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IRB Membership, Expertise, Staff, Support And Workload



IRB Documentation, Findings, and Procedures



Other

Determination letters, also referred to as compliance oversight letters by
Borror et al. (2003), are issued by OHRP in response to substantive allegations
or indications of noncompliance with the Department of Health and Human
Services (DHHS) regulations (45 CFR 46). Borror et al. acknowledges in their
research of determination letters that allegations of noncompliance can come
from various sources including research subjects, their family members, whistleblowers, patient/subject advocates, as well as OHRP staff based on the staff's
review of data published in professional journals. Borror et al. reports that 269
letters contained 1120 citations of noncompliance and deficiencies. One hundred
and forty-two of the 155 institutions in which determination letters were issued
had at least one citation of non-compliance.
In a similar study conducted by Burris and Welsh (2007) 271 letters within
the timeframe of January 1, 2002, and June 30, 2004, with 5 letters being issued
before the study period, were reviewed for their study. Burris and Welsh‘s data
set consisted of 174 letters being studied. Although Borror et al. (2003) and
Burris (2007) conducted similar analysis of determination letters, their analysis
resulted in divergent interpretation of the findings.
Borror‘s analysis indicated that institutions did not have adequate IRB
policies and procedures and did not maintain records according to regulatory
requirements. Borror‘s findings focused on the gaps in documentation of
68

researchers‘ written materials including informed consent documentation and the
process of the research project. While Burris & Welsh‘s qualitative study four
years later also reviewed determination letters and focused on the lack of
adequate information in consent documents, the level at which consent
documents were written and wording issues in the informed consent.
The later study by Weil et al. (2010) reviewed 235 determination letters
that the Office of Human Research Protection issued to 146 institutions between
August 1, 2002, and August 31, 2007. Weil et al.‘s examination of OHRP
determination letters revealed 762 citations of noncompliance and deficiencies.
However, similar to their first study of determination letters Weil et al. did not
focus on the discipline specifically of biomedical or social science research in
which the citations of noncompliance and deficiencies represented.
Burris & Welsh‘s study focused on patterns of noncompliance. They
concluded that although there were patterns of noncompliance no subjects were
harmed. Burris and Welsh puts forward that their research suggests that
documented procedures not explicit researcher unethical implementation of the
research projects has been cause for excessive documentation burdens for
human research protection programs and researchers. They refer to this process
as mission creep as detailed in the Illinois White Paper, Improving the System for
Protecting Human Subjects: Counteracting IRB Mission Creep (White Paper) by
Gunsalus et al. (2005) as a crisis being caused by the increased workload of
IRBs and their inability to handle the workload effectively efficiently. Thereby, the
focus is placed on the less difficult path of procedures and documentation rather
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than identifying difficult ethical issues which may be presented in research
studies. The authors of the White Paper (Gunsalus et al., 2007) suggest that the
institutions‘ efforts to comply with federal requirements even when research is
minimal risk amounts to exaggerated precautions to protect against program
shutdowns, and efforts to protect the institution against lawsuits.
Notably, Borror et al.‘s findings focused on the gaps in documentation of
written materials including informed consent documentation and process. Fiftytwo percent of noncompliance or deficiency citations were a result of institutional
review board approval of informed consent document/process (27%) or the initial
review process (25%). Four percent of overall citations were considered the most
serious form of noncompliance putting research subjects at risk if not at serious
risk.
Burris and Welsh‘s study, four years later, focused on what OHRP
determination letters consistently detailed. The letters included reference to the
lack of adequate information in consent documents, the level at which documents
were written and other grammatical misuse of wording in the consent form.
Burris and Welsh also suggest:
Very, very few researchers investigated by OHRP appear
to have deliberately broken or disregarded the rules.
Very, very few researchers conducted their studies in a
way that endangered their subjects. The rate of serious
problems—cases in which subjects were put at serious
risk or suffered harm—was low, especially when the
denominator is not the number of letters, complaints, or
audits but the far greater number of studies going on in
this period. Most of the violations uncovered involved the
failure to document something that may actually have
been done, or a failure to do something that, while
required by the regulations, does not appear to have
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exposed anyone to any harm or even put anyone at any
appreciable risk (p. 671)
The literature has presented the studies of Borror et al., and Burris &
Welsh as reviewing the contents of the determination letters but their research
nor other research studies in the literature has suggested what portion of the
citations can be attributed to social science research. Additional research is
warranted to address the gap in the literature of the impact of regulating social
science research with biomedical regulations. standards.
Scarce data exists in the literature documenting whether OHRP‘s citations
of noncompliance are the result of biomedical or social science research
projects. Knowing if the attributes of noncompliance and deficiencies have its
place in biomedical or the social science discipline may assist in better defining
the utility of the Common Rule to social science research projects. Additional
research in this area will assist in the discourse for continued research of the
applicability of IRBs using biomedical standards of research to address social
science research. A qualitative content analysis of determination letters will add
to the body of literature in this area.

71

National Bioethics Advisory Commission
The National Bioethics Advisory Committee (NBAC) was established by
Executive Order 12975 signed by President Clinton on October 3, 1995. NBAC
advises the President on bioethical issues that may emerge from advances in
biomedicine and related areas of science and technology. NBAC‘s functions
were defined as follows:
a) NBAC shall provide advice and make recommendations to the
national Science and Technology Council and to other
appropriate government entities regulating the following matters:
1. the appropriateness of departmental, agency, and other
governmental programs, policies, assignments, missions,
guidelines, and regulations related to bioethical issues
arising from research on human biology and behavior, and
2. applications, including the clinical applications, of that
research.
b) NBAC shall identify broad principles to govern the ethical
conduct of research, citing specific projects only as illustrations
of such principles.
c) NBAC shall not be responsible for the review and approval of
specific projects.
d) In addition to responding to requests for advice and
recommendation from the national science and technology
Council, NBAC may also accept suggestions of issues for
72

consideration from both the Congress and the public. NBAC
may also identify bioethical issues for the purpose of providing
advice and recommendations, subject to the approval of the
national science and technology Council (NBAC, 2001).
By 1997, the NBAC required that no person in the United States should be
enrolled in research without the double protections of informed consent by an
authorized person and independent for review of the risk and benefits of the
research (NBAC, 2001). In 1999 the White House issued orders for the NBAC to
compile a report on the concerns related to the human research enterprise.
Several areas of concern were indicated to the White House in 1999 that
included:


not all research participants are protected by the federal
oversight system,



several federal departments and agencies that sponsor primarily
non-biomedical research or modest amounts of research has
failed to implement fully the federal protections available,



the federal protections do not always include specific provisions
for individuals who are especially vulnerable, and



the federal protections are difficult to enforce and improve
effectively across the government, in part, because no single
authority or office oversees research protections across all
agencies and departments (NBAC, 2001, p. 1).

The NBAC expressed concern stating, "the oversight system for protecting
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research participants is losing credibility among some investigators, IRB's,
institutions, and, perhaps most important, the public, causing more frustration
and less willingness to commit time and resources to the system‖ (p. 16). The
NBAC well aware that the current system for protecting human research subjects
in need of reform was in agreement with social science researchers that the
system of protection "was often burdened by excessive bureaucracy, confusing
or conflicting interpretations of rules and an inability to respond to emerging
areas of research" (p. viii).
Human Research Protection Programs
Chodosh (2006) puts forward that human research history has been
marred with examples of ethical principles of human research being ignored.
Although, most human research scientist have followed the basic tenets of
ethical research, those scientists who were the exceptions created a necessity
for legal measures formed to avoid future problems. Chodosh proposes that the
Western society produced scientists that would not engage or permit the human
research atrocities as seen in the World War II Nazi experiments. Although it was
factual in most cases that medical researchers would abide by ethical research
standards, the western academic world also produced risky biomedical research.
The oversight that clinical administrative chiefs provided as guidance to the
investigators became much more tenuous as the clinical services expanded and
research generated much more operating funding.
Chodosh (2006), Dyer & Dermeritt (2009), Jones (1993) suggests that the
Tuskegee Syphilis Study and other unethical research practices brought about a
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realization by the scientific community that better means for protecting human
research subjects was needed. No longer was just peer review of research
protocol enough. Federal agencies now required more intense review of research
protocols. Institutional Review Boards now provided the oversight of research
projects once held by department supervisors. Edgar & Rothman (1995) suggest
that there are two goals which are the focus of IRBs: to determine if the benefits
of the project outweigh the risks; and to ensure that all the relevant information is
provided in the informed consent document.
The volume and complexity of research protocols increased as did
regulatory demands. Chodosh (2006) further suggests that additional resources
did not always keep up with the demands. ―The IRB's primary role in protecting
human subjects often became secondary to meeting regulatory requirements.
The institution‘s need to meet the conditions of their assurance and continue the
income and prestige of the institutions research program became the primary
IRB function" (p. 14).
Increased federal funding for research projects increased regulatory
demands, and the need to create a culture of research integrity within the
campus investigators brought about the need for the three components of the
human research protection program that include the investigators; the IRB; and
the institution (see Figure 1) to become congruent with protecting human
research subjects, Chodosh (2006).
Zywicki (2007) suggests that the size and expense of administrative such
as HRPPs have grown substantially in recent decades. He points to the ―growing
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accumulation of government regulation‖ which has required the creation of new
administrative staff to take care of the regulatory responsibilities. Zywicki
suggests, some of the growth of IRBs has been spurred by superfluous
governmental regulations (p. 872). In addition, Zywicki proposes that ―the
preoccupation of IRBs with paperwork and forms has been promoted by a regime
of ―fear‖ of governmental oversight, ―fear by the institution that it will be ‗out of
compliance‘ with one or more aspects of the paperwork, and subject to penalty
upon audit, be that by the NIH, the OHRP, the U.S. Department of Agriculture, or
whatever other organization is involved‖ (p. 875).

Investigators

IRB

Institution

Figure 1. Components of Human Research Protections Program
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Institutional Review Board
Our IRB system is endangered by excessive paperwork
and expanding obligations to oversee work that poses
little risk to subjects. The result is that we have
simultaneous overregulation and under protection‖ IRBs'
burdens have grown to include studies involving
interviews, journalism, secondary use of public-use data,
and similar activities that others conduct regularly without
oversight. Most of these activities involve minimal risks-surely less than those faced during a standard physical
or psychological examination, the metric for everyday risk
in the federal regulations. And IRBs are pressured to
review an expanding range of issues from research
design and conflicts of interest to patient privacy. These
are beyond the scope of research protection and are best
left to others (Gunsalus, 2006, p. 1441).

With the end of WW II bringing large amounts of federal funding for
medical research projects, medical research projects escalated substantially.
Institutional review boards (IRB) gained a larger role in the review and approval
of human research. Haggarty (1966) suggests IRBs were primarily to determine
the medical benefits of federally funded research projects. Later some IRBs
began reviewing nonmedical research. In the United States, regulations
protecting human subjects first became effective on May 30, 1974. The
regulations established the IRB as one mechanism through which human
research subjects would be protected (Edwards, Ashcroft, & Kirchin, 2004).
The National Research Act passed in July, 1974, established the National
Commission for the Protection of Human Subjects of Biomedical and Behavioral
Research (the Commission). Peckman (2001) suggests that prior to 1938 the
United States placed no restrictions on human experimentation. The Hippocratic
Oath of ―do no harm,‖ was the guiding principle of research ethics for
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experiments on humans, suggests Peckman. Operating in sync with the
proponents of ―do no harm‖ was the ―cultural bias that relied upon and trusted the
expertise of professionals‖ (Peckman, 2001, p. K-3). However, the acts of
unethical experimentation with human subjects lead to the creation of peer
review committees (Levine, 1988; Peckman, 2001; Candilis et al., 2006; Advisory
Committee on Human Radiation Experiments, 1995). By February, 1966
institutions that received federal funding for biomedical research, were required
to create an institutional committee to review their colleagues grant applications
including protocol for involvement of human subjects (Peckman, 2001).
By 1974 IRB‘s became more formalized (Chadwick, 2000; NBAC, 1999;
Edgar & Rothman, 2004). They became committees to oversee the responsible
conduct of biomedical and social science research, protect the rights of research
participants, reduce their risks, and increase the benefits of the research (Levine,
2001; Gilbert, 2006). The Common Rule provides the structure of institutional
review boards in the United States. The Common Rule includes explicit reference
to the operations of the institutional review board. IRB operations are found in
the following Federal Regulations:
§46.107 IRB membership.
§46.108 IRB functions and operations.
§46.109 IRB review of research.
§46.110 Expedited review procedures for certain kinds of
§46.111 Criteria for IRB approval of research.
§46.112 Review by institution.
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§46.113 Suspension or termination of IRB approval of research.
For more than 10 years Institutional Review Boards (IRBs) have been
placed under intensive scrutiny as a result of the Office of Inspector General
(OIG) of the Department of Health and Human Services report, Institutional
Review Boards: A Time for Reform (1998). The report represented a one-year
study by OIG. The key findings of the report‘s concluded that: 1) IRBs face major
changes in the research environment as a result of increases in the quantity of
research, the commercialization of research, and the number of multicenter trials;
2) IRBs conduct minimum continuing review of approved research; 3) IRBs are
overworked; 4) IRBs often lack sufficient scientific expertise to review protocols
adequately; 5) IRBs face conflicts of interest that may undermine their
independence, and 6) IRBs provide little education or training to members.
The report recommended that:


IRBs should be held more accountable;



continuing protections for human subjects, such as data safety
monitoring boards and adverse event reporting, should be
strengthened;



federal requirements should be enacted to promote education
on research ethics for IRB members and investigators;



steps should be taken to insulate IRBs from conflicts of interest,



more institutional resources should be devoted to IRBs, and



the federal oversight process should be revamped.
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Extensive criticism has permeated the IRB review and approval process
(Dyer & Demeritt, 2009; Gordon, 2003, Oakes, 2004, AAUP, 2000). Dubois
(2004) depicts IRBs as the instruments of a system of licensing in which
scholars, students and other researchers must get permission to conduct
research with human subjects. He suggests that IRBs are far more dangerous
than the research they review and they offer little if any protection for human
subjects.
Although, IRBs have garnered much of the negative criticism from
researchers, the IRB staff has also contributed to the concerns researchers have
with human research protection programs. Menikoff (2007) suggests that the
―IRB staff may not be adequately educated about applicable regulations, and
may be placing inappropriate burdens on researchers, or there may be
insufficient staffing leading to inappropriate delays in the review of studies‖
(p. 798). Rothman (1995) suggests that staff require excessive documentation
rather than providing guidance in the interpretation of the regulations.
Burris & Welsh (2007), details IRBs as a regulatory system that often
distracts from rather than focus on key ethical issues. The sentiments of DeVries
et al. (2004 p. 234) suggests that IRBs have been extensively criticized as
inefficient, obstructionist, and indifferent to the researchers needs and ineffective
at protecting human research safety and ethical concerns because of excessive
regulations required in biomedical research that impacts social science research.
Brendel‘s (2008) writings from the biomedical point of view suggest that there
must be a pragmatic approach to IRBs review and approval of clinical research.
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The author notes that, the IRB focus should be using case-by-case moral
problem solving as ―how to balance the drive toward scientific discovery with the
need to protect human subjects in clinical research‖ (p. 25). The sentiments of
Zywicki (2007) suggests that ―IRBs have become a ubiquitous presence on the
landscape of America‘s higher education system‖ using a system of review of
research projects which suggests a one-size-fits-all approach (p. 861).
Social scientists routinely encounter impediments to their research when
navigating Institutional Review Board (IRB) review process to obtain approval for
their research studies. Gordon (2003) suggests that the Common Rule and the
interpretation of the Common Rule by the IRB, which is modeled heavily on
biomedical research, is not effective for social scientists and especially ineffective
in its applicability to anthropological approaches to research (p. 300) concurs
with social science scholars having similar concerns of the overregulation in
social science research for more than 35 years. Burris, Buehler & Lazzarini
(2003); Burris et al. (2003, Winter) propose that good regulations must be
effective and efficient. They suggest that the Common Rule may not achieve the
―desired behavior among regulated and protected at the lowest possible cost‖
(Burris, Buehler, & Lazzarini, 2003, p. 650).
Social science researchers point out that research procedures associated
with biomedical research cannot be transplanted into the procedures for
conducting social science research. Seiler and Murtha (1980) suggested that the
federal regulatory efforts censor social research more prominently in federally
funded research projects. Seiler and Murtha further argued more than 30 years
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ago that the increased documentation and paperwork required by federal
oversight agencies and, institutional review boards added no additional
protections for human subjects. They proposed that using the biomedical model
of protecting research subjects offers no evidence to show that the "swirl of
paperwork either protects research participants or substantially changes the
quality of social research‖ (p. 154).
Additionally, Seiler and Murtha put forward that the increase bureaucracy
has made for increased delays for researchers, increased workloads and loss of
control of even their work situation ―leading to a variety of unintended
consequences‖ (p. 154). The consistency of this argument continues to resonate
with social science researchers with little if any difference in contention.
In 2001, the National Bioethics Advisory Commission (NBAC) complained
that Institutional Review Boards (IRBs) were overwhelmed not only
by high workloads generated by the amount of actions to process just one
research project (see Figure 2) and limited resources but also by ―a regulatory
system that often distracts from rather than focuses on key ethical issues‖ (p. A
14). NBAC attributed ―emphasis by regulators on procedure‖ for contributing to
―an atmosphere in which review of research becomes an exercise in avoiding
sanctions and liability rather than in maintaining appropriate ethical standards
and protecting human participants‖ (p. 22). The procedure-prone regulator of
greatest concern to NBAC was the federal Office for Human Research Protection
(NBAC, 2001).
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Protocols submitted to the IRB for:
Review and Approval

IRB staff review protocols to ensure all requirements of federal regulations are addressed,
and protocol is ready for IRB review. If needed protocol is returned for revision and
resubmission as necessary

IRB conducts a review to:
Identify risk and potential benefits to participants and others.

IRB‘s ethical analysis of risk and potential benefits after risk identified and minimized,
possible benefits identified

Components designed solely to answer
the research question(s

Components that also offer the prospect
of direct benefits to participants

Are the Risks Reasonable in Relation
to Potential Benefits of Knowledge?

Are the risk reasonable and in relation to
potential benefits for participants?

 Requires assessment of the
study's objective.
 May require input from experts
and community representatives.

 Assessment of risk and potential
benefits separately from experimental
and control procedures.
 The study pass test of research at
equipoise?
o Sufficient data exist to validate
control or experimental
procedure?
o May require input from experts
and community representatives.

STUDY ACCEPTABLE ONLY IF ALL COMPONENTS PASS
ETHICAL TEST.
Figure 2. Process of IRB Review including analysis of Risk and Potential
Benefits
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IRB Administrative Support Staff
The IRB Administrative support staff is critical to an institution‘s human
research review system. Although as McGough (2002) points out, the Common
Rule at 45 CFR 46.103(b)(2) does not specifically state that staffing is to be hired
to support an institutional review board. However, for IRBs to function adequately
they must have staff to assist them with administrative duties (Chodosh, 2002).
The staff should have appropriate training and expertise and have access to
needed resources. McGough (2002) adds that the positions the members serve
on the IRB are as volunteers that cannot be expected to provide the
administrative work necessary for IRB review of human subject research and
daily oversight of the administrative duties required. Additionally, McGough
suggests that in order to manage these tasks and many others needed by the
IRB, for the mission of protecting those participants in human research, there
must be qualified administrative IRB staff support in place with resources
provided by the institution to support IRB functions.
The IRB review process can be burdened with excessive paperwork
required by Federal Regulations (NBAC, 2001, Gunsalus, 2005, King, 1999;
Pattullo, 1985). Although the paperwork fulfills procedural rule requirements of
the federal oversight agencies, and is designed to ensure compliance with ethical
standards, the paperwork requirements have little relevance to ethical standards
or the protection of participants (NBAC, 2001). IRB's also lack the resources
suggested by the Office of Human Research Protection, including meeting
space, adequate staff and equipment to support IRB functions. They have
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increasingly large workloads with inadequate staff and inadequate resources that
inhibit the protocol review and approval process (Sugarman, 2000).
Social Science Research Regulation
Almost no one believes the social sciences should be
utterly free from oversight. The history of psychology,
for example, is studded with experiments whose designers
gave too little thought to the well-being of their subjects.
Shea (2000, p. 4)
Prior to 1974 social science research was unregulated by the federal
government (Seiler & Murtha, 1980). The authors suggest that the 1974 National
Commission for the Protection of Human Subjects of Biomedical and Behavioral
Research would require the social sciences to undergo federal scrutiny for
research funded by the federal government. Seiler & Murtha suggests there was
no concern of ethical violations reported of social science research during that
time, making increased scrutiny of social science research unnecessary. Patullo
(1979) agrees, saying that ―the record of social scientists is remarkably good‖ (p.
531).
Although, as with biomedical research, there is always a possibility of
harm to those participants of social science research projects through
carelessness or ignorance or lack of character or those who abuse the
standards, suggests Pattullo. The author further suggests that the possibility of
injury in social science research is rare. The concern of social science research
harms originated with the Surgeon General's concern at that time for "insuring
the integrity of research his agency financed‖ (p. 533).
Oakes (2002) and Keith-Spiegel & Koocher (2005) suggest that social
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scientists are undisturbed by federal regulatory oversight. However, the authors
suggest, it is IRB's that have increased their scrutiny of research projects
including social science research projects unnecessarily. The increased scrutiny
has caused frustration to many social scientists because it results in excessive
documentation to address the IRB concerns of perceived risks to research
participants (Gunsalus et al., 2004; White, 2007). There is little debate regarding
the need to protect volunteers in social science research (Bozeman, 2003;
Braxton, 1994; Malone 2003) but social scientists posits that there continues to
be a need for improvement of system, improvement that appropriately represents
the risks of social science research (Dyer & Demeritt, 2009; Citro et al., 2003;
Pittenger, 2003; White, 2007).
Oakes (2002) suggests that as a result of the guidelines proposed by the
Department of Health Education and Welfare (DHEW) in August 1979, social
research has been made to undergo IRB review despite funding source, and
requiring the same rigor as biomedical research. Social scientists, as evidenced
by the literature, have argued for decades that the increased scrutiny, identical to
that of biomedical research had no foundation of evidence of physical harm
occurring in social science research (Pattullo, 1980, Seilar & Murtha, 1980).
Oakes (2002) and Pattullo (1984) puts forward that social scientists were
not involved in the development of the Common Rule. Without social scientists
involvement in the development process, there was little applicability of the
Common Rule to social science research thereby resulting in inappropriate
regulations for the social sciences.
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However, Amdur & Bankert (2002, p. 105) suggests:
There is no legal or regulatory basis for making the
distinction between social science and biomedical
research from the IRB standpoint. Specifically, the U.S.
Dept. of Health and Human Services (HHS) regulations
that focus on the IRB do not mention the terms social
science, behavioral science, or biomedical science. The
regulations describe ethical standards for research based
on the specific characteristic of the risk to research
participants. Not on the academic field into which
research may be classified. The fact that the regulations
do not distinguish between social science and biomedical
science emphasizes the similarities between these two
general types of research in terms of ethical standards
and research regulation (p. 105).
Amdur and Bankert (2002) suggest that as a result of physical harm
imposed on research subjects, ethical codes were developed. The risk of
physical harm is not a component of social science research, causing some
researchers to not fully understand the applicability of the Common Rule to both
biomedical and social science research. The authors point out that social science
research does, in fact, have a potential for social harms.
Social harms can include a decrease in quality of life resulting from
―information being created or used in a way that is damaging to the individual‖
causing ―loss of employability, loss of insurability and criminal or civil litigation‖ (p.
106). Often social harm takes the form of disruption of personal relationships,
causing embarrassment, humiliation, discrimination or stigmatization. Amdur &
Bankert further suggest that social harm is just as much a threat to the rights and
welfare of research participants as physical harm (p. 106).
Sieber (2004) suggest that the system of protecting human subjects has
been enacted in response to high profile conflicts between the values and
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activities of scientists and the values of society as a whole (p. 402). As an
example the author also refers to the 40 year of study of untreated syphilis by the
U.S. Public Health Service in which informed consent and ethical oversight of
research became the requirement. Sieber further suggest that regulations should
not be confused with ethics. Ethics have a duty to address the unique
characteristics of a circumstance, ―regulations are specific requirements, the
wording may seem to imply that one size fits all (p. 403).‖ Although most
regulations are written in a way that may be interpreted with some flexibility, the
flexibility has not always been extended, causing problems for social scientist,
Sieber suggests.
Mission Creep and Overregulation
Marshall (2003) acknowledges that IRBs have had a profound impact on
the regulation of research with human participants. The author further
acknowledges that the OHRP has shut down research at several United States
institutions because of violations of human subjects' protections. Marshall
suggests that there is a place for the work of OHRP, although they are
overzealous in their approach. The majority of criticisms from researchers concur
with Marshall in the observation that regulatory oversight entities are useful and
needed, however federal regulatory entities are overzealous in their interpretation
and application of federal guidelines, exacerbating the challenges faced by
researchers in all fields of human research seeking approval of their research
studies (Mosher, 1988).
Kahn, Mastrianni & Sugarman (1998); Emanuel, Wendler & Grady (2000);
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and Beyrer & Kass (2002) suggest that in recent years there has been increased
debate in both public and professional arenas about a range of ethical concerns
involving research with human participants. The authors agree, IRBs play
critically important roles in evaluating and managing the risks inherent in
research while they protect the rights and welfare of human research
participants. Resnick‘s (2004) concurs with Marshall (2003) and Oakes (2002) in
their opinion that IRBs have been placed under intense scrutiny. In 1998, the
Office of Inspector General (OIG) of the Department of Health and Human Services
issued its report, Institutional Review Boards: A Time for Reform. The report
suggests that the regulatory system of protecting human subjects has
weaknesses that threaten the effectiveness of the system. This, researchers
suggest, has been a major factor in the increased documentation called for by
IRBs from researchers and performed by human research protection programs.
This progression of documentation has had an adverse effect on researchers,
while affording little if any additional protections for research subjects.
NBAC (2001) suggests that an IRB‘s assessment of risks and potential
benefits is central to determining that a research study is ethically acceptable and
would protect participants of the study. However, with no clear criteria for IRBs to
use in judging whether the risks of research are reasonable in relation to what
might be gained by the research participant or society, the ambiguity of
measuring reasonable risks is left to individual interpretation. The lack of
consistency and continuity of the review process is of grave concern to social
scientists (Gunsalus, 2006). Zywicki (2007) puts forward that ―IRB decisions on a
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vague and capacious metric of ‗harm‘ amounts to making decisions according to
no predictable rules‖ (p. 892). Researchers put forward that investigators and
IRBs must be more effective and efficient in carrying out their responsibilities, in
that way, improving research protections and increasing public trust in research.
Indications of noncompliance resulting in risk of harm to those
participating in social science research remains minuscule compared to OHRP
findings of noncompliance in biomedical research activity (Braxton, 1994).
Although there has been much anecdotal comment in the literature on the topic
of the application of a one-size-fits-all approach to regulating social science
research with biomedical regulations, there seems to be no abundance of
literature of the research to substantiate the assertions that research participants
are better protected in social science research studies resulting from the
biomedical regulatory model of the Common Rule (Gunsalus, 2007 Mueller,
2007). Similar to others in the literature, Zywicki (2007) states that:
The requirement of IRB preapproval for research applies
only to federally funded research. Nonetheless, universities
have extended the mandate to all research involving human
subjects, even though the vast majority of social science
research is not federally funded. This requirement is typically
justified by belief that IRBs are a necessary part of a system
of checks and balances to curb the self-interest of
researchers, whose natural inclinations may lead them to
discount improperly the dangers to human subjects from
their research. But the argument that IRBs are necessary to
counterbalance the self-interest of researchers is somewhat
ironic in that there are no institutional checks to balance the
self-interested expansionist tendencies of IRB
administrators. Thus, in a classic example of the problem of
―who watches the watchers,‖ IRB administrators arrogate to
themselves the power to oversee all research involving
human subjects, even the vast majority of social science
research that is not federally funded (p. 888).
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De Vries et al. (2004) suggests social science researcher may be over
scrutinized for the harms that may result from their research based on the
amount of risk in typical social science research, including surveys, interviews,
oral history research and others. The imposed regulations by OHRP on social
science research continue to weigh heavily on institutions as they attempt to
balance the need for protecting human subjects in research, the need to support
their researchers‘ scholarly efforts and the need to minimize any untoward
liability claims on the institution. Gunsalus et al. (2007) suggests that the
increased workload burden of the IRB and administrative staff provide a negative
impact on high-risk research needing to be reviewed and approved.
The Common Rule - Intent and Impact of Policy
―All compliance systems require the buy-in and collaboration of the
regulated, and it will be a sad day if scholars come to see human protection in
research as the source of frustrating delays and expensive paperwork‖
(Gunsalus, 2006, p 26). The literature does not reveal prodigious support for the
regulatory system of protecting human subjects in the social sciences with
biomedical regulatory standards. Governments translate their political agendas
and programs through policymaking to deliver outcomes desired to reflect
change (Fischer, 1995). The Common Rule was the United States answer to
protecting human subjects in a uniform manner, representing a 10 year
collaboration that resulted in 17 federal departments and agencies adopting one
set of regulations to include biomedical and social science research (NBAC,
2001). To obtain a more consistent form of protection for research subjects, in
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1995 the NBAC surveyed agency's policies and procedures focused on the
protection of human subjects research.
The survey instrument was to assess "each department's activities to
protect human subjects in research and the structure's, policies, and procedures
in place for the review and oversight of human subjects protections‖ (NBAC, p. J2). The survey tool was designed to assess department‘s compliance level with
the Common Rule and any difficulties arising from the implementation of the
Common Rule. The data collected suggested concerns in the following areas:


Federal protections for persons serving as subjects in research
do not extend to all Americans.



Despite widespread implementation of Federal Regulations by
those departments and agencies sponsoring substantial
amounts of biomedical research on a number of departments
and agencies that sponsor primarily non-biomedical research or
little research over all, have failed to implement fully, the federal
protections.



Many federal agencies find the interpretation and
implementation of the Common Rule unnecessarily
burdensome.



Federal protections are difficult to enforce and improve the
effect of the lead throughout the federal government, in part
because no single authority or office oversees research
protections across all government agencies and departments.
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New techniques are needed to ensure implementation at the
local level.

Although many federal agencies reported improvement in the way they
addressed protecting human research subjects, years later problems still
remained. Some problems as noted by the National Bioethics Advisory
Commission in 2001 included:
1. Appropriateness of the Common Rule
Nonclinical nonmedical research communities reported
having the greatest difficulty in the interpretation and
application of the Common Rule especially as it applies to
the finding minimal risks.
Although the vast majority of agencies support nonclinical
research, many of the agencies challenged the biomedical
model of the Common Rule for addressing the unique
concerns raised by behavioral, social science and
educational research (p. J. 14).
2. Lack of a knowledgeable IRB
Agencies that do not have effective IRBs in place to assess
research proposals prior to their funding may not have the
appropriate information in place to adequately request
revisions or even disapprove greater than minimal risk
research, leaving protections for human subjects lacking.
3. Determining exemptions
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The interpretations of exemption categories across agencies
vary as well as who the designated entity will be to interpret
the exemption categories.
4. Adequacy of Administrative Structures
Federal agencies are responsible for communicating policies
to relevant research institutions and IRB's, establishing a
structure of peer review for scientific merit of research
proposals. In addition, negotiating assurances with research
institutions verifying that IRB's and researchers comply with
Federal Regulations and in investigating and providing
follow-up on any complaints of noncompliance
The data suggested that agencies did not devote sufficient
resources to administrative structures.
The concerns raised by the NBAC in 2001 reflect many similar concerns
of social science researchers recently such as that of Coleman (2009); Kotzer &
Milton (2007); Dyer & Dermeritt (2009). In particular, their concerns reflect the
findings of the NBAC regarding the interpretation and implementation of the
Common Rule as confusing and, or, unnecessarily burdensome. The literature
provides a profusion of social science researchers‘ concern that the Common
Rule provides overregulation for social science research. As discussed, social
scientists suggest that the biomedical regulatory framework of protecting human
research subjects is not congruent with social sciences.
Byrne (1987) suggest that cost-benefit calculations play a role in policy
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decisions, although, the value of cost-benefit analysis is in the discipline that
brings to the policy process the ability to address social problems in a systematic
and efficient manner. Earlier in this discussion details of the basis for federal
intervention in unethical research practices funded by the federal government
were highlighted detailing Federal intervention, due to unethical research
practices, led to the development of Common Rule protection of human research
subjects.
The federal policy is a guide for the research practices of biomedical and
social science research. The policy is based on a biomedical model of human
research protections that also is the basis for protections in social science
research. Social Science researchers puts forward that the cost of the federal
policy has been in overregulation, human research protection programs deluged
in unnecessary paperwork and documentation, having little benefit to research
participants and that a reasonable solution has not been achieved for protecting
human participants of social science research (Oakes, 2002; White, 2007;
Vanderpool, 1996; Pattullo, 1985; Malone, 2003; Marshall, 2003).
Fischer (1987) suggests that cost-benefit analysis in the policy process
was institutionalized through the Office of Management and Budget (OMB)
during the Reagan administration. Economy and efficiency is the focus of costbenefit analysis, and "politicians have found cost-benefit analysis to be
conveniently compatible with their own biases" (p. 116). Gunsalus (2004), calls
for refinements to the regulatory system that will provide a set of policy
regulations designed for non-biomedical research. Gunsalus puts forward that
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the challenges of the application of the policy (the Common Rule) must be better
understood and implemented. Better understanding will assist the IRB and their
support staff to ―direct attention to the areas of greatest risk, while intentionally
scaling back oversight in areas of lesser risk‖ (Gunsalus, p. 86).
Levine‘s (2001, January) testimony to The Committee on Assessing the
System for Protecting Human Research Subjects (see Appendix O ) suggested
even then that there were ―growing fault lines in the system that protects human
participants and that a gap has developed between law and policy on the books
and in action‖ in the author‘s testimony to the American Sociological Association
(p. 2). Levine states, ―For the social and behavioral sciences, the overall problem
with the system is the attempt to fit our research into a framework that was over
specified and designed for biomedical-clinical research.‖
Seiler and Murtha (1980, p 147) suggest that the 1974 National Research
Act that was ―signed under pressure of Congress to complete the task prior to the
next administration coming in‖. The authors suggest that in the haste for
completion of the regulations, there was no mechanism in place to inform the
social science community of the new rules that would apply to them or to get their
input or feedback (p. 148). The regulations produced were a product of mainly
extensive drafting by the NIH staff. Tropp (1978) suggests that:
Under the gun of imminent congressional passage of the
National Research Act, and in order to preempt a
possible Senate move to include in it mandatory ethical
standards governing federally sponsored research, the
secretary of HEW on May 22, 1974, signed a regulation
on ―Protection of Human Subjects‖ which essentially
transformed the predecessor NIH guidelines into
department policy. The regulation was largely a product
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of the ―H‖ part of HEW, drafted without participation by
those HEW agencies which customarily commission
social science research products and maintain daily
conduct with the social science research world. (p. 391)
Having little participation in the construction of development of the policy
to regulate human subject research, social scientists need additional
mechanisms to address their concerns and to insure that the Common Rule as a
tool for protecting human subjects is the most effective and efficient mechanism
for doing so (Haggerty, 2004).
The Common Rule, from its inception was formed and charged with the
responsibility of insuring research protection for those participating in federally
funded research projects, using the Common Rule as the federal regulatory
stance for the institution‘s human research policy foundation (Aronson, 2008;
Payne, 2000; Coleman, 2009). In 1985, Patullo suggests that institutions had
adopted policies much more restrictive for protecting human subjects than they
need to be, stating that, ―outraged by a few excesses we have responded like
one who burns down a house to rid the attic of squirrels‖ (p. 524). Nearly 30
years later social science researchers are still critical of the overregulation of a
one-size-fits-all model of applying biomedical standards to social science
research.
White (2007) and Bozeman & Hirsch (2005) suggests the negative
publicity of institutions appearing in the OHRP database of determination letters
has made for increased institutional scrutiny, overregulation and mission creep of
human research projects submitted for review and approval. White points out that
deficiencies in research protocols recorded by the institution‘s HRPP, that
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prevents approval of social science projects, mainly represent documentation
concerns that have little or nothing to do with the safety and risk to human
subjects. Gunsalus et al. (2005) concurs, that HRPPs have increased
documentation practices to the extent that researchers see the increased
documentation practices as overregulation and mission creep.
The concerns expressed by social scientists about overregulation includes
as Wagener et al. (2004, October) points out , HRPPs are requesting much more
additional safeguards to be included in minimal risk research projects. Mission
creep in Institutional Review Boards permeates the literature of institutional
review mission, practice and oversight related to the IRB system of protecting
human research subjects. Although, IRBs are a critical safeguard in the system
of protecting human research subjects, and social scientists give them credit for
such, researchers suggest the system of human research protection is devoid of
effective control that does little in protecting human subjects (Coleman, 2004;
Resnik, 2004; Oakes, 2002; Burris & Welsh 2007; Marshal, 2003).
Moreno (2000) suggests that IRB members should have more training to
understand the regulatory issues that arise in research projects when
collaborating with other institutions. The assertion is that research studies are
delayed because of the uncertainty of a process to address collaborative
projects. Recommendations for increased training and education are also
included in the findings of Borror et al. (2003) and Burris & Welsh (2007) along
with increased funding for IRB activities. Good practice guidelines for diverse
areas of research are highlighted in reports on ethical and policy issues in human
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subjects' research published by the Institute of Medicine (2000 & 2001), the
National Bioethics Advisory Commission (2001a, 2001b), Similar
recommendation, has been proposed by the National Academy of Science's
panel on IRBs and social science research. While there is consensus about the
general purpose of IRBs, significant problems remain in the applicability of the
review process for social science research protocols (Edgar & Rothman, 1995;
Ferraro and Orvedal, 1998; Marshall, 1998; Chadwick and Dunn, 2000).
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Summary
The history of research violations that brought about the intervention of
formal codes and regulations to protect the safety and well-being of human
research participants is well documented in the literature. Social science
researchers are concerned with the applicability of biomedical research
standards to their minimal and less than minimal research. The challenges faced
by an oversight system for protecting the rights and welfare of human subjects
have resulted in overregulation and under protection of the Common Rule,
suggest social scientists. The concerns raised by social scientists mirror similar
concerns of the in the NBAC. The over emphasis on procedural requirements
has been a major concern of social science researchers as is excessive
paperwork requirement of the IRB and its support staff to fulfill the policy
requirements of the Common Rule that provides little added protection for human
subjects suggest researchers. The quandary of what additional policies need to
be put in place continues to be unanswered after more than three decades of
contention with utilizing a biomedical model of protecting those human research
participants involved in social science research.
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Chapter 3
Methods
The Code of Federal Regulations, 45 CFR 46 is not separately
distinguished by applicability to the disciplines of biomedical or social science
research. The Federal Regulations at 45 CFR 46 contain Subparts A-E (see
Figure 3). Subpart A is the basic HHS Policy for the Protection of Human
Subjects. Additional protections for vulnerable populations involved in research
are included in Subparts B through D. Subpart B provides additional protections
for pregnant women, human fetuses and neonates. Subpart C provides
additional protections for research involving prisoners, and Subpart D provides
additional protections for children. Added to 45 CFR 46 within 2009, Subpart E
provides instruction for registration of IRBs. This research study focuses on
Subpart A, the Basic HHS Policy for the Protection of Human Research Subjects.
The literature identifies challenges for social science researchers that
range from excessive time delays in the implementation of their research projects
to disapproval of the projects based on standards applicable to biomedical
research projects. Social scientists contend that the current review process
applicable to biomedical research may not fit social science methodological
research practices. Researchers in the literature provide antidotal experiences
that include what they perceive as over-regulatory practices and mission creep.
As a result of some over-regulatory practices and mission creep, researchers
suggest that some researchers do not seek IRB review and approval for research
activity prior to conducting the research study. Although, conducting research
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without IRB approval could have an adverse impact on the research subjects
depending on the level of risk associated with the project (Dyer & Dermeritt,
2009).

Figure 3. Subparts A - E of HHS Federal Regulation 45 CFR 46.

Gunsalus (2005) suggest the requirement for documentation of social
science research projects remains the same as that of biomedical research
projects. As a result, the university‘s human research protection program
becomes entangled in a bottleneck of protocols that requires excessive
documentation of minimal risk and less than minimal risk research. Imitating the
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identical review and approval process for social science research projects as for
biomedical research projects may present challenges for all concerned, including
the researcher, the human research protection program, as well as the university
or college exercising the tenets of their human research protection program to
comply with federal agency funding requirements.
To receive federal research funding, universities and colleges must abide
by an Assurance from The Office of Human Research Protection (OHRP). The
Assurance (see Appendix N) is a document administered by OHRP, signed by an
institutional signatory official committing the institution to abide by the regulatory
statutes overseeing the conduct of human research as specified in the Common
Rule as well as to the Subparts of 45 CFR 46. OHRP requests institutions to
investigate concerns of noncompliance or deficiency with the regulatory statutes
overseeing human research protection. The institution receives a document
called a determination letter detailing issues that must be addressed by the
institution.
To provide additional understanding of the impact of regulating social
science research with biomedical regulations this qualitative study describes and
analyze the contents of OHRP determination letters, analyze in-depth interviews
of human research protection program administrators and evaluates the
Common Rule policy.
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Theoretical Framework
Denzin & Lincoln (2005) suggest that qualitative research can be viewed
as ―interpretive activities‖ having ―no single methodological practice over another‖
(p. 6). They suggest that qualitative research is void of a ―theory or paradigm that
is distinctly its own‖ and does not belong to a single discipline having its own
methods or practices. Merriam (1998) suggests the theoretical framework of a
qualitative study is "the structure, the scaffolding, the frame of your study" (p. 5).
As suggested by Merriam, the theoretical framework encompasses "concepts,
terms, definitions, models and theories of a particular literature or base and
disciplinary orientation" (p. 46). The combination of these, she suggests, affects
all features of the study including articulating the purpose and problem of the
study, to how we interpret the data collected.
Miles & Huberman (1994) are in agreement with Merriam(1998)
suggesting, ―any researcher, no matter how unstructured or inductive‖ comes
with some orienting ideas (p. 17) being necessitated by the need to structure the
process, the gathering of data, interpreting data, and reporting data in ways that
is understandable. The authors suggest that the conceptual (theoretical)
framework is a combination of theoretical understandings and experiences of the
researcher in order to conceptualize the study. Anfara and Mertz (2006) posits
that the researchers‘ use of any framework or theory is appropriate, considering
that it allows the researcher to see and comprehend particular aspects of the
phenomenon being studied. The authors suggest that ―no theory, or theoretical
framework, provides a perfect explanation of what is being studied" (p. 27). With
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that said, the theoretical framework to accomplish the goals of this study includes
a qualitative methodology of study for content analysis, in-depth interviews and
policy analysis.
Research Questions
Based on the statement of the problem as discussed in Chapter 1, the
research questions are:
1. What are the findings of deficiencies and findings of
noncompliance indicated in OHRP determination letters (DL) for
social science research projects?
2. What impact does the Common Rule have on social science
research protocol review by human research protection
programs?
3. Has the Common Rule achieved its intended purpose of
protecting human research subjects participating in social
science research?
Research Design
This study encompasses a three prong qualitative methodological
approach to answer the research questions above using content analysis, indepth interviews, and policy evaluation.
Content Analysis of Documents
Determination letters alert the institution and public of any noncompliance
or deficiency issues resulting from research conducted by the institutions‘ faculty,
students and staff. Determination letters range from communicating to the
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institution that minor deficiencies in a research protocol might have occurred, to
notification of shut down of the institutions‘ research projects. Availability to
OHRP determination letters when viewed by the public can result in bad publicity
for an institution. The threat of bad publicity for institutions may in turn promote
human research protection programs (HRPPs) to surpass the regulatory
mandates of the Common Rule and impose extended institutional policies for
reviewing and approving research projects, subjecting research protocol to
increased institutional policies for protecting human subjects (Gunsalus, 2005).
The overly copious policies and regulations can provide additional workload for
HRPPs, time delays for the review and approval of research studies, and in many
cases, as suggested by the literature, without adding any increased protections
for human subjects, but providing better protections for the institution.
Qualitative content analysis of documents encompass a theoretical
framework having an approach of empirical, methodological controlled analysis
of texts within the context of communication, using systematic content analytical
scientific methodology. Krippendorff (1969) suggests that "content analysis is a
research technique for making replicable and valid inferences from texts (or other
meaningful matter) to the context of their use. The author suggests specialized
procedures are used with content analysis that can provide ―new insights,
increase the researchers understanding of particular phenomena, or informs
practical actions‖ (p. 18). Krippendorff suggests that ―content analysis is a
scientific tool‖ (p. 18), as it is ―a replicable and valid method for making specific
inferences from text to other states or properties of its source" (p. 103)
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Marshall and Rossman (1999) suggests that content analysis can be a
supplement to additional forms of research including participant observation,
interviewing, and analyzing documents used in the course of everyday events as
well as those documents specifically constructed for the research at hand. As
appropriate for this study, content analysis can render deeper understanding
when used with in-depth interviews of human research protection program
administrators and evaluation of the Common Rule policy. Qualitative content
analysis of documents, being rich in ―portraying the values and beliefs of
participants in the setting‖ is an unobtrusive method of compiling information and
data (p. 116). In addition, the authors note that content analysis should be linked
to research questions in the theoretical framework for the study. Marshall and
Rossman note that:
Although content analysis was once viewed as an objective and
natural way of obtaining a detailed description of the contents of
various forms of communication, thus counting the mention of
specific items was important has evolved, it is viewed more
generously as a method for describing and interpreting the
artifacts of a society or social group (p. 117).
Content analysis is nonreactive and can be conducted without disturbing
the natural setting in any way (Babbie, 2004). It is the researcher that determines
where to place the greatest emphases after the data has been compiled (Schutt,
2006; Babbie, 2004; Marshall & Rossman, 1999). However, the researcher can
be a potential weakness for the interpretation of the data. Marshall and Rossman
suggest that "care should be taken in displaying the logic of interpretation used in
inferring meaning from the artifacts" (p. 162)
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McBurney & White (2009) credits Lasswell (1951) for formulating the
core questions of content analysis: "Who says what, to whom, why, to what
extent and with what effect?" Formulating this line of discourse is appropriate
when studying the communication of determination letters, because this line of
query can supply rich and deep insight. Holsti (1969) offers a broad definition of
content analysis as "any technique for making inferences by objectively and
systematically identifying specified characteristics of messages" (p. 14) The
objective inferences systematically taken from determination letters assists in
putting forward a rigorous scientific method for analyzing the texts applicable to
the federal regulation of the Common Rule, Subpart A.
Data Collection
The Office Of Human Research Protections (OHRP) is responsible for
overseeing compliance with the Department of Health and Human Services
(DHHS) regulations governing human subject research. OHRP has made
determination letters available to the public via their Internet portal since 2000.
These letters detail noncompliance and deficiencies of approved federally funded
research studies. Letters were collected from January 2000 until December
2010. Letters are collected that reference academic institutions. The address
block in the letters identifies the specific organization. Those organizations that
appear to be academic institutions are separated from those organizations and
institutions that appear to be by name medical.
The collection phase of data collection identifies in the body of the letter,
reference to social science research projects. When a letter determined to
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address social science research the letters were separated for further review.
When determination letters seeming to reference social science research
projects have been separated, they were reviewed for the following:


Institution name



Project title



Reason for correspondents from OHRP



Response from institution



Initial finding of OHRP



Final finding of OHRP

The results of the review of determination letters are compiled using
Complementary Analysis Research Method Application (CARMA).
Telephone Interviews
Morgan (1988) suggests that an interview is a purposeful conversation
with the purpose to obtain information from the other. Marshall and Rossman
(1999) note that in-depth interviews focus on the individual‘s lived experience.
This phase of the study focuses on human research protection program (HRPP)
administrators. Marshall and Rossman suggest that in-depth interviews are used
as a strategy to capture the deep meaning of the individual‘s experienced in his
or her own words. HRPP Administrators are recruited for this phase of the study.
HRPP Administrators must process specific skills and knowledge of
protecting human subjects. Their knowledge includes a high level of proficiency
in regulations that oversee ethical standards of human research. In-depth
knowledge of the Federal policy (45 CFR 46) which governs human research
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protection standards is the paramount expectation for the HRPP Administrator,
as the Common Rule (Subpart A) is the basic policy for the protection of human
research subjects. Comprehensive knowledge and understanding of the Federal
policy is required of the HRPP Administrator to perform adequately in the position
(Bankert and Amdur, 2006). The authors suggest the HRPP Administrator has
complex responsibilities of understanding, interpreting, and documenting
research regulations as well as hold the position of the institution‘s chief authority
on regulations pertinent to the IRB whose primary function is to protect human
research subjects.
The HRPP Administrator ensures the IRB is operating in full compliance
with Federal and institutional research compliance regulations. The IRB
Administrator provides leadership in establishing and modifying IRB policies and
procedures including developing ways to improve the IRB functions, policy
changes, criteria for classifying projects as research, forms for documentation of
IRB activities, as well as develops standard wording in the consent document
(Bankert & Amdur, 2004, p. 70). The authors suggest HRPP administrators often
are advisers to risk-management and compliance officials for institutional
research policies, and advise the institution‘s teaching professionals on the
standards for research compliance for those conducting human research. The
HRPP Administrator is also required to develop a structured education program
for IRB members and researchers related to human research regulation and the
facets of IRB review and approval of research protocols.
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Amdur & Bankert further suggest that HRPP Administrators devote
―considerable amount of time to continuing education‖ and their profession
because of new regulations being circulated and existing regulations ―being
interpreted in new ways‖ (p. 71). The authors additionally put forward that many
HRPP Administrators engage in professional organizations specific to their
profession, subscribe to professional IRB journals, attend conferences and
become members of IRB forums. HRPP administrators are consistently aware of
social science research projects submitted and can be in daily contact with the
project‘s investigators. Therefore, HRPP administrators can offer noteworthy
insight for this study.
In-depth interviewing is used as a technique to gather descriptive data in
the subjects‘ own words for the purpose of developing insight as to how the
HRPP Administrator interprets some portion of their professional world. Bogdan
& Biklen (2003) put forward that, although qualitative interviews are relatively
open-ended and can vary in the degree to which they are structured, the
interviews can be focused on a specific topic and may be guided by general
questions. Bogdan & Biklen furthermore, suggest that semi-structured interviews
can ensure the researcher of obtaining comparable information across
respondents.
Babbie (2004, p. 300) suggests that the qualitative interviewer must be
completely familiar with the questions to be asked, allowing the interview to have
a natural and smooth progression. The interviewer in this study has more than 10
years‘ experience in human research protections as a Director and IRB
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Administrator. This research project includes a mode of semi-structured
questions. Follow-up questions are asked as appropriate to the participants‘
response.
The qualitative research technique of in-depth interviewing involves
individual interviews with a small number of respondents to investigate their
perspectives on a particular idea, program, or situation (Creswell, 2007). As
noted by Marshall and Rossman (1999) "the participant‘s perspective on the
phenomenon of interest should unfold as the participant views it, not as the
researcher views it. Boyce and Neale (2006, p. 3) suggest that "in-depth
interviewing is a qualitative research technique that involves conducting
intensive individual interviews with a small number of respondents to explore
their perspectives on a particular idea, program, or situation.‖ They posit that
those associated with the program may be interviewed about their experiences
and expectations in regard to the program, including program operations,
processes, outcome, and any changes they perceive they have experienced in
the program. Six participants were interviewed for this phase of the study.
Boyce and Neale‘s perspective parallel with the intent of this phase of the
research project which involves interviewing HRPP administrators about their
experiences in the duties they perform and oversee. The emphasis of the
interview questions is to compile data of their experiences, and expectations of
their program to protect human research subjects.
The primary advantage of in-depth interviews is that they provide more
detailed extensive information than what is available through other data collection
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methods, although there can also be disadvantages. Qualitative data from
interviews can be ambiguous which may result in a more difficult analysis
process. In-depth interviews are useful when detailed information about a
person‘s thoughts and behaviors are to be explored. Interviews are often used to
provide context to other data such as the content analysis approach being used
in this study for additional understanding of the impact of regulating social
science research with biomedical regulations.
However, there are limitations and weaknesses to in-depth interviews.
Marshall and Rossman (1999) suggest that interviews involve personal
interaction and cooperation is essential. Interviews have particular strengths.
According to Marshall and Rossman, in-depth interviews can result in large
amounts of data quickly with the possibility of immediate follow-up and
clarification. Marshall and Rossman further suggests that there are limitations
and weaknesses to the interview process. "Interviews involve personal
interaction and cooperation is essential. Interviewees may be unwilling or may be
uncomfortable sharing all that the interview hopes to explore, or they may be
unaware of recurring patterns in their lives" that may cause the respondent
concern (p .110). Although large amounts of data can be acquired through
interviewing, the data are very time consuming to analyze.
In-depth interviews are flexible in that they can be presented in a number
of ways, having no specific format to follow. In-depth interview data may stand
alone or be included in a larger evaluation report (Patton, 2002). The author
suggests when presenting results of in-depth interviews, care must be taken in
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presenting the data by the use of qualitative descriptors rather than try to quantify
the information.
Therefore, with the understanding that in-depth interviews are effective as
a tool to use in combination with other research methods, in depth interviews are
appropriate for this study. The purpose of the interviews is to explore the HRPP
administrators‘ point of view as it relates to protecting human research subjects,
specifically those involved in social science research projects. Using open ended
questions in a semi-structured format, the goal of this phase of the project is to
interpret what is being said in order to explore the respondent‘s viewpoint,
position and perspectives (Creswell, 1997 and Guion, 2006).
Creswell (1997); Denzin and Lincoln (2005); Kvale (1996); Babbie (2004)
posits that there must be a positive rapport with the respondent keeping in mind
that the researchers paramount duty is to listen and observe what is being
articulated. Guion (2006) and Babbie (2004) suggests strategies to improve the
quality of the in-depth interview experience include rephrasing and, allowing the
respondent to speak freely as the researcher guides the conversation to ensure
issues of interest are covered, to be open to deficiencies from the topic but using
care to return the conversation back to the topic (see Figure 4). For increase
accuracy and reference, audio record the conversation when possible. In-depth
interviewing is used in combination with content analysis and policy evaluation.
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Figure 4. Strategies for In-Depth Interviewing

Telephone Interview Questions
1. What is your role in your institution‘s human research protection
program?
How long have you worked in this role?
2. What has been the role of the HRPP in protecting human
research

subjects involved in social science research?

3. If your institution has ―un-checked‖ the box on the Federalwide
Assurance, how has un-checking the box affected the review
and approval of social science research projects?
4. The Common Rule is based on a biomedical regulatory model
of human research protections. How are the components of the
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biomedical regulatory model working for social science research
projects?
5. What, if any, concerns have social science researchers reported
to your HRPP related to the review and approval of their
research projects?
a. How does the Common Rule address some of these
concerns?
b. What do you (if you do) see as the major impediment in
applying the Common Rule to social science research project
review?
6. How would you characterize the regulation of social science
research?
7. If you could modify the Common Rule to be specific to social
science research projects, what would the change/s look like?
Policy Evaluation
The system of protecting human participants in social science research
studies relies on federal regulatory standards imposed in the policy of the
Common Rule. Relying on Fischer‘s work on policy evaluation method, this
phase of the study is focused on the author‘s four interrelated discourses of
policy evaluation including: program verification; situational validation; societal
level vindication, and social choice, aligned with CARMA as shown in Table 6.
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Jezierska (2009), in collaboration with the author Putney successfully
applied CARMA to an evaluation of policy. A similar application of alignment of
CARMA with Fischer‘s‘ Four Steps of Inquiry is used in this study.
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TABLE 6
CARMA Aligned with Fischer’s Four Steps of Inquiry/Four Interrelated
Discourses

Policy
Expectations

Evident
Implementation

Results

Conclusions and
Recommendations

Initiator's

Users/Participants Compare/Contrast
expected with
evident

Evaluate
Interpretations

Who is being
served? Who
is involved?

All are evident
participants?

Expected versus
evident

How are
participants to
be served?

How are
participants using
the service?

Expected versus
evident

What will be
produced by
participants in
the program?

What was
produced by
participants in the
program?

Expected versus
evident

What are the
implications?
Modify or maintain
program
What are the
implications?
Modify or maintain
program
What are the
implications?
Modify or maintain
program

Step 1

Step 2

Step 3

Step 4

Verification:
Intended
Outcomes

Validation:
Objectives

Societal
Vindication:
Goals

Social Choice
Values

Program objective
Policy fulfills its relevant to the
Instrumental or
stated
problem
contributive value
objective?
situation?
to society?
Source: Putney (2008) & Jezierska (2009)
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Provides for a
legitimate
resolution for
conflicting
judgments?

Fischer (1995) suggests that policy evaluation is also referred to as policy
analysis or policy science. Fischer (2003) indicates that Harold Lasswell‗s
influential approach to policy analysis include assumptions of empiricist and post
empiricist thought as a visionary in the evolution of the policy analysis. Quade
(1982) denotes that policy analysis is "a form of applied research carried out to
acquire a deeper understanding of sociotechnical issues and to bring about
better solutions‖ (p. 5). Yanow (1996, p. 2) suggests that policy analysis is
"designed to supply information about complex social and economic problems
and to assess how a policy or program is formulated and implemented."
Wagener (2003) maintains that policy analysis, as Fischer also suggests, is
fundamentally interpretive and reflexive (p. 30). Therefore, to evaluate the
Common Rule for better understanding of its effectiveness for the social
sciences, policy analysis is appropriate as an investigation technique for this
study.
Policy analysis emerged in the 1960s and the 1970s with the practice now
being used throughout governmental institutions and political organizations with
the emphasis on producing and transforming information and arguments relevant
to policy problems. In 1987 Byrne suggested that values are not easily quantified
and can often be in conflict, but although a definite solution may not be achieved,
a reasonable solution can be achieved, provided there is informed understanding
of the general levels of costs and benefits and their distributions (p. 73).
Fischer indicates that the logic of cost-benefit analysis involves a
compilation of costs and benefits of a policy to determine its net value. Fischer
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further suggests that cost-benefit analysis has been the subject of theoretical and
practical disagreement due to its difficulty to quantify ―policy inputs‖ and ―policy
outputs,‖ stating ―the technique systematically underplays social objectives that
cannot easily be measured in quantitative terms." (p. 116). Writing in 1987, John
Byrne also suggests that cost benefit analysis was the tool of public policy
making and evaluation. Dunn suggests that ―policy analysis can be formally
defined as an applied social science discipline, which uses multiple methods of
inquiry and arguments to produce and transform policy relevant information that
may be utilized in political settings to resolve policy problems‖ (1981, p. 35). As
previously discussed, there are many instances in which biomedical research
policy has benefited from the Common Rule Policy. Social scientists have
concerns that the Common Rule policy does not have similar benefit or have
similar impact on research in their disciplines because the policy is geared
towards the biomedical model of research.
Lasswell, identified as the founder of the policy field, defined policy
science orientation utilizing three characteristics (1) a multidisciplinary
approach,(2) problem oriented focus that was contextual in nature and (3) and
explicitly normative orientation (Fischer, 2003, p. 3). Yet another way of
assessing policy is asking the question, is the policy accomplishing its stated
purpose or not (Fischer, 1995)? The question asked by Fischer is also asked in
in the analysis using the CARMA methodology.
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Validity
Klenke (2008) suggests that the terms of validity in qualitative paradigms
are the terms credibility, which parallels internal validity, transferability which
parallels external validity, dependability which parallels reliability and
confirmability which parallels objectivity. Lincoln and Guba (1985) suggests that
trustworthiness of qualitative research methods consist of credibility,
dependability, transferability, and confirmability.
Credibility/Internal Validity
Credibility is the extent to which the results as indicated in qualitative
research are credible or are believable from the standpoint of the participant.
Credibility can be a test when there is the presence of multiple realities to insure
the realities are represented adequately. Credibility is seen as the greatest
available estimate to the truth of intentions. Internal validity in qualitative research
concerns the findings of the research study and its approximate match to the
reality espoused (Patton, 1990, Merriam, 2001). It is the degree in which
interpretations and concepts share mutual meanings. While, Lincoln and Guba
(1985) state that "the determination of such isomorphism is in principle
impossible" (p. 294) since ―the precise nature of that reality‖ (p. 295) is not known
whereas, Kvale (1996) suggests that validity can apply to qualitative
methodology given that, in a broader concept validity can pertain to whether a
method of observations reflect the phenomenon or variables of interest, thereby
in principle qualitative research can lead to valid scientific knowledge..
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Patton (1990) suggests credibility of qualitative data can be enhanced
through the use of triangulation of research methods used. As discussed, a three
pronged methodological approach consisting of content analysis of documents,
in-depth interviews and policy evaluation is used. ―Member checks‖ as posed by
Lincoln and Guba (1985, pp. 313-316) can also be used to address credibility.
Member checks are used with participants of in-depth interviews along with
making the data available for others to analyze.
Transferability/External Validity
Transferability is the extent to which results of the findings can be
transferred to additional contexts or settings. In qualitative research although the
researcher is unable to specify if the results of the study can be transferred to a
larger population ,it can be conceded that the information can be extrapolated to
determine if it fits a particular situation (Lincoln and Guba, 1985; Patton, 1990).
Dependability/Reliability
Dependability in qualitative research aligns closely with reliability in
quantitative research suggests Lincoln and Guba (1985, p. 300). The authors
puts forward that dependability is achieved when independent investigators can
obtain similar results of the study. Lincoln and Guba further suggests the use of
an ―inquiry audit‖ to enhance dependability of qualitative research (p. 317). The
man in his own ―inquiry audit‖ is achieved by reviewers‘ examination of the data
for consistency of the process and the product of the research study (p. 317). All
data from this study will be available for the minimum of three years for
reviewers‘ to perform an inquiry audit.
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Confirmability/Objectivity
Lincoln and Guba (1985) propose that confirmability is the extent to which
an audit inquiry of raw data, analysis notes, reconstruction and synthesis
products, process notes, personal notes and preliminary development
information can be confirmed by another. All data will be made available for
confirmation.
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Summary
Social science researchers have suggested, the components of their
research activity contained much less risk to human research subjects than that
of biomedical research. Institutions are required to follow the policies of the
Common Rule for federally funded research projects, as they are also required to
follow their institutions‘ policies for human subject research. Social scientist
suggest that using the Common Rule to review and approve their research that is
minimal and less than minimal risk amounts to overregulation and mission creep
by institution‘s HRPP (Schrag, 2009; Pittenger, 2003; Lincoln, 2005).
To better understand the impact of the Common Rule on social science
research activity three methods of inquiry are applied in this qualitative study.
Content analysis of OHRP determination letters, in-depth interviews of human
research protection program administrators and policy evaluation of the Common
Rule will provide a better understanding of the impact of the Common Rule for
social science research activity.
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Chapter 4
Findings of the Study
The findings of three qualitative research methods are presented in this
chapter. Content analysis of OHRP determination letters using CARMA as a tool
of analysis, in-depth interviews of human research protection program
administrators, and policy evaluation of the Common Rule utilizing CARMA
aligned with Fischer‘s Four Steps of Inquiry were the methods used to address
the following research questions:
1. What are the findings of deficiencies and findings of
noncompliance indicated in OHRP determination letters (DL) for
social science research projects?
2. What impact does the Common Rule have on social science
research protocol review by human research protection
programs?
3. Has the Common Rule achieved its intended purpose of
protecting human research subjects participating in social
science research?
Content Analysis of OHRP Determination Letters Using CARMA
CARMA is used as an analysis tool to address Question 1: What are the
findings of deficiencies and findings of noncompliance indicated in OHRP
determination letters (DL) for social science research projects? Steps in
preparation to gather the sample for the analysis of the OHRP determination
letters are described below.
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Determination letters are publically available and located on the OHRP
Internet website at: http://www.hhs.gov/ohrp/compliance/letters/index.html . The
public access site contains letters sent to institutions beginning, July 2000. A total
of 763 letters (the initial sample) were sent to institutions from OHRP between
2000 and 2010 (see Appendix P). A total of 763 letters were reviewed in Step
One of the content analysis of OHRP determination letters.
In Step Two of the content analysis, the researcher further reviewed from
the sample letters addressed to colleges and universities within the United States
(U.S.). The vast majority of colleges and universities that were sent determination
letters fall within the Carnegie Foundation‘s Classification Description of RU/VH:
Research Universities (very high research activity); RU/H: Research Universities
(high research activity); and DRU: Doctoral/Research Universities.20 These
research institutions conduct social science, and or biomedical research.
However, it was beyond the purview of this research project to definitively
calculate which institutions conducted social science research projects,
biomedical research projects or both social science and biomedical research
projects. RU/VH, RU/H and DRU institutions within the U.S. were included in the
sample. Letters sent to what appeared by name to be medical centers, medical
companies, hospitals, pharmacies, clinics and other medical facilities were not
included in the sample because social science research projects were the focus
of this study. There was a high probability that determination letters sent to
20

The Carnegie Foundation appointed the Carnegie Commission on Higher Education in 1970 to develop
a classification of colleges and universities to support its program of research and policy analysis. The
classification system was derived from empirical data on colleges and universities. The Carnegie
Classification was originally published in 1973, and has been updated in 1976, 1987, 1994, 2000, 2005, and
2010 to reflect changes among colleges and universities.
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medical facilities and universities reflected noncompliance or deficiencies in
medical research projects. Therefore, in Step Two, the revised sample included
288 determination letters.
In Step Three, the determination letters were reviewed for project
information contained in the Reference (RE:) section of the letter. If the
determination letters did not reference a Project Title in the ―RE:‖ section of the
determination letter, the letter was not included in the sample. Project titles that
suggest biomedical research projects were excluded. Samples of biomedical and
social science research project titles are shown in Table 7. Two hundred and
forty-five determination letters, with what appeared to be biomedical projects
were excluded from the sample. Forty-three letters representing social science
research projects remain in the new sample.
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Table 7
Examples of Social Science and Biomedical Research Project Titles from
OHRP determination letters

Social Science
Examples
of
Research
Project
Title

Biomedical

 Socio-Cultural
Determinants of
Utilization of Breast
Cancer Awareness and
Prevention Services
 The Impact of
Education in Navajo
Nation Border
Community Public
Schools
 Study of HIV/AIDS
Perception, Attitudes,
and Knowledge Among
University Students
 Research Investigating
How Restaurants
Handle FoodPoisoning Complaints
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 Dynamical Studies in
Frontal and Temporal
Lobe Epilepsy
 A Phase I/II Study of
Sequential Vaccinations
with ALVAC-CEA with
the Addition of IL-2 and
GM-CSF in Patients
with CEA Expressing
Tumors
 A Dose Response
Study of Inhaled Nitric
Oxide in the Treatment
of Adult Respiratory
Distress Syndrome
 Study of 4% Lidocaine
Intranasally to Treat
Migraine

In Step Four, the contents of the remaining sample of 43 OHRP
determination letter were analyzed for noncompliance and deficiency matters
related to social science research projects. The sample of 43 documents were
analyzed for noncompliance and deficiencies containing reference to the
Common Rule, Subpart A, §101-124 using Complementary Analysis Research
Method Application (CARMA), as shown in Table 8. A determination letter that
appears to be a social science research study (in reviewing the project title) can
be found at Appendix Q.
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Table 8
Complementary Analysis Research Method Application (CARMA)
1
Determination
Letter
Expectations
NOTE-TAKING

2
Evident
Implementation
NOTE-TAKING

Initiators

Users/Participa
nts

Compare/Contr
ast expected
with evident

Evaluator
Interpretations

Who is being
served?
Who is
involved?

Who are
evident
participants?

Expected vs.
evident

What are the
implications?
Modify or
maintain
program?

How are
participants to
be served?

How are
participants
using the
service?

Expected vs.
evident

What are the
implications?
Modify or
maintain
program?

What will be
produced by
participants in
the program?

What was
produced by
participants in
the program?

Expected vs.
evident

What are the
implications?
Modify or
maintain
program?
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3
Results
NOTEMAKING

4
Conclusions
and
Recommendati
ons
NOTEREMAKING

The CARMA process of analysis consists of first, Note-Taking. NoteTaking is used in this study in two ways. First, in Table 9, Column 1, Note-Taking
represents the expectations of the program and then compares the expectations
of the program with what is evident in how the program functions. The researcher
examined what the program initiator (OHRP) expected to accomplish with the
determination letter program.

Table 9
Note-Taking Expectations of Initiators and Participants of OHRP
Determination Letter Program
1
Determination Letter
Expectations
Note taking
Initiators

Who is being served?
Who is involved?

How are participants
to be served?

What will be produced
by participants in the
program?

Note-Taking

The Office Of Human research Protection (OHRP) initiates
correspondence to institutions that have obtained an FWA
from OHRP. Institutions are notified when OHRP finds that
there may be a matter of noncompliance or a deficiency with
the approved research study. The determination letter
details date-specific required action by the institution and
responds to the action taken by the institution.
The institution is ultimately involved as a result of being
engaged in research that is covered by the Common Rule
and has an approved Federalwide Assurance. Specifically,
the institutional review board having approved the research
project, human research protection program which provides
administrative assistance to the institutional review board,
and the social science researcher, who implements the
research project are served by the correspondence from
OHRP.
OHRP provides leadership in the protection of the rights,
welfare, and wellbeing of subjects involved in research by
providing oversight and guidance to institutions. OHRP does
this in one way by the issuance of determination letters.
The institutional review boards, human research protection
programs, researchers and institutions, as a result of the
correspondence from OHRP address concerns of
noncompliance and deficiencies stated in the determination
letter as applicable to the Common Rule in an attempt to
provide protection of the rights, welfare, and wellbeing of
subjects involved in the research project.
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Second, the researcher then compared the expectations to what is
Evident Implementation (how the program is being carried out) of the
determination letters being sent by OHRP and received by the participants (the
institution) as shown in Table 10.

Table 10
Note-Taking Evident Implementation
2
Evident
Note-Taking
Implementati
on
Users/Particip Institutions respond to Federal requirements as
ants
documented in the determination letters. HRPPs
revise and add additional policies and procedures in
reference to the findings of the determination letters.
IRBs revise their review and approval process to
address the determination letters findings of
noncompliance and/or deficiencies. Researchers
revised their research study to address issues of
noncompliance, and or deficiencies.
Who are
Same
evident
participants?
How are
Institutions implemented additional policies and
participants
procedures, increased human research educational
using the
programs for researchers, institutional officials, and
service?
human research protection program staff. All changes
were related to the regulations of the Common Rule
as indicated in the findings of noncompliance, and or
deficiencies detailed in the determination letter sent to
the institution by OHRP.
What was
To ensure that research subjects are fully protected
produced by
from harm and that research funding is not withdrawn
participants in from the institution by Federal agency sponsors,
the program? additional policies, and increased procedures, with an
increased level of scrutiny in the research protocol
review process commenced.
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suggests the Note-Taking strategy in this phase is to discern what is evident in
the actions of participants. In Table 10 the researcher has described the evident
implementation of the program from the researcher‘s point of view.
Although the entire response from institutions responding to the
correspondence from OHRP is not publicly available, the subsequent response
from OHRP referencing portions of the institutions response is publicly available.
It is the subsequent response information from OHRP that is used for NoteMaking as shown in Table 11 to further analyze the reactions to the
determination letter by the participants. The Expectations are then compared with
the Evident Implementations for interpretation of the data and thereby changing
the Note-Taking phase to the Note-Making phase to ascertain whether
congruence or divergence exists as shown in Table 11. During the Note-Making
stage the researcher sought to determine if the Evident Implementation fit the
expectation of response from the institution to OHRP.
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Table 11
Note-Making Results of Expectations and Implementations of OHRP
Determination Letters
3
Results
Compare/Contrast
expected with
evident

Note making
Institutions respond to Federal requirements as
requested by OHRP in the determination letters.
Institutions revise and add additional policies and
procedures in reference to the findings of the
determination letters. IRBs revise their review
and approval process to address the
determination letter‘s notation of noncompliance
and, or deficiencies. Researchers revised their
research protocol to address issues of
noncompliance or deficiencies.
OHRP‘s resubmittal of correspondence in reply to
the institution‘s corrective actions taken in the
determination letter indicated that the issues of
noncompliance and or deficiencies indicated was
slated to be addressed by the institution
immediately. In all cases the expectation of the
correspondence was addressed by the institution.

Modify or
maintain?

Expected vs.
evident
Expected vs.
evident

In all cases institutions and their human research
protection programs, institutional review boards,
and researchers complied with requests in the
determination letter made by OHRP. It would
appear that OHRP‘s publicly available
determination letters should be maintained.
Same
Social science researchers are expected to
safeguard the welfare and rights of those that
volunteer in their research projects. From the
indications of corrective action requested by
OHRP as noted in the determination letters,
research subjects were not in imminent danger of
being harmed based on the determination letters.
It was evident that social science researchers
were protecting the welfare and safety of their
research subjects since determination letters did
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not indicate that there had been incidents of
imminent danger to the research subjects.
Administrative procedural deficiencies of the
institution were the major focus of determination
letters sent to institutions regarding approved
social science research projects. Based on the
information contained in the determination letters
it‘s supported that institutions needed additional
guidance in promulgating the Common Rule.

Expected vs.
Evident

Determination letters served as an educational
tool for institutions and should be maintained.
Institutions and their human research protection
program, institutional review boards and
researchers provide additional documentation
and practices to address the concerns cited in
the determination letter. OHRP acknowledged
the corrective action that has been addressed. In
all cases from the review of each determination
letter it was evident that the corrective action was
in the process of being addressed, or had been
addressed by the institution.

The final stage of the analysis was Note-Remaking as shown in Table 12.
The researcher‘s interpretation from Expectations and Evident Implementation
was determined, resulting in the subsequent step, Recommendations. The
analysis clearly indicates the evident and expected were aligned.
Forty-three cases of noncompliance and or deficiencies from June 2000 to
January 2011 represented social science research projects as determined by the
project name listed in the determination letter on the OHRP publicly available
Internet portal. In all cases OHRP indicated that institutions were taking
corrective action or had taken corrective action to mitigate the concerns of the
agency.
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Table 12
Note-Remaking Results of Expectations and Implementations of OHRP
Determination Letters
4
Results
Note Remaking
Maintain or modify
Of 763 determination letters reviewed from 2000 to
program in terms of 2010 43 letters appear to be related to social science
who is being served research projects in which OHRP cited issues of
noncompliance or deficiencies. Seven hundred and
twenty (720) letters were sent to institutions which
referenced biomedical research projects.

Maintain or modify
program in terms of
how systems are
being served

Maintain or modify
program in terms of
outcomes being
produced by them

As a result of the corrective actions requested by
OHRP, biomedical research projects should be the
main focus of the regulatory elements of the Common
Rule.
The number of social science research projects (43) as
compared to the number of biomedical projects (720) to
receive determination letters may indicate there are far
fewer incidents of noncompliance or deficiency in social
science research than biomedical research. It may also
indicate that biomedical research is funded by federal
agencies at much greater rates than social science
research. Also the disparity of the disciplines‘ numbers
could suggest that social science has most of its
research falling into the exempt or expedited categories
of the Common Rule.
The program should be modified to address the unique
differences of social science research projects due to
the level of risk involve in the majority of it research
activity. .
Biomedical research projects in general contain a
higher level of risk to the subjects than that of social
science research as indicated in a corrective action
requests by OHRP. Research implemented at a much
lower level of risk to the research subject may not
warrant the identical regulatory standards and scrutiny
of the institution‘s IRB as biomedical research projects.
The regulatory oversight by OHRP of social science
projects should be modified to accommodate research
which contains much less risk than that of biomedical
research projects.
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The concerns of OHRP as documented in determination letters of social
science projects were overwhelmingly focused on inadequacies of the review
and approval process completed by the IRB, and administrative errors
representing noncompliance or deficiencies as shown in Table 13. Based on the
specific Federal regulation of the Common Rule, OHRP requested that the
institution address findings of noncompliance, and deficiencies involving the
particular research study, policies and procedures directly related to the
institutional review board, administrative procedures, and institutional human
research policies.
The majority of OHRP concerns raised in determination letters were
directly related to the functioning of the IRB and their administrative support staff.
Very few OHRP concerns raised in the determination letters could be directly
attributed social science researchers increasing the risk of harm to subjects
participating in their studies. A selection of OHRP‘s determination letters detailing
Required Actions are found in Appendix Q. The database of determination letters
can be viewed at http://www.hhs.gov/ohrp/compliance/letters/index.html.
Risk of imminent harm or danger to research subjects did not appear to be
the focus of noncompliance or deficiency indicated in the correspondence of the
determination letter referencing social science research projects.
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Table 13
Noncompliance or Deficiencies Cited In Social Science
Determination Letters from 2000-2010
Federal
Regulation

OHRP Reference to the Section Of The Common Rule

46.101(b)

IRB has applied an exemption to research activities that exceeded these
categories.

46.103(a)

assurance regulations not documented properly in IRB policy

46.103(b)

study conducted without IRB approval

46.103(b)(2)

IRB did not have a duly constituted, functioning IRB and the IRB did not
conduct initial or continuing review of the protocol review and recordkeeping
duties

46.103(b)(4)

no written procedures conducting initial and continuing review

46.103(b)(4) & (5):

written IRB policies and procedures do not provide specifics of operational
details (i.e., initial review, conducting continuing review, etc.)

46.103(b)(4)(iii)

protocol changes were initiated to the approved protocol without further IRB
review and approval
no written policies for unanticipated problems involving risks to subjects or
others or any serious or continuing noncompliance

46.103(b)(5)

46.103(f)

IRB does not have written procedures adequately describing IRB activities

46.103(f)

IRB did not review grant application referenced in protocol prior to the initiation
of research

46.107 (e)

chair and associate chair have conflicting interest – staff of Office of
Sponsored Programs

46.107(a)

IRB not sufficiently qualified regarding race, gender, cultural background, and
sensitivity to community attitudes

46.109(a)

HRPP sent letter of approval to the investigator prior to getting modifications
as requested by IRB move

46.109(e)

regulations make no provision for any grace period extending the conduct of
the research beyond the expiration date of IRB approval

46.110(b)

expedited review procedures failed to be carried out by the IRB chairperson or
by one or more experienced reviewers designated by the chairperson from
among members of the IRB

46.110(b)(1)

IRB inappropriately compounds the concept of minimal risk and expedited
review
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Table 13
Noncompliance or Deficiencies Cited In Social Science
Determination Letters from 2000-2010 (continued)
46.110(b)(2 )

inappropriate use of expedited review procedures

46.110( C )

IRB did not keep all IRB members advised of the approval of expedited
protocol

46.111

IRB approval of the proposed research not deferred, pending subsequent
review by the convened IRB of responsive material., IRB lacked sufficient
information to make determinations required for approval of research

46.111(a)(7)

there are no adequate provisions to protect the privacy of subjects and to
maintain the confidentiality of data

46.115(a)(1)

difficult to reconstruct a complete history of all IRB actions related to the
protocols, copies of research proposals and backup materials and other
documents not available to OHRP

46.115 (a)(2)

IRB meeting minutes not documented

46.115(a)(2)

vote of IRB actions including number of members voting for, against, and
abstaining not recorded in the minutes

46.115(b)

signed parental permission forms must be retained for at least three years
after completion of the research (no mention of time-frame in protocol)

46.116

IRB failed to require legally effective informed consent or parental permission,
and/or document waiver of informed consent Informed consent not presented
in language understandable to the subject

46.116(a)

study did not include basic elements of informed consent that was reviewed
and approved by the IRB

46.116(a)(1)

IRB did not review adequate explanation of purposes of the research and
complete description of procedures to be followed

46.116(a)(2)

adequate description of risk and benefits not described in protocol that was
reviewed and approved by the IRB
informed consent documents and parental permission forms that reviewed and
approved by IRB did not include all of the elements outlined in the regulations
that was reviewed and approved by the IRB

46.116(b)

46.116(d)

no documentation or procedure which alters or waives the requirements for
informed consent

46.117( C )

no documentation of IRB waiver of signed informed consent form
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Analysis of Determination Letters
To answer the Research Question 1: what are the findings of deficiencies
and findings of noncompliance indicated in OHRP determination letters (DL) for
social science research projects, a qualitative approach to content analysis of
documents (DL) was utilized in this study. Seven hundred and sixty three (763)
letters were reviewed by the researcher in order to identify nonmedical academic
research institutions that had received a DL from OHRP. Two hundred and
eighty-eight (288) DL were identified from the sample of 763 DL as being
nonmedical institutions. The 288 DL project title was reviewed for wording that
appeared to denote a social science research project.
Forty-three (43) letters were found to have reference to what appeared to
be social science research projects. The sample of 43 letters were further
reviewed for OHRP reference to the Common Rule, Subpart A, §101-124. Using
CARMA to analyze the contents of the sample, Note-Taking (1) (Table 9)
identified the expectations of the OHRP DL program. OHRP was identified as the
initiator of the DL program, with the institution including the IRB, and the HRPP
administrative staff identified as the participants that are being served by the
OHRP DL program.
The next stage (2) of Note-Taking in Table 10 identified how the program
is implemented and what was produced by the program participants including the
institution), the HRPP, the IRB and social science researchers. The next stage
(3) Note-Making, in Table 11, was used to determine the expected response from
the participants (the institution) versus the evident response related to the
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requests of OHRP in the DL. In all cases program participants responded to the
requests noted in the DL. The expected and evident response was congruent.
The last stage (4) of CARMA was Note-Remaking. Note-Remaking
focuses on assessing whether the program should be maintained or modified.
The findings of the Note-Remaking stage suggests the OHRP determination
letters program indicate that noncompliance and, or deficiencies to the Common
Rule were attributed overwhelmingly to IRBs and their support staff, but not
specifically to social scientists‘ research projects. The concerns of OHRP as
documented in the DL of social science projects were overwhelmingly focused on
inadequacies of the review and approval process completed by the IRB, and
administrative errors of the HRPP. Therefore CARMA suggests that the vast
majority of OHRP determination letters were effective in providing guidance and
oversight to HRPPs in general, the OHRP determination letter program did not
reveal a profusion of non-compliance or deficiencies that could be specifically
attributed to social science research projects.
Telephone Interviews of HRPP Administrators
Telephone interviews consisted of identifying and contacting human
research protection program administrators (HRPP administrators).HRPP
administrators were identified from determination letters sent to the institutions
HRPP administrators within the last 7 years. OHRP make determination letters
available to the public, thereby publicizing the name and title of the HRPP
administrator for the institution notified of non-compliance and or deficiency to the
Common Rule. Determination letters (DL) are publically available on the OHRP
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internet portal found at: http://www.hhs.gov/ohrp/compliance/letters/index.html.
Contact information for the HRPP administrator was available on the institution‘s
employee directory site.
Five HRPP administrators were contacted as a result of the determination
letter. One HRPP administrator was chosen at random from the list of universities
found on the Carnegie Foundations website at:
http://www.carnegiefoundation.org/ . A total of six HRPP administrators were
interviewed by telephone. HRPP Administrator‘s identity remains confidential in
this report. Interviewees‘ names were replaced by identification numbers and
their institution is not referred to in this analysis. All participants in the study
expressed concern that their institution remain confidential for the purposes of
this study. Confidentiality and privacy was maintained in this study. Table 14
shows questions and responses from the interviewees conducted on March 25,
and March 28, 2011.
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Table 14
Telephone Interviews - Questions and Responses
Question 1: What is your role in your institution‘s human research
protection program? How long have you worked in this role?
Interviewee
000-050
Interviewee
052-093
Interviewee
095-179
Interviewee
181- 227
Interviewee
233-286
Interviewee
291-342

IRB Administrator.
6 years
IRB Director and voting member of the committee.
23 years
Administrative Director, Social Behavioral IRB.
8 years
HRPP Program Director
11 years
Director, Institutional Research and Effectiveness.
9 years
Director of Research Compliance.
8 years

Question 2: What has been the role of the HRPP in protecting human
research subjects involved in social science research

Interviewee
000-050

Interviewee
052-093

We’ve done a lot of enhancements in terms of our
procedures of our guidance documents and
educational outreach to educate our investigators.
We now have a stronger program
We protect subjects involved in all types of
research
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Table 14
Telephone Interviews - Questions and Responses (continued)

Interviewee
095-179

Interviewee
181- 227

Interviewee
233-286

The university has worked very hard to be
progressive where the federal regulations allow
particularly for social and behavioral research. We
have unchecked the boxes on our FWA, for
research that is federally sponsored that fall under
social and behavioral sciences IRB. We have
created demonstration projects, we have issued 2
year approval periods, we have created a new
exemption category, and we have done a lot of
work to try and maintain a superior level of
protection for our subjects but also implemented
some different procedures that decrease
administrative burden while keeping subjects safe.
As far as social science we have provided some
education but not nearly enough for researchers to
fully understand the Federal rules and regulations
including why what seems to him to be minimal risk
research still needing to go through that process.
We have done a better job in providing education
for the IRB. We constantly try to keep up with the
new types of social science research we’re seeing.
Some of it is now collaborative research with
biomedical
We have a lot of workshops with the IRB and
researchers. I have a staff person that provides
education for researchers and the IRB. This has
helped us with the review process to insure
research participants are safe and we have a much
faster turnaround time for social science protocols
since researchers know what the IRB is looking for
in providing an ethically sound study.
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Table 14
Telephone Interviews - Questions and Responses (continued)

Interviewee
291-342

Our role is not unlike that of biomedical. But I think
it may be a little more difficult for the IRB to
address some of the issues related to social
science and the Common Rule. We just had a
qualitative study that was very difficult since most
of our members do not have experience in
qualitative research. The protocol was combined
with medical records review and blood draws. So
you see how that can be cause for lots of
deliberation. Sometimes there is no clear path
except common sense. We provided education for
the campus and the IRB but we have lots of empty
seats.

Question 3: If your institution has ―un-checked‖ the box on the Federalwide
Assurance how has un-checking the box affected the review and approval
of social science research projects?

Interviewee
000-050

Interviewee
052-093

Interviewee
095-179

We have unchecked the box. We still review
everything the same way but I think the one thing it
may have done is given us more flexibility in terms
exempt category 1 vs. expedited category 7. So if
we’re on the fence we can be a little more lenient
than we would be otherwise.
No, our committee reviews social science and
biomedical research. We treat the review process
the same.
By unchecking the box you are able to get flexibility
in how you can create equivalent protections for
human subjects, so we are trying to take
advantage of that by creating different procedures
where we are able to, where there is not federal
sponsorship or where the research is not held to
the Common Rule by contract.
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Table 14
Telephone Interviews - Questions and Responses (continued)

Interviewee
181- 227

Interviewee
233-286

Interviewee
291-342

We have just unchecked the box. I think it will
mainly help in the review of unfunded research
especially student research projects. The expedited
reviewer and the IRB will have more flexibility in the
approval of minimal risk research.
We unchecked the box two years ago. Review of
protocol and now be done much faster. The
protocol receives this same amount of scrutiny it
did prior to the box being unchecked but the IRB
can now use more latitude in the review process.
We have not unchecked the box yet. I expect we
will get to it in the next few months. The IO is on
board but there are still members of the IRB that
believe unchecking the box will have an impact on
how we are perceived to our constituents, although
we know that the system of review will not change.
We will get to it I am sure. It can only help with the
speed in getting protocols approved for the
researcher

Question 4: The Common Rule is based on a biomedical regulatory model
of human research protections. How are the components of the biomedical
regulatory model working for social science research projects?

Interviewee
000-050

I think there are some gaps, one is the exempt vs.
the expedited particularly in that area with kids and
in the other areas some of the regulations need to
be updated in regards to what we see in the social
sciences in Internet research and newer research
areas like that. So we have tried to have templates
for each area and we try to use the common sense
approach since the Common Rule is written for the
biomedical area.
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Table 14
Telephone Interviews - Questions and Responses (continued)

Interviewee
052-093

Interviewee
095-179

Interviewee
181- 227

I guess I disagree I think the regulations of the
Belmont report applies to all research and can be
affectively applied to all research
That’s a fabulous question. I think social scientists
and the IRB have had to work creatively to fit
certain social science models into those
regulations because as you mentioned they really
were contemplated for the biomedical arena so it
does take some creativity to do that. I think more
recently across three to five years we have noticed
a change in the perspective of social science
research. For example there is much more biospecimen and bio-banking collection associated
with social science research so, it has more of a
biomedical flavor to it than it use to. I also think
another emerging research portfolio is research
involving the internet research and social
networking. That has actually been a challenge to
try and find places for that type of research model
within the Common Rule because it was clearly not
contemplated several decades ago. So on one
hand you have a component to social science
research getting more of a biomedical flavor on the
other hand you have some research diverging
even more from those regulations.
They could be working better for social and
behavioral science research projects. With so
many different areas that are not addressed (in the
Common Rule) it can be difficult for us in the prereview process and for the IRB
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Table 14
Telephone Interviews - Questions and Responses (continued)

Interviewee
233-286

Interviewee
291-342

I think researchers the IRB and all involved in
conducting research want to have to safe studies.
The Common Rule does provide components that
work for social science research but it is up to the
HRPP to provide education for increased
understanding of the flexibility within the
regulations. The biomedical model used for social
science may not accommodate or address the
aspects of social science research. The exempt
and expedited categories are trying to address
some of the aspects but new areas of research
including social media, is challenging for the IRB. A
revamping of the Common Rule is really needed to
support our researchers and the IRB better.
It has worked relatively well here since we began
workshops a couple of years ago to address areas
of social science research studies with the IRB,
staff and our researchers. We are still spending a
lot of time on some projects and have no clear
guidance like that of biomedical studies. Most of
our research here is social and behavioral science.

Question 5: What, if any, concerns have social science researchers
reported to your HRPP related to the review and approval of their research
projects.

Interviewee
000-050

Interviewee
052-093

Of course everyone wants their projects approved
yesterday. Chairs and committee members change
and the researcher questions why a protocol was
approved on day and not approved the next? So I
think there are questions about continuity and
disapprovals so they get pretty upset with this.
They (social science investigators) felt they had to
do it (go through the IRB process) because they
are at a medical institution
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Table 14
Telephone Interviews - Questions and Responses (continued)

Interviewee
095-179

Interviewee
181- 227

Interviewee
233-286

Interviewee
291-342

I think savvy researchers realize the Common Rule
was not written with social scientists in the forefront
of the feel of those regulations, and I think the
savvy researchers find the IRBs need to kind of fit
a square peg into a round hole troublesome for
them because they feel it limits their flexibility,
probably the biggest concern for us.
Investigators frequently remind us that the approval
process is too long and that they are required to
make revisions to the protocol that protect the
institution and not their research participants. Of
course we provide training sessions from
completing the protocol form to understanding 45
CFR 46 but they still are very frustrated for the
most part when the protocol has to conform to the
standards of the regulations.
Turn-around time is always a big issue. Exempt
protocols are another one. We have an exempt
reviewer that turns the study around rather quickly.
Most of our researchers don’t have a lot of
concerns with our office they just want to begin the
research as soon as possible.
We have recently had a few calls about additional
documentation needed for internet studies. Chat
room research has become very popular here. The
concern is that we review it mainly as expedited
research and there is some concern that it should
be an exempt review.

Question 5a: How does the Common Rule address some of these
concerns?
Interviewee
000-050

It doesn’t.
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Table 14
Telephone Interviews - Questions and Responses (continued)
Interviewee
052-093

Interviewee
095-179

Interviewee
181- 227
Interviewee
233-286
Interviewee
291-342

It’s pretty clear that it (the regulations) applies to
everything, all types of research.
There are so many different models of social
science research. I think it (the concerns) is not
being addressed. I think the IRB has had to work
very hard to make it (the Common Rule) fit the
research models. For example some of the issues
around waver of documentation of informed
consent can be particularly challenging. For
example, for more than minimal research you can’t
always issue a waiver of documentation because
that is prohibited by the regulations. That is exactly
the time you would want to issue it (the waiver).
You don’t want the subjects name connected to the
research or on a piece of paper of informed
consent because it’s a risky for the subjects but we
are prohibited from waiving that documentation.
I’m not sure it does. But maybe the key is to
understand what is allowable in the regulations
during the review process
It doesn’t that I am aware of.
There is no mention of Internet research in the
regulations. This is one of the concerns we have in
applying the regulations to the different kinds of
research we have here.

Question 5b: What do you (if you do) see as the major impediment in
applying the Common Rule to social science research project review?

Interviewee
000-050

I think it’s just keeping up with the times because it
(the Common Rule) just has not changed since it
was written and there is so much need for its
flexibility in
terms of some of the investigators with research
that just doesn’t meet the category of exemption
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Interviewee
052-093

Interviewee
095-179

Interviewee
181- 227
Interviewee
233-286

Interviewee
291-342

I don’t see an impediment.

Some of the Common Rule elements have too
much specificity and not enough flexibility for the
IRB to make some of the determinations and that
example I gave about when you could issue a
waiver of documentation is a perfect one.
It just not the same fit as it is for biomedical. We
spend a lot of time trying to make it fit.
What I see is a lot of busy work that keeps us from
doing the essential work of protecting participants.
We have to have some guidelines and right now
this is all we have. I don’t see so much of an
impediment as I see in the need for a specific set of
social and behavioral guidelines for human-subject
protections.

Question 6: How would you characterize the regulation of social science
research?

Interviewee
000-050
Interviewee
052-095

They could use some updating. The regulations are
just not keeping up with the times, like internet
research.
I think the regulations are flexible enough to work
for all research
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Table 14
Telephone Interviews - Questions and Responses (continued)

Interviewee
095-179

Interviewee
181- 227

Interviewee
233-286

Interviewee
291-342

It is awkward because the Common Rule has
expectations that much of the work will be clinical
in nature with the exception of the exemptions
which clearly carve out educational research and
some other components like that but, strict to Part
A, it does not leave enough flexibility with the IRB.
It makes it awkward. It makes it a challenge to fit all
the different types of social science research
models within that. For example, It’s quite different
when you are being asked to review an
ethnography study from a study of children in a
behavioral interventional kind of perspective one
requires flexibility and the other requires additional
protections for the children and neither one of
those elements are contemplated well when those
Common Rule elements do have such a
biomedical focus.
It can be daunting. On one hand we want to make
sure research participants are protected but we
don’t want to instill unnecessary concern by
including everything that might happen to them as
a result of the study. The regulations address the
necessity to be very specific for biomedical
researchers by the very nature of the kinds of
research. Many times it’s just over kill for social
science research. IRBs want to make sure they
adhere to their charge and require that which is
required for biomedical studies.
We have not had any major incidents so I guess
that would speak to the effectiveness of the
regulations. IRB deliberations can be very complex
and time consuming but they get it right mainly.
The regulations are very useful in protecting human
subjects but it needs to be more specific to social
and behavioral science projects
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Table 14
Telephone Interviews - Questions and Responses (continued)

Question 7: If you could modify the Common Rule to be specific to
social science research projects, what would the change/s look like?

Interviewee
000-050
Interviewee
052-093

Interviewee
095-179

Interviewee
181- 227

I would give it a facelift especially the exempt
categories and also add more flexibility in terms of
the continuations and the one-year rule.
I think the regulations are flexible enough to work
for all research
As previous in my answer question I would ask that
the IRB be given more flexibility to make additional
determinations based on the nature of the project
particularly if you are not talking about research
with vulnerable subjects that would fall under the
subparts. That would be really helpful because
again I recognize that the government does not
want to touch the regulations frequently and
change them. Then if that’s their model they should
either issue guidance more frequently to allow IRB
to make certain determinations or expand the
determinations possible under the regulations or
give the IRB more flexibility to do that themselves
with more latitude than the Common Rule currently
offers that way we can adapt to new models.
I would look into disciplines of the social sciences
and not group them under the same umbrella of
regulation. Research in education may be much
different than research in oral history. The
humanities are much different than economics. It
can be difficult at times for staff and the IRB to
reconcile how the regulations best serve a study in
these fields. I would just like to make the
regulations more in line with social science
research.
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Table 14
Telephone Interviews - Questions and Responses (continued)

Interviewee
233-286

Interviewee
291-342

Increase the exempt categories to reflect more of
the work that social and behavioral science
conducts. I would make specific reference in the
regulations to things like Internet research.
Two separate set of regulations would make the
process of review and approval so much more
efficient and effective for all concerned. We spend
so much time in meetings discussing protocols that
should be expedited but are not clearly defined as
such in the regulations.
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Analysis of Telephone Interviews of HRPP Administrators
Six human research protection program administrators (HRPP
administrators) were recruited to be interviewed for this study. HRPP
administrators were identified from determination letters that had been sent to
their institution by OHRP. Carbon copies of determination letters are sent to the
institution‘s HRPP administrators, thereby publicizing the name and title of the
HRPP administrator for that institution. Since determination letters (DL) are
publically available on the OHRP internet portal found at:
http://www.hhs.gov/ohrp/compliance/letters/index.html the researcher had access
to the contact information for the HRPP administrator from the institution‘s
employee directory. Five HRPP administrators were contacted as a result of the
determination letter. One HRPP administrator was chosen at random from the list
of universities found on the Carnegie Foundations website at:
http://www.carnegiefoundation.org/ . A total of six HRPP administrators were
interviewed by telephone. HRPP Administrator‘s identity remains confidential in
this report. Interviewees‘ names were replaced by identification numbers and
their institution is not referred to in this analysis. Interviewees were conducted on
March 25, and March 28, 2011.
The role of all HRPP administrators suggested the leadership position in
the HRPP, although titles were somewhat different. Titles included IRB
Administrator, IRB Director, Administrative Director, Program Director, Director,
Institutional Research and Effectiveness and Director of Research Compliance.
Years of leadership service in the role was from 6-23 years. HRPP administrators
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reported enhancing the procedures in their program and documents and revising
documents (HRPP policies) for a stronger program of protection for human
research subjects.
Interviewee 095-179 reported that the university had worked hard to be
progressive especially where the federal regulations allow for social and
behavioral research. The administrator had unchecked the boxes on the FWA, to
disallow research that is not federal funded from being under the purview of the
Common Rule. This being especially beneficial for social science projects that
are not federally funded projects. Demonstration projects have been created, and
unlike research which falls under the purview of the Common Rule, 2 year
approval periods have been issued instead of one year approval periods.
Administrator 095-179 also reports that they have ―created a new exemption
category, and we have done a lot of work to try and maintain a superior level of
protection for our subjects but also implemented some different procedures that
decrease administrative burden while keeping subjects safe,‖ as shown in Table
14, Question 2.
Administrators report additional human research compliance education for
the IRB and researchers as well as the HRPP keeping abreast of new areas of
social science research such as social media. Social media is a concern for
HRPPs, in that the Common Rule does not directly address this form of research.
Interviewees also reported that there are ―gaps‖ in the Common Rule which
needs updating to address newer research areas. The lack of flexibility was
another concern of administrators. An additional concern as stated by
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Interviewee 291-342, in Table 14, Question 2, IRB members ―do not have
experience in qualitative research‖ to be efficient in the review and approval
process.
Five out of six interviewees expressed concern that the Common Rule did
not accommodate social science research practices and that IRB‘s struggle in
deliberation with the review and approval process for social science projects
often this resulted in excessive documentation, revision requests of the
researcher to conform to the standards of the Common Rule while creating time
delays for the approval of the researcher‘s study. Administrators suggest that the
concerns of the IRB and researchers related to qualitative research, level of
review for social media and other new areas of research studies is not addressed
in the Common Rule. The lack of regulatory guidance for social science research
projects continue to be a large concern for HRPPs providing regulatory guidance,
for IRB‘ in their deliberation processes and for the social science researchers
needing approval for their research projects while protecting human research
subjects and avoiding overregulation and mission creep.
Findings from the phone interviews included comments from HRPP
Administrators suggesting the need for additional human research compliance
education for the IRB and researchers, as well as for the HRPP staff to keep
abreast of new research areas of social science research. Some administrators
had already begun additional educational components to their programs but
others needed to provide more education. The additional education was useful
for HRPP staff and the IRB. The administrators reported that social media is a
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concern for HRPPs, in that the Common Rule does not directly address this form
of research. Interviewees also reported that there are ―gaps‖ in the Common
Rule which needs updating to address newer research areas. The lack of
flexibility of the Common Rule was recurring concern reported by administrators.
Administrator 291-342, Question 2 in Table 14 reported that IRB members ―do
not have experience in qualitative research‖ to be efficient in the review and
approval process for social science qualitative research projects.
The finding in the chapter also included interviewees expressed concern
that the Common Rule did not accommodate social science research practices
and that IRB‘s struggle in deliberation with the review and approval process for
social science projects often resulting in excessive documentation, revision
requests of the researcher to conform to the standards of the Common Rule
while creating time delays for the approval of the researcher‘s study. The lack of
regulatory guidance for social science research projects was found to be a large
concern for HRPPs providing regulatory guidance for IRB‘ in their deliberation
processes and for the social science researchers needing approval for their
research projects while protecting human research subjects and avoiding
overregulation and mission creep.
Policy Evaluation Using CARMA Aligned with Fischer’s
Four Steps of Inquiry
This section of the research study addresses the Research Question 3:
has the Common Rule achieved its intended purpose of protecting human
research subjects participating in social science research? Fischer suggests that
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policy related ideas are mainly arguments favoring various ways of looking at the
world, which results in resolving the problem and therefore policy should be
evaluated in terms of efficiency or effectiveness. In determining efficiency or the
effectiveness of a policy, Fischer suggests four interrelated discourses can be
used to evaluate the policy: 1) technical analytic discourse or program verification
(outcomes), 2) contextual discourse or situational validation systems (objectives),
3) systems discourse or social vindication (goals), and 4) ideological discourse or
social choice (values).
Program Verification: The aim of program verification is to understand how
the program fulfills its objectives efficiently and effectively. Program verification
assesses if the program has fulfilled its objective/objectives, are there secondary
or unanticipated effects that offset program objectives and does the program
fulfill objectives more efficiently than alternative means available.
Situational Validation: Situational validation focuses on if the program
objectives are relevant to situation at hand. Validation has its concern in
understanding if the program objective is relevant to the situation, are there
circumstances that may require exception to the objectives, and are their two or
more conditions that are also relevant to the problem situation.
Societal Vindication: The focus of societal vindication is on the societal
system in its entirety, and the consequences of the policy to the societal system.
The concerns of societal vindication are deliberated in concerns of instrumental
or contributive value for society, and does the policy goal result in unanticipated
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problems with important societal consequences, and does the policy goal lead to
consequences that are judged to be equitably distributed.
Social Choice: Social choice is discerned by assessing whether the social
order is essentially provided with a basis for a legitimate and equitable resolution
of judgments that may be in conflict, and is there evident support for an
alternative ideology to the policy.
Putney‘s (2008) qualitative evaluation tool, Complementary Analysis
Research Method Application (CARMA) is similarly an evaluation tool to describe
and interpret efficiency or effectiveness of a program or in this case, the
Common Rule policy. Therefore, to assess efficiency or effectiveness of the
Common Rule CARMA was aligned with Fischer‘s (1999) framework of public
policy evaluation. Aligning both qualitative methods assisted in the assurance of
credibility of this study.
CARMA and Fischer‘s framework for public policy evaluation contained
four essential steps. Each step of CARMA; (Expectations, Implementation ,
Results and Conclusions /Recommendations) was aligned with each of the four
steps of Fischer‘s framework for public policy evaluation (Verification, Validation,
Vindication, and Social Choice). The alignment of CARMA with Fischer‘s
interrelated discourses produced the following results as shown in Table 15.
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Table 15
The Common Rule Policy aligned with CARMA and Fischer’s
Four Steps of Inquiry
1. Program Expectations
Note-Taking
Program initiator : Office of Human
Research Protections (OHRP)

1. Verification
Outcomes
Program: Common Rule policy
with oversight by OHRP‘s of
institutions having an FWA and
conducts human subject
research regulated by the
Common Rule

Who is being served? Who is
involved?
Institutions, HRPPs, IRBs,
Researchers are being served and
are involved in the program.

Does the program empirically
fulfill its stated objectives?
The Common Rule instructs
institutional review boards to
ensure that ―risks to subjects are
minimized‖ and ―risks to subjects
are reasonable in relation to
anticipated benefits, if any, to
subjects, and the importance of
the knowledge that may be
reasonably expected to result (45
CFR 46.111(a)(1, 2).

How are participants to be served?
Notified by OHRP of
noncompliance or deficiencies in
the approved research project of
actions and requests that ought to
be taken to insure the safety and
welfare of research subjects.

What will be produced by
participants in the program?
Requests made by OHRP including
revision of institutional human
research policies, additional
documentation in research
protocols, additional education for
HRPP staff, IRB, and researchers,
additional time investment in the
review and approval of research
protocols.

Does the empirical analysis
uncover secondary or
unanticipated effects that offset
the program objectives?
The regulations of the Common
Rule may in some cases
increase the risks of those
participating in social science
research projects (i.e.,
anthropological studies). The
doctrine of signed informed
consent may not be applicable to
all disciplines within social
science.
Does the program fulfill the
objectives more efficiently than
alternative means available?
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2. Evident implementation
Note-Taking
Users/participants.
The institution consisting of its
HRPP, the IRB, social science
researchers.

Who are evident participants?
Same

How are the participants using the
service? Required actions by
OHRP to fulfill the requirements of
the Common Rule result in
corrective actions being taken by
the institution.

What will be produced by
participants in the program?
Implementation of additional
policies and procedures may
suggest that risks to subjects are

Disciplines of social science are
guided by their own professional
ethics to protect human subjects.
However, to qualify for Federal
funding for research projects the
institution must hold an
assurance with OHRP and agree
to abide by all regulations of the
Common Rule. Therefore it has
not been established if the
program fulfill the objectives
more efficiently than alternative
means available seeing that
alternative means would not elicit
the funding needed to complete
the research project. Additionally,
most institutions have opted to
follow the regulations of the
Common Rule and regardless of
funding source
2. Situational Validation
Objectives
Is the program objective relevant
to the problem situation?
The objective of OHRP is to
protect the rights, welfare, and
wellbeing of subjects involved in
research conducted or supported
by the U.S. Department of Health
and Human Services (DHHS)
based on the regulatory
provisions of the Common Rule.
However, in order to accomplish
their objectives OHRP regulators
suggest that the institution, its
HRPP, the IRB and social
science researchers must define
their research practices in the
Common Rule.
Are there circumstances in the
situation that require an
exception to be made to the
objectives?
There are no exceptions made to
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minimized.

the objectives of the Common
Rule in its protection of human
research subjects. However,
§46.110 espouse expedited
review procedures for certain
kinds of research involving no
more than minimal risk, and for
minor changes in approved
research.
3. Results
3. Societal Vindication
Note-Making
Goals
Who are the participants?
Systems discourse: Does the
Same
policy goal have instrumental or
contributive value for the society
as a whole.
How are they working together?
The Common Rule is comprised
Expected vs. evident, alignment or
of a shared system of
departure?
responsibility for protecting
Federal agencies supporting social human research subjects as
science research studies,
indicated in corrective action
institutions and their researchers
taken by institutions when
work together to provide a culture of notified of incidents of
research compliance for the safety
noncompliance or deficiencies.
and welfare of research participants The shared system includes the
as indication in the determination
institution, the institutional review
letters. They appear to be aligned
board with its administrative
to provide ethical research
support staff (HRPP) and
practices articulated in the Common researchers. The Common Rule
Rule.
lays the foundation for ethical
research practices contributing to
the safety and welfare of
Modify or maintain?
research subjects. The policy
This practice should be maintained goal has a contributive value for
given that it appears from the
the society as a whole.
determination letters that
participants are working together to Does the policy goal result in
protect human research subjects.
unanticipated problems with
important societal
What was produced?
consequences?
Additional practices were
OHRP‘s publicly available
implemented as detailed in the
information regarding research
institution‘s revised policies and
studies that have issues of
procedures for protecting human
noncompliance or deficiencies
subjects. Amended policies and
cause institutions to act swiftly in
procedures included ethical
order to continue with the
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research education and training for
IRBs, administrative staff and
researchers.

Expected vs. evident, alignment or
departure?
These factors are in alignment. The
goal of the OHRP program,
institutions and their researchers is
to protect the safety and welfare of
research participants.
Modify or maintain?
Although the program appears to
be working, it is doing so since
there are no other alternatives. The
institution, HRPPs, the IRB and
social scientists have little options
to alternative programs.
4. Recommendations
Note-ReMaking
Researcher
The Common Rule policy of
regulating Social science research
by the same standards as
biomedical research appears on
the surface to be working.
However, facets of the biomedical
model of human research
protection cannot always be
applicable to social science
research.

Informed consent is an essential
element of the Common Rule.
Informed consent can be approved
by the IRB as signed informed
consent or verbal consent, as in
telephone interviews. Social
scientists have concerns that the
IRB may not utilize the flexibility of
the Common Rule in the
application of verbal consent,

research, and mitigate bad
publicity that can occur to the
institution and ensure continued
funding for the project. By acting
swiftly institutions may only be
able to provide the minimum
remedy to address the
determination letter when
remediation in different ways
could have additional impact on
the system of social science
research.

4. Social Choice
Values
Do the fundamental ideas (or
ideology) that organizes the
accepted social order provide a
basis for a legitimate resolution
of conflicting judgments?
The Common Rule provides a
medium for shared meanings of
the ethical standards by which
human research must be guided.
The Common Rule effectively
provides guidelines in which this
can be accomplished. The
Common Rule also provides
flexibility in the usage of the
ethical standards and guidelines
applicable to human research.
Social scientists contend that
flexibility of the Common Rule‘s
usage is not made readily
available to them; thereby social
scientists see a need for specific
regulations to address social
science research.
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causing cumbersome and time
consuming measures for the
researcher and the research
subjects.

Modify or maintain program?
The Common Rule should be
modified to specifically address
new areas of social science
research.

Analysis of Policy Evaluation
To answer Research Question 3: has the Common Rule achieved its
intended purpose of protecting human research subjects participating in social
science research, Fischer‘s (1995) four interrelated discourses consisting of:
1) program verification (outcomes), 2) contextual discourse or situational
validation systems (objectives), 3) systems discourse or social vindication
(goals), and 4) ideological discourse or social choice (values) was aligned with
CARMA, Putney (2008). CARMA consists of four areas of evaluation, 1) program
expectations, 2) evident implementation, 3) results, and 4) recommendations.
The alignment was used to interpret efficiency and effectiveness of the Common
Rule policy. Disciplines of social science are guided by their own professional
ethics to protect human subjects. However, to qualify for Federal funding for
research projects the institution must hold an assurance with OHRP and agree to
abide by all regulations of the Common Rule. Therefore it has not been
established if the program fulfill the objectives more efficiently than alternative
means available seeing that alternative means would not elicit the funding
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needed to complete the research project. Additionally, most institutions have
opted to follow the regulations of the Common Rule regardless of funding source.
Alignment 1 consists of program expectations (note-taking) with program
verification (outcomes). The Office of Human Research Protections (OHRP)
oversees the Common Rule policy as operational human research subject policy
and guidelines for Institutions, HRPPs, IRBs, and researchers. The Common
Rule instructs institutional review boards to ensure that ―risks to subjects are
minimized‖ and ―risks to subjects are reasonable in relation to anticipated
benefits, if any, to subjects, and the importance of the knowledge that may be
reasonably expected to result‖ (45 CFR 46.111(a)(1, 2). Requests made by
OHRP as a result of noncompliance or deficiency to the Common Rule are
documented to the institution. Requests can include revision of institutional
human research policies, additional documentation in research protocols,
additional education for HRPP staff, IRB, and researchers.
Secondary or unanticipated effects that offset the program objectives
include, as an example the doctrine of signed informed consent may not be
applicable to all disciplines within social science and additional time investment in
the review and approval of research protocols are produced by the participants.
The regulations of the Common Rule may in some cases increase the risks of
those participating in social science research projects (i.e., anthropological
studies).
Alignment 2, evident implementation (note-taking) and situational
validation (outcomes) suggests the institution consisting of its HRPP, the IRB,
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and social science researchers fulfill required actions requested by OHRP
consistent with the Common Rule. The objective of OHRP is to protect the rights,
welfare, and wellbeing of subjects involved in research conducted or supported
by the U.S. Department of Health and Human Services (DHHS) based on the
regulatory provisions of the Common Rule. However, in order to accomplish their
objectives OHRP regulators suggest that the institution, its HRPP, the IRB and
social science researchers must define their research practices with the
regulations of the Common Rule, not necessarily by social scientists professional
code of ethics. There are no exceptions made to the objectives of the Common
Rule in its protection of human research subjects. However, §46.110 espouse
expedited review procedures for certain kinds of research involving no more than
minimal risk, and for minor changes in approved research.
Alignment 3 of results (note-making) and societal vindication (goals)
suggest Federal agencies supporting social science research studies, institutions
and their researchers work together to provide a culture of research compliance
for the safety and welfare of research participants as indication in the
determination letters appear to be aligned to provide ethical research practices
articulated in the Common Rule. The Common Rule is comprised of a shared
system of responsibility for protecting human research subjects as indicated in
corrective action taken by institutions when notified of incidents of noncompliance
or deficiencies. The shared system includes the institution, the institutional review
board with its administrative support staff (HRPP) and researchers. The Common
Rule lays the foundation for ethical research practices contributing to the safety
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and welfare of research subjects. The policy goal has a contributive value for the
society as a whole.
OHRP‘s publicly available information regarding research studies that
have issues of noncompliance or deficiencies cause institutions to act swiftly in
order to continue with the research, and mitigate bad publicity that can occur to
the institution and that may cancel federal funding for the research project. By
acting swiftly institutions may only be able to provide the minimum remedy to
address the determination letter when remediation in different ways could have
additional impact. Based on the analysis of alignment the program should be
modified to address additional research areas that impact social science such as
social media, qualitative research, anthropological research, and areas specific
to social science.
Alignment 4 Recommendations (note-Taking) and social choice (values)
The Common Rule policy of regulating Social science research by the same
standards as biomedical research appears on the surface to be working.
However, facets of the biomedical model of human research protection cannot
always be applicable to social science research, especially the new areas of
research. Do the fundamental ideas (or ideology) that organizes the accepted
social order provide a basis for a legitimate resolution of conflicting judgments?
The Common Rule provides a medium for shared meanings of the ethical
standards by which human research must be guided. The Common Rule
effectively provides guidelines in which this can be accomplished but may lack
the flexibility needed by social scientists to conduct their research in an effective
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and efficient manner. Although the Common Rule provides some flexibility in the
usage of the ethical standards and guidelines applicable to human research,
social scientists contend that flexibility of the Common Rule‘s usage is not made
readily available to them by the IRB, leaving many social scientists to see a
need for specific regulations to address social science research (Gunsalus et al.,
2006; Schrag, 2009).
The analysis of the alignment of CARMA with Fischer‘s Four Steps of
Inquiry indicates that although the Common Rule is somewhat effective for social
science research seeing that it is part of the only federal regulatory tool available,
it is not efficient in its use by HRPPs, the IRB and importantly, social science
researchers. The inefficiency presents itself in overregulation and mission creep
(Gunsalus, 2006; Schrag, 2009). Following, Chapter 5 presents discussion of the
findings, recommendations and chapter summaries of this study.
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Chapter 5
Discussion, Recommendations and Chapter Summaries
Implications from the Results of Data
Social science researchers suggest the components of their research
activity contained much less risk to human research subjects than that of
biomedical research. Social scientists conducing human research are required to
follow the policies of the Common Rule for federally funded research projects.
Using the Common Rule they suggest, to review and approve their research,
most of which is minimal and less than minimal risk to research subjects amounts
to overregulation and mission creep. To better understand the impact of the
Common Rule on social science research, implications from the data of three
methods of inquiry in this qualitative study is discussed. Three methods of inquiry
include: 1) content analysis of OHRP determination letters, 2) in-depth interviews
of human research protection program administrators, and 3) policy evaluation of
the Common Rule, Subpart A.
OHRP oversees human research conducted with federal funding. When
research projects are found to be in noncompliance to or deficient in the
regulations governing human research, OHRP provides a determination letter to
the institution. The determination letter contains findings of deficiency or
noncompliance based on the regulations of the Common Rule that regulates
biomedical and social science research. In an attempt to understand the impact
of regulating social science human research with biomedical regulations this
study sought to answer the Research Question 1: what are the findings of
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deficiencies and findings of noncompliance indicated in OHRP determination
letters (DL) for social science research projects? The qualitative approach to
content analysis of documents revealed that of the 763 letters 43 were found to
reference what appeared to be social science research projects. The sample of
43 letters were further reviewed for OHRP reference to the Common Rule,
Subpart A, §101-124. It was determined that deficiencies or noncompliance to
the Common Rule was attributed overwhelmingly to IRBs and their support staff,
but not specifically to social scientists‘ research projects.
The implication of the OHRP determination letter content analysis data
suggests that participants of social science research activity reviewed by OHRP
were not at risk of harm from the research activity. The data did however imply
that in many cases the IRBs and their administrative staff did not handle
procedural matters of the review and approval process correctly. Implications
from the data suggest that additional education and training related to the
Common Rule is necessary for the HRPP to develop better institutional human
research protection policies and procedures.
Six human research protection program HRPP administrators were
recruited for telephone interview for this study to answer the Research Question
2: What impact does the Common Rule have on social science research
protocol review by human research protection programs? The role of the HRPP
administrators interviewed suggested they held a leadership position in the
HRPP, with years of leadership service in the role ranging from 6-23 years.
Consistently administrators reported that there was a need for additional human
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research compliance education for the IRB and researchers as well as the HRPP
staff to keep abreast of new areas of social science research such as social
media. New research areas specifically was an expressed concern since
Common Rule does not directly address social media as a form of research.
Interviewees also reported that there are ―gaps‖ in the Common Rule which
needs updating to address newer research areas. The lack of regulatory flexibility
of the Common Rule was another consistent concern of administrators, as also
was the IRB‘s lack of experience in qualitative research methods. The
administrators also expressed concern that the Common Rule did not fully
accommodate social science research practices as it did for biomedical
researchers.
Implications from the interview data suggest that IRB‘s struggle in
deliberation with the review and approval process for social science projects,
often resulting in excessive documentation, revision requests of the researcher to
conform to the standards of the Common Rule while creating time delays for the
approval of the researcher‘s study. Lack of regulatory guidance for social science
research can result in inconsistent review of research projects by the IRB during
the deliberation process. Requiring additional documentation and revision to
protocols when no clear regulatory procedure can be relied upon can contribute
to overregulation and mission creep.
The fundamental notion of protecting human subjects whether in
biomedical research or social behavioral research is consistent within the
disciplines of human research as cited in the literature. However, the quandary of
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how best to facilitate the highest levels of human research protection in the social
science discipline remains vague. At the core of the issue is the Common Rule
and its application to the review and approval process of social science research
studies including what the literature suggests is minimal and less than minimal
social science research.
The majority of cases of unethical scientific research have focused on
biomedical investigations. As a result, federal regulations have provided
guidelines to ensure ethical research standards. The Common Rule is the
standard by which all federal human research is held, biomedical and social
science research. Analysis of the data in this research study indicates the
Common Rule does not have the flexibility of regulations to specifically regulate
the facets of social science research. IRBs are left to participate in deliberations
of social science research areas (with some being new areas of research such
as social media) without adequate regulatory guidelines, albeit in an attempt to fit
the social science research review and approval process within biomedical
regulations of the Common Rule.
The question of, has the Common Rule achieved its intended purpose for
social science research was analyzed via policy evaluation, aligning CARMA with
Fischer‘s Four Steps of Inquiry for four interrelated discourses. The analysis
indicates that the elements of biomedical research regulations do not translate to
the tenets of social science research. Although, the Common Rule is somewhat
effective for social science research it is not efficient in its use by researchers,
IRBs and the HRPP to address the tenets of social science research.
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The implications from the data of this study also suggest that the Common
Rule does not fully accommodate social science research practices. Partial
accommodation of social science research practices my lead to partial
protections for social science research subjects. However, implications of the
data also suggest that researchers, IRBs and HRPPs may find flexibility in the
Common Rule when the applicability of the Common Rule regulations is fully
understood in its application to social science research. As an example, waiver of
documentation of informed consent (45 CFR 46.117) may not be used to the
extent allowable when there is ambiguity regarding its use. The implication from
the data of the need for on-going education is prevalent in the data.
Recommendation for Policy Consideration
Institutional review boards need better regulatory guidelines for the
effective and efficient review and approve social science research. A separate
regulatory policy applicable to the tenets of social science research should be
developed for use by those conducting, reviewing and approving research
projects. Definitions must be included in the policy that adopts the language of
the disciplines of the social science profession. The policy development should
be undertaken by social scientists, vetted in the Federal Register and made
applicable to funded as well as unfunded and privately funded research projects.
Consistency of the application of the regulations social science research projects
should be a priority in the development of the document.
Researchers need to be assured that a policy in whole is applicable to
their research discipline. Categories of research applicable to the regulation
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should be delineated within the policy as to add consistency throughout the
social science research enterprise. The social science research policy should be
a document that can be revised and updated as new research areas are
identified. The policy should make provisions for all categories of exempt
research listed to be reviewed at the department of the primary investigatory. The
recommendations should serve as a beginning to removing a one-size-fits-all
approach to protecting human research subjects participating in social science
research activity.
Recommendation for Further Research
This study has provided a foundation for additional qualitative inquiry to
assess the impact of the Common Rule‘s biomedical standards being applicable
to social science research from the lens of the OHRP determination letters,
HRPPs and the Common Rule. Further research on IRB social science
deliberation strategies applicable to exempt, expedited and full board strategies
are needed to build on the foundation of the Common Rule‘s applicability to
social science or the lack thereof. Continued research, from varied social science
disciplines qualitatively investigating the impact of a one-size-fits-all regulatory
approach to protecting human subjects is needed. This research focused on the
basic policy for protection of human subjects, 45 CFR 46 Subpart A, additional
Subparts including Subparts B - E should be invested to assess the applicability
to social science research. Continued investigation of the current system of
human research protections for social science research may warrant an overhaul
to influence institutions, and politicians to revise institutional policies and
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procedures and federal regulatory mandates that are effective and efficient for
the varied disciplines of social science.
Chapter Summaries
Introduction - Chapter 1
In Chapter 1 of this study vegetable and meat experimentation with young
Jewish prisoners as early as the sixth century is reported as human research.
Prior to and including the 18th, the 19th, 20th centuries and beyond, revealed
human experimentation that has resulted in disease and death to some research
subjects. This chapter reveals that only since the 20th century has protections for
human research subjects been a requirement for ethical human research.
Although ethical requirements have been embodied in various professions, a
human research protection has taken a longer time frame to be embraced by
researchers. As a result of public outrage for unethical medical syphilis
experiments, the Berlin Code of 1900 (see Appendix B) was developed. Needing
a stronger code of ethical conduct for human subject research, and as a result of
the conviction of 16 of the 23 physician defendants, of which seven of those
indicted were sentenced to death, the Nuremberg Code was established. The
Nuremberg Code established additional standards of ethical medical behavior for
the post-World War II human rights era. Although German scientists were found
to have committed atrocious research experiments on human research subjects,
U.S. medical researchers still considered the research doctors as trusted and
revered scientists.
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The United States had committed its own unethical medical research for
many years without much concern for the human research subjects in their
studies. One of the most infamous studies was conducted by the U.S. Public
Health Office, was the Tuskegee Syphilis Study, conducted from 1932 until 1972,
in which men diagnosed with syphilis were left untreated to study the natural
progression of the disease. The Willowbrook State Hospital Study is the most
widely known unethical study on children. The study involved children diagnosed
with mental retardation, living at the Willowbrook State Hospital as patients from
1956 to 1971. Researchers infected the otherwise healthy children with hepatitis
to gauge the disease‘s natural history, prevention, and treatment.
While the 1947 Nuremberg Code was the world‘s reaction to Nazi war
crimes, the 1974 National Research Act Public Law 93-348 (see Appendix J) was
the response of the United States to the Tuskegee Syphilis Study. The National
Research Act established the IRB process requiring formal peer review and
approval of all DHHS research involving human subjects. The 1974 National
Research Act legislation also created the National Commission for the Protection
of Human Subjects of Biomedical and Behavioral Research (Commission).
Additionally, out of the Commission‘s Report came what was called the Belmont
Report, named for the Belmont Conference Center where the Commission met to
draft the report. The Belmont Report summarizes the basic ethical principles
identified by the Commission as respect for persons, beneficence and justice in
its application to informed consent, assessment to risk and benefits and the
selection of subjects. However, the Belmont Report did have its critics regarding
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its applicability to nonmedical research. It was noted that although the Belmont
Report ―is a notable achievement in the exploration of the ethical challenges
raised by medical research, but which serves as a poor guide to research in the
social sciences and humanities …‖ Although medical research was the initial
focus of human research protection intervention by the Federal government, the
―new sciences,‖ anthropology, sociology, economics, and political science also
came under scrutiny.
Social scientists voiced concern and suggested that the kinds of limited
harm social science research engenders is far less detrimental than that of
biomedical research. They put forward that seemingly ―over-zealous medical
scientist‖ has brought an increased level of scrutiny to social science research
evidenced by governmental regulations. Additionally, it was put forward that the
fields of anthropology, journalism, oral history, ethnography and other social
science fields already had well-established ethical research guidelines for their
profession.
Social scientists suggests that while these efforts to provide increased
protections for human research participants reflect a laudable goal, the
regulations do not necessarily apply or translate well to all disciplines of
research, particularly social science research. Social scientists further suggest
that the current human subjects regulations are obstacles to their research
studies and view the regulations as overregulation and mission creep because
the patterns of noncompliance and litigation are not seen in social science
research as in biomedical or clinical research.
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Therefore, the research problem of this study suggests there is a need to
test the critical assessment of the Common Rule in its application to the social
science research. The research questions of, 1) what are the findings of
deficiencies and findings of noncompliance indicated in OHRP determination
letters (DL) for social science research projects, 2) what impact does the
Common Rule have on social science research protocol review by human
research protection programs, and 3) has the Common Rule achieved its
intended purpose of protecting human research subjects participating in social
science research.
Review of Literature – Chapter 2
Chapter 2 presents a review of the literature related to social scientists‘
concerns of what, in the literature is called, ―over-regulation and mission creep‖.
The Chapter documents the historical perspectives of unethical human
experimentation as well as the regulatory standards put in place to protect
human subjects. In addition, the Chapter discusses prior research related to
researcher and institutional human research compliance while outlining the
necessity to investigate the impact of social science research that is regulated by
a medical model of human research protections.
Chapter 2 details social scientists concerns of the IRBs ―blizzard of
paperwork getting in the way of the fundamental mission to protect the dignity
and well-being of human subjects‖. Discussed also in this chapter is institutional
review board (IRB) workloads expanding beyond their ability to handle, due to
focusing much more on procedures and documentation, unclear definitions,
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leading to unclear responsibilities and efforts to comply with the standards of
human research requirements even when research is not federally funded. Social
science researchers characterize their concerns as overregulation and mission
creep resulting from the application of a regulatory process created for medical
research being applied to non-invasive and minimal risk social science research,
that usually is unfunded or privately funded. The chapter details social science
researchers increased concerns of the delay and even denial of their research
projects.
Historical perspectives of unethical human experimentation is documented
in the literature and presented in Chapter 2. Human experimentation in the
eighteenth century included regular offers of free pardon to inmates to participate
in human experiments. Experiments that included the inoculation of prisoners
with infectious small pox in variolation experimentation popularized in England in
1721-1722 is discussed with the same procedures being used in America on
slaves. Despite public concern of unethical research practices questionable
research practices continued for many years. Victoria Nourse‘s work, In Reckless
Hands, examines the case of Skinner versus Oklahoma (2008).21 Nourse details
a history of America's experiment with eugenics22 resulting in thousands of
incarcerated men and women having been sterilized. The ambiguity of American
human research practices during the 1920s and 1930s to attain ethical research

21

Skinner v. State of Oklahoma,1942, the United States Supreme Court ruling held that compulsory sterilization
could not be imposed as a punishment for a crime.
22
Eugenics is the study and practice of human selective breeding. The aim is to improve the species.
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standards arising from the uncertainty of using experimental research methods is
expounded.
Research regulation including the Berlin Code of 1900, one of the earliest
documents to address the outrage of medical research and its unethical
practices, the Nuremberg Code (1947) established as a set of ethical research
principles, the Declaration of Helsinki (Declaration) of 1964, revised in 1975,
developed by the World Medical Association as a set of ethical principles for the
medical research community is discussed.
Chapter 2 discusses the historical factors of the Common Rule having
been designed with a focus on biomedical research, with social science
researchers questioning whether the Common Rule should apply to social
science research. The Chapter presents details of The Office for Human
Research Protections (OHRP) as an agency of the Department of Health and
Human Services that provides leadership and oversight for the protection of the
rights, welfare, and wellbeing of subjects involved in research conducted or
supported by HHS agencies. OHRP documentation of the finding of deficiencies
and non-compliance in the form of determination letters is discussed. The
determination letters specifically outline what actions must be taken by the
institution to return to a compliant state, rectify a deficiency, or resume research
activity. The communication from OHRP to the institution is publicly available.
Research scientists posit that public availability of determination letters force
institutions to enact highly conservative in their IRB deliberative decisions.
Previous research relevant to this study is identified and discussed. The
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literature of determination letters studies revealed three similar research studies,
conducted by Borror et al. (2003), Burris and Welsh (2007) and Weil et al.(2010).
In each case their quantitative research revealed the numbers of citations of
noncompliance. The research projects did not delineate the numbers of
biomedical or social science citations of noncompliance or deficiencies. The
authors focused on the categories and numbers of noncompliance and
deficiencies found in determination letters. The focus was not on the discipline in
which those noncompliance and deficiencies were found.
The chapter expounds on the components of human research protection
program consisting of the investigators, the Institutional Review Board (IRB) and
its administrative staff as well as the institution. The HRPP of an institution
oversees the responsible conduct of biomedical and social science research,
protect the rights of research participants, reduce their risks, and increase the
benefits of the research. The literature review details concerns of social scientist
with their institution‘s HRPP administrative staff as they routinely encounter
impediments to their research when navigating Institutional Review Board (IRB)
review process to obtain approval for their research studies.
In 2001, the National Bioethics Advisory Commission (NBAC) complained
that Institutional Review Boards (IRBs) were overwhelmed not only
by high workloads generated by the amount of actions to process just one
research project (see Figure 2) and limited resources but also by a regulatory
system that often distracts from rather than focuses on key ethical issues.
Review of the literature in this chapter illustrated that investigators and
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IRBs must be more effective and efficient in carrying out their responsibilities, in
that way, improving research protections and increasing public trust in research.
The literature indications of noncompliance resulting in risk of harm to those
participating in social science research remains minuscule compared to OHRP
findings of noncompliance in biomedical research activity. Although there has
been much anecdotal comment in the literature on the topic of the application of
a one-size-fits-all approach to regulating social science research with biomedical
regulations, there seems to be no abundance of literature of the research to
substantiate the assertions that research participants are better protected in
social science research studies resulting from the biomedical regulatory model of
the Common Rule. Therefore, leading to the assertion that the social science
researcher may be over scrutinized for the harms that may result from their
research based on the amount of risk in typical social science research, including
surveys, interviews, oral history research and other types of minimal risk
research. The chapter discusses the federal regulations in its application to social
science research that continue to weigh heavily on institutions as they attempt to
balance the need for protecting human subjects in research, the need to support
their researchers‘ scholarly efforts and the need to minimize any untoward
liability claims on the institution.
Methods - Chapter 3
Chapter Three discusses the methods used to address three research
questions, 1) what are the findings of deficiencies and findings of noncompliance
indicated in OHRP determination letters (DL) for social science research projects,
183

2) what impact does the Common Rule have on social science research protocol
review by human research protection programs, and 3) has the Common Rule
achieved its intended purpose of protecting human research subjects
participating in social science research?
This study encompasses a three prong qualitative methodological
approach to answer the research questions above respectively using, content
analysis, in-depth interviews, and policy evaluation. To better understand the
impact of the Common Rule on social science research activity three methods of
inquiry are applied in this qualitative study. Content analysis of OHRP
determination letters, in-depth interviews of human research protection program
administrators and policy evaluation of the Common Rule is discussed as
providing a better understanding of the impact of the Common Rule for social
science research activity.
Relying on qualitative content analysis of documents to encompass a
theoretical framework having an approach of empirical, methodological controlled
analysis of texts within the context of communication and using systematic
content analytical scientific methodology is used to study OHRP determination
letters. The next phase of the study includes human research protection program
(HRPP) administrators. In-depth interviewing is used as a technique to gather
descriptive data in the subjects‘ own words for the purpose of developing insight
as to how the HRPP Administrator interprets some portion of their professional
world. In-depth interviews are used at this stage of the study as a strategy to
capture the deep meaning of the administrators‘ ―lived experience‖ of the HRPP
184

administrator in his or her own words. Six HRPP administrators were recruited for
this phase of the study due to their high level of knowledge of the Common Rule,
are advisers to risk-management and compliance officials for institutional
research policies, and advise the institution‘s teaching professionals on the
standards for those conducting human research.
The final method discussed in Chapter 3 is policy evaluation. This phase
of the study is focused on the Fischer‘s Four Steps of Inquiry for four interrelated
discourses of policy evaluation including: program verification; situational
validation; societal level vindication, and social choice, aligned with Putney‘s
Critical Analysis Research Method Application (CARMA). Policy analysis is used
in this study to evaluate the Common Rule for better understanding of its
effectiveness for the social sciences.
Findings of the Study Summary - Chapter 4
Chapter 4 details the findings of this study. To answer the Research
Question 1: what are the findings of deficiencies and findings of noncompliance
indicated in OHRP determination letters (DL) for social science research projects,
a qualitative approach to content analysis of documents (DL) was utilized in this
study. Seven hundred and sixty three (763) letters were reviewed resulting in
two hundred and eighty-eight (288) letters identified as nonmedical institutions.
The 288 DL project title was reviewed for wording that appeared to denote a
social science research project. Forty-three (43) letters were found to have
reference to what appeared to be social science research projects.
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The sample of 43 letters were further reviewed for OHRP reference to the
Common Rule, Subpart A, §101-124. Using CARMA to analyze the contents of
the sample, Note-Taking (1) (Table 9) identified the expectations of the OHRP
DL program. The findings suggest OHRP as the initiator of the DL program, with
the institution including the IRB, and the HRPP administrative staff identified as
the participants being served by the OHRP DL program.
The next stage (2) of Note-Taking in Table 10 found that the OHRP
program provided guidance to HRPPs and researchers based on their findings to
revise policies and procedures, and revise research protocol. The next stage (3)
Note-Making, in Table 11, used to determine the expected response from the
participants (the institution) versus the evident response related to the requests
of OHRP in the DL found that in all cases program participants responded to the
requests noted in the DL. The expected and evident response was congruent.
The last stage (4) of CARMA was Note-Remaking. Note-Remaking
focused on assessing whether the program should be maintained or modified.
The findings of the Note-Remaking stage suggests the OHRP determination
letters program indicate that noncompliance and, or deficiencies to the Common
Rule were attributed overwhelmingly to IRBs and their support staff, but not
specifically to social scientists‘ research projects. The concerns of OHRP as
documented in the DL of social science projects were overwhelmingly focused on
inadequacies of the review and approval process completed by the IRB, and
administrative errors of the HRPP. Therefore CARMA suggests that the vast
majority of OHRP determination letters were effective in providing guidance and
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oversight to HRPPs in general, the OHRP determination letter program did not
reveal a profusion of non-compliance or deficiencies that could be specifically
attributed to social science research projects.
To answer Research Question 2: what impact does the Common Rule
have on social science research protocol review by human research protection
programs six human research protection program administrators (HRPP
administrators) were recruited and interviewed by phone for this study. Findings
from the phone interviews included comments from HRPP Administrators
suggesting the need for additional human research compliance education for the
IRB and researchers, as well as for the HRPP staff to keep abreast of new
research areas of social science research. Some administrators had already
begun additional educational components to their programs but others needed to
provide more education. The additional education was useful for HRPP staff and
the IRB. The administrators reported that social media is a concern for HRPPs, in
that the Common Rule does not directly address this form of research.
Interviewees also reported that there are ―gaps‖ in the Common Rule which
needs updating to address newer research areas. The lack of flexibility of the
Common Rule was recurring concern reported by administrators.
The finding in the chapter also included interviewees expressed concern
that the Common Rule did not accommodate social science research practices
and that IRB‘s struggle in deliberation with the review and approval process for
social science projects, often resulting in excessive documentation, revision
requests of the researcher to conform to the standards of the Common Rule
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while creating time delays for the approval of the researcher‘s study. The lack of
regulatory guidance for social science research projects was found to be a large
concern for HRPPs providing regulatory guidance for IRB‘ in their deliberation
processes and for the social science researchers needing approval for their
research projects while protecting human research subjects and avoiding
overregulation and mission creep.
To answer Research Question 3: has the Common Rule achieved its
intended purpose of protecting human research subjects participating in social
science research, Fischer‘s (1995) four interrelated discourses consisting of:
1) program verification (outcomes), 2) contextual discourse or situational
validation systems (objectives), 3) systems discourse or social vindication
(goals), and 4) ideological discourse or social choice (values) was aligned with
the CARMA, Putney (2008). The alignment was used to interpret efficiency and
effectiveness of the Common Rule policy. Disciplines of social science are
guided by their own professional ethics to protect human subjects. However, to
qualify for Federal funding for research projects the institution must hold an
assurance with OHRP and agree to abide by all regulations of the Common Rule.
The findings of the alignment of CARMA with Fischer‘s Four Steps of Inquiry
indicates that although the Common Rule is somewhat effective for social
science research seeing that it is part of the only federal regulatory tool available,
it is not efficient in its use by HRPPs, the IRB and importantly, social science
researchers. The inefficiency presents itself in overregulation and mission creep
(Gunsalus, 2006; Schrag, 2009).
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Discussion, Recommendations and Chapter Summaries - Chapter 5
Chapter 5 discussed the implications of the data that suggests that OHRP
determination letters contained findings of deficiencies and noncompliance could
be attributed to procedural factors of the IRB and HRPP administration. In most
cases determination letters referenced policies that needed to be developed or
revision of the institutions existing human research policies, revealing that social
science research projects specifically, did not increase risks to human subjects.
Telephone interviews of HRPP administrators revealed that excessive
documentation, lack of flexibility in the deliberation process and may contribute to
overregulation and mission creep.
Recommendations for policy consideration included the need for better
regulatory guidelines for effective and efficient review and approval of social
science research. The findings of the research suggests that a separate
regulatory policy for social science should be considered and undertaken by
researchers representing various fields within the social science discipline.
Recommendations for further research included investigating deliberation
strategies applicable to exempt, expedited and full board protocol review.
Strategies are needed to build on the foundation of the Common Rule‘s
applicability to social science as well as the lack thereof. Chapter 5 included the
introduction to this author‘s research study, history of unethical research
practices, a review of the literature applicable to this research study, methods of
research to answer the research questions, findings, and finally, discussion of the
research.
189

Epilogue
Research ethics and its impact continue to be a contemporary issue
reaching into the past to rectify wrongs created by what could be seen as a lack
of Federal oversight. On October 5, 2010 the New York Times reported that from
―1946 to 1948 American public health doctors infected nearly 700 Guatemalans‖
that were comprised of ―prison inmates, mental patients and soldiers with
venereal diseases in what was meant as an effort to test the effectiveness of
penicillin.‖ It is not clear if the penicillin was effective and used to treat those that
had been infected by the American medical researchers. Again, financed with
American tax dollars the NIH ―even paid for syphilis-infected prostitutes to sleep
with prisoners‖, since Guatemalan prisons allowed such visits.
When the prostitutes did not succeed in infecting the men, some prisoners
had the bacteria poured onto scrapes made on their penises, faces or arms, and
in some cases it was injected by spinal puncture.‖ The Secretary Of State Hillary
Clinton and HHS Secretary Kathleen Sebelius ―offered an apology to the
government and the survivors and descendants of those infected.‖ The complete
article is found at:
http://www.nytimes.com/2010/10/02/health/research/02infect.html?_r=2
A recent publicized example of the lack of flexibility in the application of
the Common Rule is reported in Inside Higher Ed on March 25, 2011 as ―IRB
Overreach‖ of social science research:
An associate professor of education has sued
Brown University for barring her from using her own data
because she paid her human research subjects different
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amounts of money based on their economic status. The
suit raises questions about the role of IRBs in regulating
privately funded research, the fairness of their process
and the tensions that arise when such boards govern the
work of social scientists.
Based on the researchers recommendation discussed above this situation
could have been avoided to the satisfaction of the IRB and the researcher using
appropriate institutional and regulatory policies. On-going education for IRBs and
their support staff lends itself to better understanding of the flexibility available in
the Common Rule and regulatory procedures of protecting human subjects.
Although the immediate future does not suggest revamping of the Common Rule
to separately address social science research projects, the current literature
continues to promote that a one-size-fits-all regulatory oversight for social
science research and biomedical research may not be as effective or as efficient
as it could be otherwise. The article in its entirety can be found at:
http://m.insidehighered.com/layout/set/popup/news/2011/03/18/brown_professor
_sues_university_for_barring_her_from_using_her_research .
On July, 2011 the U.S. Department of Health and Human Services issued
an Advance Notice of Proposed Rulemaking (ANPRM) that proposed changes to
the Common Rule as of July 2011. DHHS suggests the proposal entitled: Human
Subject Research Protections: Enhancing Protections for Research Subjects and
Reducing Burden, Delay, and Ambiguity for Investigators has been proposed for
two reasons, (1) the human subject research landscape has changed
dramatically since the early 1980s when the current regulations were first being
formulated and (2) in light of that, there is a need to address effectiveness and
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the efficiency of the regulations for human subject protections in the current
research environment. Proposed changes can be found at:
http://www.hhs.gov/ohrp/humansubjects/anprmqanda.html .
This research study also suggested in the analysis of determination
letters, interviews with human research protection administrators and analysis of
the evaluation of the Common Rule, the need for change to the federal
regulations given the identical reasons as indicated above. The most recent
article from Inside Higher Ed by Doug Lederman on August 3, 2011 further
affirms the timeliness of this study. The article suggests that this is ―the federal
government's first major review of its so-called Common Rule governing the
protection of human research subjects and has the potential to ease if not
resolve many of the concerns of scholars.‖ The article entitled ―Updating the
Common Rule‖ can be found at:
http://www.insidehighered.com/news/2011/08/03/u_s_review_of_human_subject
s_rules_could_ease_restrictions_on_researchers .
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Appendix A
HUMAN EXPERIMENTS: A CHRONOLOGY OF HUMAN RESEARCH
by Vera Hassner Sharav

6th century B.C.: Meat and vegetable experiment on young Jewish prisoners in Book of Daniel.
5th century B.C.: "Primum non nocere" ("First do no harm"), medical ethics standard attributed to
Hippocrates. This Oath became obligatory for physicians prior to practicing medicine in the 4th century AD
1st century B.C. Cleopatra devised an experiment to test the accuracy of the theory that it takes 40 days to
fashion a male fetus fully and 80 days to fashion a female fetus. When her handmaids were sentenced to
death under government order, Cleopatra had them impregnated and subjected them to subsequent
operations to open their wombs at specific times of gestation.
[http://www.jlaw.com/Articles/NaziMedExNotes.html#1]
12th century: Rabbi and physician Maimonides' Prayer: "May I never see in the patient anything but a fellow
creature in pain."
1796 Edward Jenner injects healthy eight-year-old James Phillips first with cowpox then three months later
with smallpox and is hailed as discoverer of smallpox vaccine.
1845-1849: J. Marion Sims, "the father of gynecology" performed multiple experimental surgeries on
enslaved African women without the benefit of anesthesia. After suffering unimaginable pain, many lost their
lives to infection. One woman was made to endure 34 experimental operations for a prolapsed uterus.
http://www.coax.net/people/lwf/jm_sims.htm
1865: French physiologist Claude Bernard publishes "Introduction to the Study of Human Experimentation,"
advising: "Never perform an experiment which might be harmful to the patient even though highly
advantageous to science or the health of others."
1896: Dr. Arthur Wentworth performed spinal taps on 29 children at Children's Hospital, Boston, to
determine if the procedure was harmful. Dr. John Roberts of Philadelphia, noting the non-therapeutic
indication, labeled Wentworth's procedures "human vivisection."
1897: Italian bacteriologist Sanarelli injects five subjects with bacillus searching for a causative agent for
yellow fever.
1900: Walter Reed injects 22 Spanish immigrant workers in Cuba with the agent for yellow fever paying
them $100 if they survive and $200 if they contract the disease.
1900: Berlin Code of Ethics. Royal Prussian Minister of Religion, Education, and Medical Affairs guaranteed
that: "all medical interventions for other than diagnostic, healing, and immunization purposes, regardless of
other legal or moral authorization are excluded under all circumstances if (1) the human subject is a minor or
not competent due to other reasons; (2) the human subject has not given his unambiguous consent; (3) the
consent is not preceded by a proper explanation of the possible negative consequences of the intervention."
http://www.geocities.com/artnscience/00berlincode.pdf
1906: Dr. Richard Strong, a professor of tropical medicine at Harvard, experiments with cholera on prisoners
in the Philippines killing thirteen.
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1913: Pennsylvania House of Representatives recorded that 146 children had been inoculated with syphilis,
"through the courtesy of the various hospitals" and that 15 children in St. Vincent's House in Philadelphia
had their eyes tested with tuberculin. Several of these children became permanently blind. The
experimenters were not punished.
1915: A doctor in Mississippi, working for the U.S. Public Health Office produces Pellagra in twelve
Mississippi inmates in an attempt to discover a cure for the disease
1919-1922: Testicular transplant experiments on five hundred prisoners at San Quentin.
1927: Carrie Buck of Charlottesville is legally sterilized against her will at the Virginia Colony Home for the
Mentally Infirm. Carrie Buck was the mentally normal daughter of a mentally retarded mother, but under the
Virginia law, she was declared potentially capable of having a "less than normal child." By the 1930s,
seventeen states in the U.S. have laws permitting forced sterilization
The settlement of Poe v. Lynchburg Training School and Hospital (same institution, different name) in 1981
brought to an end the Virginia law. It is estimated that as many as 10,000 perfectly normal women were
forcibly sterilized for "legal" reasons including alcoholism, prostitution, and criminal behavior in general.
1931: Lubeck, Germany, 75 children die in from pediatrician's experiment with tuberculosis vaccine.
1931: Germany adopts "Regulation on New Therapy and Experimentation" requiring all human experiments
to be preceded by animal experiments. This law remained in effect during the Nazi regime.
1931: Dr. Cornelius Rhoads, a pathologist, conducted a cancer experiment in Puerto Rico under the
auspices of the Rockefeller Institute for Medical Investigations. Dr. Rhoads has been accused of purposely
infecting his Puerto Rican subjects with cancer cells. Thirteen of the subjects died. A Puerto Rican physician
uncovered the experiment an investigation covered-up the facts. Despite Rhoads' hand written statements
that the Puerto Rican population should be eradicated, Rhoads went on to establish U.S. Army Biological
Warfare facilities in Maryland, Utah, and Panama, and was later named to the U.S. Atomic Energy
Commission. Rhoads was also responsible for the radiation experiments on prisoners, hospital patients, and
soldiers. The American Association for Cancer Research honored him by naming its exemplary scientist
award the Cornelius Rhoads Award.
1932-1972: U.S. Public Health Service study in Tuskegee, Alabama of more than 400 black sharecroppers
observed for the natural course of untreated syphilis.
1932: Japanese troops invade Manchuria. Dr. Shiro Ishii, a prominent physician and army officer begins
preliminary germ warfare experiments.
1936: Japan's Wartime Human Bio warfare Experimentation Program.
1938: Japan establishes Unit 731 in Pingfan, 25 km. from Harbin. Unit 731, a biological-warfare unit
disguised as a water-purification unit, is formed outside the city of Harbin.
1939: Third Reich orders births of all twins be registered with Public Health Offices for purpose of genetic
research.
1939: Twenty-two children living at the Iowa Soldiers' Orphans' Home in Davenport were the subjects of the
"monster" experiment that used psychological pressure to induce children who spoke normally to stutter. It
was designed by one of the nation's most prominent speech pathologists, Dr. Wendell Johnson, to test his
theory on the cause of stuttering.

194

1940: Poisonous gas experiments at Unit 731. One experiment conducted September 7-10, 1940, on 16
Chinese prisoners who were exposed to mustard gas in a simulated battle situation.
1940-1941: Unit 731 used aircraft to spread cotton and rice husks contaminated with the black plague at
Changde and Ningbo, in central China. About 100 people died from the black plague in Ningbo as a result.
1940s: In a crash program to develop new drugs to fight Malaria during World War II, doctors in the Chicago
area infected nearly 400 prisoners with the disease. Although the Chicago inmates were given general
information that they were helping with the war effort, they were not informed about the nature of the
experiment. Nazi doctors on trial at Nuremberg cited the Chicago studies as precedents to defend their own
research aimed at aiding the German war effort.
1941: Sterilization experiments at Auschwitz.
1941-1945: Typhus experiments at Buchenwald and Natzweiler concentration camps.
1941: Dr. William c. Black inoculated a twelve month old baby with herpes. He was criticized by Francis
Payton Rous, editor of the Journal of Experimental Medicine, who called it "an abuse of power, an
infringement of the rights of an individual, and not excusable because the illness which followed had
implications for science." Dr. Rous rejected outright the fact that the child had been "offered as a volunteer."
1942 –1945: Unit 731. Ishii begins "field tests" of germ warfare and vivisection experiments on thousands of
Chinese soldiers and civilians. Chinese people who rebelled against the Japanese occupation were arrested
and sent to Pingfan where they became human guinea pigs; there is evidence that some Russian prisoners
were also victims of medical atrocities.
"I cut him open from the chest to the stomach and he screamed terribly and his face was all twisted in
agony. He made this unimaginable sound, he was screaming so horribly. But then finally he stopped. This
was all in a day's work for the surgeons, but it really left an impression on me because it was my first time."
NYT
These prisoners were called 'maruta' (literally 'logs') by the Japanese. After succumbing to induced diseases
- including bubonic plague, cholera, anthrax - the prisoners were usually dissected while still alive, their
bodies then cremated within the compound. Tens of thousands died. The atrocities were committed by some
of Japan's most distinguished doctors recruited by Dr. Ishii.
1942: High altitude or low pressure experiments at Dachau concentration camp.
1942: Harvard biochemist Edward Cohn injects sixty-four Massachusetts prisoners with beef blood in U.S.
Navy-sponsored experiment.
1942: Japanese sprayed cholera, typhoid, plague, and dysentery pathogens in the Jinhua area of Zhejian
province (China). A large number of Japanese soldiers also fell victim to the sprayed diseases.
1942-1943: Bone regeneration and transplantation experiments on female prisoners at Ravensbrueck
concentration camp.
1942-1943: Freezing experiments at Dachau concentration camp.
1943 Refrigeration experiment conducted on sixteen mentally disabled patients who were placed in
refrigerated cabinets at 30 degree Farenheit, for 120 hours, at University of Cincinnati Hospital., "to study
the effect of frigid temperature on mental disorders."
1942-1943: Coagulation experiments on Catholic priests at Dachau concentration camp.
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1942-1944: U.S. Chemical Warfare Service conducts mustard gas experiments on thousands of
servicemen.
1942-1945: Malaria experiments at Dachau concentration camp on more than twelve hundred prisoners.
1943: Epidemic jaundice experiments at Natzweiler concentration camp.
1943-1944: Phosphorus burn experiments at Buchenwald concentration camp.
1944: Manhattan Project injection of 4.7 micrograms of plutonium into soldiers at Oak Ridge.
1944: Seawater experiment on sixty Gypsies who were given only saltwater to drink at Dachau
concentration camp.
1944-1946: University of Chicago Medical School professor Dr. Alf Alving conducts malaria experiments on
more than 400 Illinois prisoners.
1945: Manhattan Project injection of plutonium into three patients at Billings Hospital at University of
Chicago.
1945: Malaria experiment on 800 prisoners in Atlanta.
1946: Opening of Nuremberg Doctors Trial by U.S. Military Tribunal.
1945: Japanese troops blow up the headquarters of Unit 731 in final days of Pacific war. Ishii orders 150
remaining ''logs'' (i.e., human beings) killed to cover up their experimentation. Gen. Douglas MacArthur is
named commander of the Allied powers in Japan.
1946: U.S. secret deal with Ishii and Unit 731 leaders cover up of germ warfare data based on human
experimentation in exchange for immunity from war-crimes prosecution.
1946-1953: Atomic Energy Commission sponsored study conducted at the Fernald school in
Massachusetts. Residents were fed Quaker Oats breakfast cereal containing radioactive tracers.
1946: Patients in VA hospitals are used as guinea pigs for medical experiments. In order to allay suspicions,
the order is given to change the word "experiments" to "investigations" or "observations" whenever reporting
a medical study performed in one of the nation's veteran's hospitals.
1947: Colonel E.E. Kirkpatrick of the U.S. Atomic Energy Comission issues a secret document (Document
07075001, January 8, 1947) stating that the agency will begin administering intravenous doses of
radioactive substances to human subjects.
1947: The CIA begins its study of LSD as a potential weapon for use by American intelligence. Human
subjects (both civilian and military) are used with and without their knowledge.
1947: Judgment at Nuremberg Doctors Trial sets forth "Permissible Medical Experiments" – i.e., the
Nuremberg Code, which begins: "The voluntary consent of the human subject is absolutely essential."
1949: Intentional release of radiodine 131 and xenon 133 over Hanford Washington in Atomic Energy
Commission field study called "Green Run."
1949: Soviet Union's war crimes trial of Dr. Ishii's associates.
1949-1953: Atomic Energy Commission studies of mentally disabled school children fed radioactive isotopes
at Fernald and Wrentham schools.
1940s-1950s: "psychic driving" and "mental departterning" experiments conducted by Dr. Ewen Cameron,
depriving patients of sleep, using massive ECT combined with psychoactive drugs such as, LSD. After his
"treatments" patients were unable to function. In the 1950's Dr.Cameron's experiments were sponsored by
the CIA.
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1950: Dr. Joseph Stokes of the University of Pennsylvania infects 200 women prisoners with viral hepatitis.
1950: U.S. Army secretly used a Navy ship outside the Golden Gate to spray supposedly harmless bacteria
over San Francisco and its outskirts. Eleven people were sickened by the germs, and one of them died.
1951-1960: University of Pennsylvania under contract with U.S. Army conducts psychopharmacological
experiments on hundreds of Pennsylvania prisoners.
1952-1974: University of Pennsylvania dermatologist Dr. Albert Kligman conducts skin product experiments
by the hundreds at Holmesburg Prison; "All I saw before me," he has said about his first visit to the prison,
"were acres of skin."
1952: Henry Blauer injected with a fatal dose of mescaline at New York State Psychiatric Institute of
Columbia University. U.S. Department of Defense, the sponsor, conspired to conceal evidence for 23 years.
I
1953 Newborn Daniel Burton rendered blind at Brooklyn Doctor's Hospital due to high oxygen study on RLF.
1953-1957: Oak Ridge-sponsored injection of uranium into eleven patients at Massachusetts General
Hospital in Boston.
1953-1960: CIA brainwashing experiments with LSD at eighty institutions on hundreds of subjects in a
project code named "MK-ULTRA."
1953-1970: U.S. Army experiments with LSD on soldiers at Fort Detrick, Md.
1954-1974: U.S. Army study of 2,300 Seventh-Day Adventist soldiers in 157 experiments code named
"Operation Whitecoat."
1950s –1972: Mentally disabled children at Willowbrook School (NY) were deliberately infected with hepatitis
in an attempt to find a vaccine. Participation in the study was a condition for admission to institution.
1956: Dr. Albert Sabin tests experimental polio vaccine on 133 prisoners in Ohio.
1958-1962: Spread of radioactive materials over Inupiat land in Point Hope, Alaska in Atomic Energy
Commission field study code named "Project Chariot."
1962: Thalidomide withdrawn from the market after thousands of birth deformities blamed in part on
misleading results of animal studies; the FDA thereafter requires three phases of human clinical trials before
a drug can be approved for the market.
1962 to 1966, a total of 33 pharmaceutical companies tested 153 experimental drugs at Holmesburg prison
(PA) alone.
1962-1980 Pharmaceutical companies conduct phase I safety testing of drugs almost exclusively on
prisoners for small cash payments.
1962: Injection of live cancer cells into 22 elderly patients at Jewish Chronic Disease Hospital in Brooklyn.
Administration covered up, NYS licensing board placed the principal investigator on probation for one year.
Two years later, American Cancer Society elected him Vice President.
1962: Stanley Milgram conducts obedience research at Yale University.
1963: NIH supported researcher transplants chimpanzee kidney into human in failed experiment.
1963-1973: Dr. Carl Heller, a leading endocrinologist, conducts testicular irradiation experiments on
prisoners in Oregon and Washington giving them $5 a month and $100 when they receive a vasectomy at
the end of the trial.
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1964: World Medical Association adopts Helsinki Declaration, asserting "The interests of science and
society should never take precedence over the well being of the subject."
1965-1966: University of Pennsylvania under contract with Dow Chemical conducts dioxin experiments on
prisoners at Holmesburg.
1966: Henry Beecher's article "Ethics and Clinical Research" in New England Journal of Medicine.
1966: U.S. Army introduces bacillus globigii into New York subway tunnels in field study.
1966: NIH Office for Protection of Research Subjects ("OPRR") created and issues Policies for the
Protection of Human Subjects calling for establishment of independent review bodies later known as
Institutional Review Boards.
1967: British physician M.H. Pappworth publishes "Human Guinea Pigs," advising "No doctor has the right
to choose martyrs for science or for the general good."
1969: Judge Sam Steinfield's eloquent dissent in Strunk v. Strunk, 445 S.W.2d 145, the first judicial
suggestion that the Nuremberg Code should influence American jurisprudence.
1969. Milledgeville Georgia, investigational drugs tested on mentally disabled children. No institutional
approval.
1969: San Antonio Contraceptive Study conducted on 70 poor Mexican-American women. Half received
oral contraceptives the other placebo. No informed consent.
1973 Ad Hoc Advisory Panel issues Final Report of Tuskegee Syphilis Study, concluding "Society can no
longer afford to leave the balancing of individual rights against scientific progress to the scientific
community."
1974: National Research Act establishes National Commission for the Protection of Human subjects and
requires Public Health Service to promulgate regulations for the protection of human subjects.
1975: The Department of Health, Education and Welfare (DHEW) raised NIH's 1966 Policies for the
Protection of Human subjects to regulatory status. Title 45 of the Code of Federal Regulations, known as
"The Common Rule," requires the appointment and utilization of institutional review boards (IRBs).
1976: National Urban League holds National Conference on Human Experimentation, announcing "We
don't want to kill science but we don't want science to kill, mangle and abuse us."
1978: Experimental Hepatitis B vaccine trials, conducted by the CDC, begin in New York, Los Angeles and
San Francisco. Ads for research subjects specifically ask for promiscuous homosexual men.
1979: National Commission issues Belmont Report setting forth three basic ethical principles: respect for
persons, beneficence, and justice.
1980: The FDA promulgates 21 CFR 50.44 prohibiting use of prisoners as subjects in clinical trials shifting
phase I testing by pharmaceutical companies to non-prison population.
1981: Leonard Whitlock suffers permanent brain damage after deep diving experiment at Duke University.
1986: Congressional subcommittee holds one-day hearing in Washington, called by Rep. Pat Williams of
Montana, aimed at determining whether U.S. prisoners of war in Manchuria were victims of germ-warfare
experimentation. Hearing is inconclusive.
1981-1996: Protocol 126 at Fred Hutchinson Cancer Center in Seattle.
1987: Supreme Court decision in United States v. Stanley, 483 U.S. 669, holding soldier given LSD without
his consent could not sue U.S. Army for damages.
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1987:" L-dopa challenge and relapse" experiment conducted on 28 U.S. veterans who were subjected to
psychotic relapse for study purposes at the Bronx VA.
1990: The FDA grants Department of Defense waiver of Nuremberg Code for use of unapproved drugs and
vaccines in Desert Shield.
1991: World Health Organization announces CIOMS Guidelines which set forth four ethical principles:
respect for persons, beneficence, nonmaleficence and justice.
1991: Tony LaMadrid commits suicide after participating in study on relapse of schizophrenics withdrawn
from medication at UCLA.
1993: Kathryn Hamilton dies 44 days after participating in breast cancer experiment at Fred Hutchinson
Cancer Center in Seattle.
1994. The Albuquerque Tribune publicizes 1940s experiments involving plutonium injection of human
research subjects and secret radiation experiments. Indigent patients and mentally retarded children were
deceived about the nature of their treatment.
1994. President Clinton appoints the Advisory Commission on Human Radiation Experiments (ACHRE) The
ACHRE Report http://tis.eh.doe.gov/ohre/roadmap/achre/index.html
1995. U.S. Department of Energy (DOE) published Human Radiation Experiments, listing 150 plus an
additional 275 radiation experiments conducted by DOE and the Atomic Energy Commission, during the
1940s-1970s. http://tis.eh.doe.gov/ohre/roadmap/experiments/0491doca.html#0491_List
1995: 19-year-old University of Rochester student Nicole Wan dies after being paid $150 to participate in
MIT-sponsored experiment to test airborne pollutant chemicals.
1995. President Clinton appoints the National Bioethics Advisory Commission.
1995: NYS Supreme Court rules (TD v NYS Office of Mental Health) against the state's policy of conducting
nontherapeutic experiments on mentally incapacitated persons - including children - without informed
consent. Justice Edward Greenfield ruled that parents have no authority to volunteer their children:
"Parents may be free to make martyrs of themselves, but it does not follow that they may make martyrs of
their children."
1995: Thirty-four healthy, previously non-aggressive New York City minority children, boys aged 6 to 11
years old, were exposed to fenfluramine in a nontherapeutic experiment at the New York State Psychiatric
Institute. The children were exposed to this neurotoxic drug to record their neurochemical response in an
effort to prove a speculative theory linking aggression to a biological marker.
1996. Cleveland Plain Dealer investigative report series, 'Drug Trials: Do People Know the Truth About
Experiments,' December 15 to 18, 1996. The Plain-Dealer found: of the "4,154 FDA inspections of
researchers testing new drugs on people [since 1977] . . . more than half the researchers were cited by FDA
inspectors for failing to clearly disclose the experimental nature of their work."
1996: Yale University researchers publish findings of experiment that subjected 18 stable schizophrenia
patients to psychotic relapse in an amphetamine provocation experiment at West Haven VA.
1997. President Clinton issues a formal apology to the subjects of the Tuskegee syphilis experiments. NBAC
continues investigation into genetics, consent, privacy, and research on persons with mental disorders.
1997. Researchers at the University of Cincinnati publish findings of experiment attempting to create a
"psychosis model" on human beings at the Cincinnati VA. Sixteen patients, experiencing a first episode
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schizophrenia, were subjected to repeated provocation with amphetamine. The stated purpose was to
produce "behavioral sensitization. This process serves as a model for the development of psychosis, but has
been little studied in humans. Symptoms, such as severity of psychosis and eye-blink rates, were measured
hourly for 5 hours."
1997. U.S. government sponsored placebo-controlled experiment withholds treatment from HIV infected,
pregnant African women. NY Times, Sept. 18.
1997. Victims of unethical research at major U.S. medical centers - including the NIMH - testify before the
National Bioethics Advisory Commission, Sept. 18.
1997. FDA Modernization Act gives pharmaceutical companies a huge financial incentive - a 6 month patent
exclusivity extension - if they conduct drug tests on children. The incentive can yield $900 million.
1998. National Bioethics Advisory Commission (NBAC) Report. Research Involving Subjects with Mental
Disorders That May Affect Decisionmaking Capacity. November 12, 1998
http://bioethics.georgetown.edu/nbac/capacity/TOC.htm
1998: The Japanese government has never formally apologized for Unit 731's activities, and did not even
admit to its existence until August 1998, when the Supreme Court ruled that the existence of the unit was
accepted in academic circles.
1998. Complaint filed with OPRR about experiments that exposed non-violent children in New York City to
fenfluramine to find a predisposition to violence.
1998: Boston Globe (four part) series, "Doing Harm: Research on the Mentally Ill" shed light on the
mistreatment and exploitation of schizophrenia patients who have been subjected to relapse producing
procedures in unethical experiments.
1999: Nine month-old Gage Stevens dies at Children's Hospital in Pittsburgh during participation in
Propulsid clinical trial for infant acid reflux.
1999: 18-year-old Jesse Gelsinger dies after being injected with 37 trillion particles of adenovirus in gene
therapy experiment at University of Pennsylvania.
1999: Administrator of National Institute of Mental Health suspends 29 clinical trials that failed to meet either
ethical or scientific standards.
2000: University of Oklahoma melanoma trial halted for failure to follow government regulations and
protocol.
2000: OPRR becomes Office of Human Research Protection ("OHRP") and made part of the Department of
Health and Human Services.
2000: President Clinton implement the Energy Employees Occupational Illness Compensation Act of 2000,
which authorized compensation for thousands of Department of Energy workers who sacrificed their health
in building the nation's nuclear defenses.
2000: The Washington Post (6 part) series, "Body Hunters" exposes unethical exploitation in experiments
conducted by U.S. investigators in underdeveloped countries. Part 4 dealt with U.S. government funded,
genetic experiments conducted by Harvard University in rural China.
http://www.washingtonpost.com/wp-dyn/articles/A26797-2000Dec19.html
2001: A biotech company in Pennsylvania asks the FDA for permission to conduct placebo trials on infants
in Latin America born with serious lung disease though such tests would be illegal in U.S.
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2001: Ellen Roche, a healthy 27-year old volunteer, dies in challenge study at Johns Hopkins University in
Baltimore, Maryland.
2001: April 4, Elaine Holden-Able, a healthy retired nurse, consumed a glass of orange juice that had been
mixed with a dietary supplement for the sake of medical research. This Case Western University Alzheimer's
experiment, financed by the tobacco industry, wound up killing her in what was called a ''tragic human error.''
Federal Office of Human Research Protections did not interview hospital staff, mostly accepted hospital's
internal report, imposed no penalty, and closed the case and did not mention the death in its letter of
determination. http://ohrp.osophs.dhhs.gov/detrm_letrs/nov01f.pdf
2001: Maryland Court of Appeals renders a landmark decision affirming "best interest of the individual child"
as a standard for medical research involving children. The Court unequivocally prohibited nontherapeutic
experimentation on children. (Higgins and Grimes v. Kennedy Krieger Institute).The case involved exposure
of babies and small children to lead poisoning in EPA funded experiment.
(http://www.courts.state.md.us/opinions/coa/2001/128a00.pdf)
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Appendix B
Berlin Code Of 1900
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Appendix C

High-Altitude Experiments

To investigate the limits of human endurance and
existence at extremely high altitudes the victims were
placed in the low-pressure chamber and thereafter the
simulated altitude therein was raised. Many victims died as
a result of these experiments and others suffered grave
injury, torture, and ill-treatment.

Source: United States Holocaust Memorial Museum, Washington, D.C.:
http//www.ushmm.org
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Appendix D

Incendiary Bomb Experiments:

To test the effect of various pharmaceutical
preparations on phosphorous burns were inflicted
on the victims with phosphorous matter taken from
incendiary bombs, and caused severe pain,
suffering, and serious bodily injury.

Source: United States Holocaust Memorial Museum, Washington, D.C.:
http//www.ushmm.org
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Appendix E

Freezing Experiments

To investigate the most effective means of treating
persons who had been severely chilled or frozen the
victims were forced to remain in a tank of ice water
for up to 3 hours. Extreme rigor developed in a short
time. Numerous victims died in the course of these
experiments. After the survivors were severely
chilled, re-warming was attempted by various
means. In another series of experiments, the victims
were kept naked outdoors for many hours at
temperatures below freezing. The victims screamed
with pain as their bodies froze.

Source: United States Holocaust Memorial Museum, Washington, D.C.: http//www.ushmm.org
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Appendix F

Sea-water Experiments
To study various methods of making sea water
drinkable the victims were deprived of all food and
given only chemically processed sea water. Such
experiments caused great pain and suffering and
resulted in serious bodily injury to the victims.

Source: United States Holocaust Memorial Museum, Washington, D.C.: http//www.ushmm.org
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Appendix G

Malaria Experiments:
To investigate immunization for and treatment of malaria
the victims were infected by mosquitoes or by injections
of extracts of the mucous glands of mosquitoes. After
having contracted malaria the victims were treated with
various drugs to test their relative efficacy. Over 1,000
victims were used in these experiments. Many died and
others suffered severe pain and permanent disability.

Source: United States Holocaust Memorial Museum, Washington, D.C.: http//www.ushmm.org
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Appendix H
THE NUREMBERG CODE (1947)
BRITISH MEDICAL JOURNAL NO 7070 VOLUME 313: P 1448,
7 December 1996.

Introduction
The judgment by the war crimes tribunal at Nuremberg laid down 10 standards to which
physicians must conform when carrying out experiments on human subjects in a new code that is
now accepted worldwide.
This judgment established a new standard of ethical medical behavior for the post World War II
human rights era. Amongst other requirements, this document enunciates the requirement
of voluntary informed consent of the human subject. The principle of voluntary informed consent
protects the right of the individual to control his own body.
This code also recognizes that the risk must be weighed against the expected benefit, and that
unnecessary pain and suffering must be avoided.
This code recognizes that doctors should avoid actions that injure human patients.
The principles established by this code for medical practice now have been extended into general
codes of medical ethics.
Permissible Medical Experiments
The great weight of the evidence before us to effect that certain types of medical experiments on
human beings, when kept within reasonably well-defined bounds, conform to the ethics of the
medical profession generally. The protagonists of the practice of human experimentation justify
their views on the basis that such experiments yield results for the good of society that are
unprocurable by other methods or means of study. All agree, however, that certain basic
principles must be observed in order to satisfy moral, ethical and legal concepts:
1. The voluntary consent of the human subject is absolutely essential. This means that
the person involved should have legal capacity to give consent, should be so situated
as to be able to exercise free power of choice, without the intervention of any element
of force, fraud, deceit, duress, overreaching, or other ulterior form of constraint or
coercion, and should have sufficient knowledge and comprehension of the elements
of the subject matter involved as to enable him to make an understanding and
enlightened decision. This latter element requires that before the acceptance of an
affirmative decision by the experimental subject there should be made known to him
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the nature, duration, and purpose of the experiment, the method and means by which
it is to be conducted, all inconveniences and hazards reasonably to be expected, and
the effects upon his health or person which may possibly come from his participation
in the experiment.

The duty and responsibility for ascertaining the quality of the consent rests upon
each individual who initiates, directs, or engages in the experiment. It is a personal
duty and responsibility which may not be delegated to another with impunity.
2. The experiment should be such as to yield fruitful results for the good of society,
unprocurable by other methods or means of study, and not random and unnecessary
in nature.
3. The experiment should be so designed and based on the results of animal
experimentation and a knowledge of the natural history of the disease or other
problem under study that the anticipated results justify the performance of the
experiment.
4. The experiment should be so conducted as to avoid all unnecessary physical and
mental suffering and injury.
5. No experiment should be conducted where there is an a priori reason to believe that
death or disabling injury will occur, except, perhaps, in those experiments where the
experimental physicians also serve as subjects.
6. The degree of risk to be taken should never exceed that determined by the
humanitarian importance of the problem to be solved by the experiment.
7. Proper preparations should be made and adequate facilities provided to protect the
experimental subject against even remote possibilities of injury, disability or death.
8. The experiment should be conducted only by scientifically qualified persons. The
highest degree of skill and care should be required through all stages of the
experiment of those who conduct or engage in the experiment.
9. During the course of the experiment the human subject should be at liberty to bring
the experiment to an end if he has reached the physical or mental state where
continuation of the experiment seems to him to be impossible.
10. During the course of the experiment the scientist in charge must be prepared to
terminate the experiment at any stage, if he has probable cause to believe, in the
exercise of the good faith, superior skill and careful judgment required of him, that a
continuation of the experiment is likely to result in injury, disability, or death to the
experimental subject.
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Appendix I
DECLARATION OF HELSINKI (1964)
[CIRP Note: Ethical research on human subjects into or about the effects of circumcision must be
conducted under the provisions of this declaration and those of the Nuremberg Code.]
Recommendations guiding physicians in biomedical research involving human subjects.
Adopted by the 18th World Medical Assembly, Helsinki, Finland, June 1964, amended by the
29th World Medical Assembly, Tokyo, Japan, October 1975, and the 35th World Medical
Assembly, Venice, Italy, October 1983.
Introduction
It is the mission of the physician to safeguard the health of the people. His or her knowledge and
conscience are dedicated to the fulfillment of this mission.
The Declaration of Geneva of the World Medical Association binds the physician with the words,
"The health of my patient will be my first consideration "and the International Code of Medical
Ethics declares that, "A physician shall act only in the patient's interest when providing medical
care which might have the effect of weakening the physical and mental condition of the patient. "
The purpose of biomedical research involving human subjects must be to improve diagnostic,
therapeutic and prophylactic procedures and the understanding of the audiology and
pathogenesis of disease.
In current medical practice most diagnostic, therapeutic or prophylactic procedures involve
hazards. This applies especially to biomedical research.
Medical progress is based on research which ultimately must rest in part on experimentation
involving human subjects. In the field of biomedical research a fundamental distinction must be
recognized between medical research in which the aim is essentially diagnostic or therapeutic for
a patient, and medical research the essential object of which is purely scientific and without
implying direct diagnostic or therapeutic value to the person subjected to the research.
Special caution must be exercised in the conduct of research which may affect the environment,
and the welfare of animals used for research must be respected.
Because it is essential that the results of laboratory experiments be applied to human beings to
further scientific knowledge and to help suffering humanity, the World Medical Association has
prepared the following recommendations as a guide to every physician in biomedical research
involving human subjects. They should be kept under review in the future. It must be stressed
that the standards as drafted are only a guide to physicians all over the world. Physicians are not
relieved from criminal, civil and ethical responsibilities under the law of their own countries.
I. Basic Principles
1. Biomedical research involving human subjects must conform to generally accepted
scientific principles and should be based on adequately performed laboratory and animal
experimentation and on a thorough knowledge of the scientific literature.
2. The design and performance of each experimental procedure involving human subjects
should be clearly formulated in an experimental protocol which should be transmitted to a
specially appointed independent committee for consideration, comment and guidance.
3. Biomedical research involving human subjects should be conducted only by scientifically
qualified persons and under the supervision of a clinically competent medical person. The
responsibility for the human subject must always rest with a medically qualified person
and never rest on the subject of the research, even though the subject has given his or
her consent.
4. Biomedical research involving human subjects cannot legitimately be carried out unless
the importance of the objective is in proportion to the inherent risk to the subject.
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5. Every biomedical research project involving human subjects should be preceded by
careful assessment of predictable risks in comparison with foreseeable benefits to the
subject or to others. Concern for the interests of the subject must always prevail over the
interests of science and society.
6. The right of the research subject to safeguard his or her integrity must always be
respected. Every precaution should be taken to respect the privacy of the subject and to
minimize the impact of the study on the subject's physical and mental integrity and on the
personality of the subject.
7. Physicians should abstain from engaging in research projects involving human subjects
unless they are satisfied that the hazards involved are believed to be predictable.
Physicians should cease any investigation if the hazards are found to outweigh the
potential benefits.
8. In publication of the results of his or her research, the physician is obliged to preserve the
accuracy of the results. Reports of experimentation not in accordance with the principles
laid down in this Declaration should not be accepted for publication.
9. In any research on human beings, each potential subject mustbe adequately informed of
the aims, methods, anticipated benefits and potential hazards of the study and the
discomfort it may entail. He or she should be informed that he or she is at liberty to
abstain from participation in the study and that he or she is free to withdraw visor her
consent to participation at any time. The physician should then obtain the subject's freely
given informed consent, preferably inheriting.
10. When obtaining informed consent for the research project the physician should be
particularly cautious if the subject is in dependent relationship to him or her or may
consent under duress. In that case the informed consent should be obtained by a
physician who isn't engaged in the investigation and who is completely independent of
this official relationship.
11. In case of legal incompetence, informed consent should be obtained from the legal
guardian in accordance with national legislation. Where physical or mental incapacity
makes it impossible to obtain informed consent, or when the subject is a minor,
permission from the responsible relative replaces that of the subject in accordance with
national legislation. Whenever the minor child is in fact able to give a consent, the minor's
consent must be obtained in addition to the consent of the minor's legal guardian.
12. The research protocol should always contain a statement of the ethical considerations
involved and should indicate that the principles enunciated in the present declaration are
complied with.
II. Medical Research Combined with Professional Care (Clinical Research)
1. In the treatment of the sick person, the physician must be free to use a new diagnostic
and therapeutic measure, if in his or her judgment it offers hope of saving life, reestablishing health or alleviating suffering.
2. The potential benefits, hazards and discomfort of a new method should be weighed
against the advantages of the best current diagnostic and therapeutic methods.
3. In any medical study, every patient- including those of a control group, if any- should be
assured of the best proven diagnostic and therapeutic method.
4. The refusal of the patient to participate in a study must never interfere with the physicianpatient relationship.
5. If the physician considers it essential not to obtain informed consent, the specific reasons
for this proposal should be stated in the experimental protocol for transmission to the
independent committee (1, 2).
6. The physician can combine medical research with professional care, the objective being
the acquisition of new medical knowledge, only to the extent that medical research is
justified by its potential diagnostic or therapeutic value for the patient.
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III. Non-Therapeutic Biomedical Research Involving Human Subjects (Non-Clinical Biomedical
Research)
1. In the purely scientific application of medical research carried out on a human being, it is
the duty of the physician to remain the protector of the life and health of that person on
whom biomedical research is being carried out.
2. The subjects should be volunteers- either healthy persons or patients for whom the
experimental design is not related to the patient's illness.
3. The investigator or the investigating team should discontinue the research if in his/her or
their judgment it may, if continued, be harmful to the individual.
4. In research on man, the interest of science and society should never take precedence
over considerations related to the well-being of the subject.
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Appendix J
NATIONAL RESEARCH ACT
PUBLIC LAW 93-348-JULY 12, 1974 - Public Law 93-348 July 12.1974
JULY 12, 1974 - [H. R. 7724]

AN ACT
To amend the Public Health Service Act to establish a program of National Research Service
Awards to assure the continued excellence of biomedical and behavioral research and to provide
for the protection of human subjects involved in biomedical and behavioral research and for other
purposes.

Be it enacted by the Senate and House of Representatives of the Re- United States of America in
Congress assembled, search Act. 42 usc 2891-1 SECTION 1. This Act may be cited as the
"National Research Act". note. National Re- TITLE I-BIOMEDICAL AND BEHAVIORAL
RESEARCH search Service Award Act of 1974. TRAINING SHORT TITLE SEC. 101. This title
may be cited as the '<National Research Service 42 U.S.C 28g1-1 Award Act of 1974". note.
FINDINGS .AND DECLARATION OF PURPOSE 42 U.S.C 2891-1 note. SEC. 102. (a) Congress
finds and declares that- (1) the success and continued viability of the Federal biomedical and
behavioral research effort depends on the availability of excellent scientists and a network of
institutions of excellence capable of producing superior research personnel ; (2) direct support of
the training of scientists for careers in biomedical and behavioral research is an appropriate and
necessary role for the Federal Government ; and (3) graduate research assistance programs
should be the key elements in the training programs of the institutes of the National Institutes of
Health and the Alcohol, Drug Abuse, and Mental Health Administration. (b) It is the purpose of
this title to increase the capability of the institutes of the National Institutes of Health and the
Alcohol, Drug Abuse, and Mental Health Administration to carry out their responsibility of
maintaining a superior national program of research into the physical and mental diseases and
impairments of man. BIOMEDICAL AND BEHAVIORAL RESEARCH TRAINING Ante, p. 135.
SEC. 103. The part H of the Public Health Service Act relating to the appointment of the
Administrators of the National Institutes of Health and the National Cancer Institute is
redesignated as part I, section 461 of such part is redesignated as section 471, and such part is
amended by adding at the end the following new sections: 42 U.S.C 289C1. "SEC. 472. (a) (1)
The Secretary shall- "(A) provide National Research Service Awards for- "(1) biomedical and
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behavioral research at and with the National Institutes of Health and the Alcohol, Drug Abuse,
and Mental Health Administration in matters relating to the cause, diagnosis, prevention, and
treatment of the disease (or diseases) or other health problems to which the activities of the
Institutes and Administration are directed, "(ii) training at the Institutes and Administration of
individual~ to undertake such research, PUBLIC LAW 93-348-JULY 12, 1974 - \ Public Law 93348 July 12.1974 AN ACT [H' R. 77241 TO amend the Public Health Service Act to establish a
program of National Research Service Awards to assure the continued excellence of biomedical
and behavioral research and to provide for the protection of human subjects involved in
biomedical and behavioral research and for other purposes. Be it enacted by the Senate and
House of Representatives of the Re- United States of America in Congress assembled, search
Act. 42 usc 2891-1 SECTION 1. This Act may be cited as the "National Research Act". note.
National Re- TITLE I-BIOMEDICAL AND BEHAVIORAL RESEARCH search Service Award Act
of 1974. TRAINING SHORT TITLE SEC. 101. This title may be cited as the '<National Research
Service 42 U.S.C 28g1-1 Award Act of 1974". note. FINDINGS .AND DECLARATION OF
PURPOSE 42 U.S.C 2891-1 note. SEC. 102. (a) Congress finds and declares that- (1) the
success and continued viability of the Federal biomedi- cal and behavioral research effort
depends on the availability of excellent scientists and a network of institutions of excellence
capable of producing superior research personnel ; (2) direct support of the training of scientists
for careers in biomedical and behavioral research is an appropriate and necessary role for the
Federal Government ; and (3) graduate research assistance programs should be the key
elements in the training programs of the institutes of the National Institutes of Health and the
Alcohol, Drug Abuse, and Mental Health Administration. (b) It is the purpose of this title to
increase the capability of the institutes of the National Institutes of Health and the Alcohol, Drug
Abuse, and Mental Health Administration to carry out their responsibility of maintaining a superior
national program of research into the physical and mental diseases and impairments of man.
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Appendix K
THE BELMONT REPORT
Ethical Principles and Guidelines for the protection of human subjects of
research
The Belmont Report
Office of the Secretary
Ethical Principles and Guidelines for the Protection of Human
Subjects of Research
The National Commission for the Protection of Human Subjects
of Biomedical and Behavioral Research
April 18, 1979
AGENCY: Department of Health, Education, and Welfare.
ACTION: Notice of Report for Public Comment.
SUMMARY: On July 12, 1974, the National Research Act (Pub. L. 93-348) was signed into law,
there-by creating the National Commission for the Protection of Human Subjects of Biomedical
and Behavioral Research. One of the charges to the Commission was to identify the basic ethical
principles that should underlie the conduct of biomedical and behavioral research involving
human subjects and to develop guidelines which should be followed to assure that such research
is conducted in accordance with those principles. In carrying out the above, the Commission was
directed to consider: (i) the boundaries between biomedical and behavioral research and the
accepted and routine practice of medicine, (ii) the role of assessment of risk-benefit criteria in the
determination of the appropriateness of research involving human subjects, (iii) appropriate
guidelines for the selection of human subjects for participation in such research and (iv) the
nature and definition of informed consent in various research settings.
The Belmont Report attempts to summarize the basic ethical principles identified by the
Commission in the course of its deliberations. It is the outgrowth of an intensive four-day period of
discussions that were held in February 1976 at the Smithsonian Institution's Belmont Conference
Center supplemented by the monthly deliberations of the Commission that were held over a
period of nearly four years. It is a statement of basic ethical principles and guidelines that should
assist in resolving the ethical problems that surround the conduct of research with human
subjects. By publishing the Report in the Federal Register, and providing reprints upon request,
the Secretary intends that it may be made readily available to scientists, members of Institutional
Review Boards, and Federal employees. The two-volume Appendix, containing the lengthy
reports of experts and specialists who assisted the Commission in fulfilling this part of its charge,
is available as DHEW Publication No. (OS) 78-0013 and No. (OS) 78-0014, for sale by the
Superintendent of Documents, U.S. Government Printing Office, Washington, D.C. 20402.
Unlike most other reports of the Commission, the Belmont Report does not make specific
recommendations for administrative action by the Secretary of Health, Education, and Welfare.
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Rather, the Commission recommended that the Belmont Report be adopted in its entirety, as a
statement of the Department's policy. The Department requests public comment on this
recommendation.
National Commission for the Protection of Human Subjects
of Biomedical and Behavioral Research
Members of the Commission

Kenneth John Ryan, M.D., Chairman, Chief of Staff, Boston Hospital for Women.
Joseph V. Brady, Ph.D., Professor of Behavioral Biology, Johns Hopkins University.
Robert E. Cooke, M.D., President, Medical College of Pennsylvania.
*** Dorothy I. Height, President, National Council of Negro Women, Inc.
Albert R. Jonsen, Ph.D., Associate Professor of Bioethics, University of California at San
Francisco.
Patricia King, J.D., Associate Professor of Law, Georgetown University Law Center.
Karen Lebacqz, Ph.D., Associate Professor of Christian Ethics, Pacific School of
Religion.
*** David W. Louisell, J.D., Professor of Law, University of California at Berkeley.
Donald W. Seldin, M.D., Professor and Chairman, Department of Internal Medicine,
University of Texas at Dallas.
***Eliot Stellar, Ph.D., Provost of the University and Professor of Physiological
Psychology, University of Pennsylvania.
*** Robert H. Turtle, LL.B., Attorney, VomBaur, Coburn, Simmons & Turtle, Washington,
D.C.
*** Deceased.

Ethical Principles & Guidelines for Research Involving Human Subjects
Scientific research has produced substantial social benefits. It has also posed some
troubling ethical questions. Public attention was drawn to these questions by reported
abuses of human subjects in biomedical experiments, especially during the Second
World War. During the Nuremberg War Crime Trials, the Nuremberg code was drafted as
a set of standards for judging physicians and scientists who had conducted biomedical
experiments on concentration camp prisoners. This code became the prototype of many
later codes(1) intended to assure that research involving human subjects would be
carried out in an ethical manner.
The codes consist of rules, some general, others specific, that guide the investigators or
the reviewers of research in their work. Such rules often are inadequate to cover complex
situations; at times they come into conflict, and they are frequently difficult to interpret or
apply. Broader ethical principles will provide a basis on which specific rules may be
formulated, criticized and interpreted.
Three principles, or general prescriptive judgments, that are relevant to research
involving human subjects are identified in this statement. Other principles may also be
relevant. These three are comprehensive, however, and are stated at a level of
generalization that should assist scientists, subjects, reviewers and interested citizens to
understand the ethical issues inherent in research involving human subjects. These
principles cannot always be applied so as to resolve beyond dispute particular ethical
problems. The objective is to provide an analytical framework that will guide the
resolution of ethical problems arising from research involving human subjects.
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This statement consists of a distinction between research and practice, a discussion of
the three basic ethical principles, and remarks about the application of these principles.
Part A: Boundaries Between Practice & Research
A. Boundaries Between Practice and Research
It is important to distinguish between biomedical and behavioral research, on the one
hand, and the practice of accepted therapy on the other, in order to know what activities
ought to undergo review for the protection of human subjects of research. The distinction
between research and practice is blurred partly because both often occur together (as in
research designed to evaluate a therapy) and partly because notable departures from
standard practice are often called "experimental" when the terms "experimental" and
"research" are not carefully defined.
For the most part, the term "practice" refers to interventions that are designed solely to
enhance the well-being of an individual patient or client and that have a reasonable
expectation of success. The purpose of medical or behavioral practice is to provide
diagnosis, preventive treatment or therapy to particular individuals.(2) By contrast, the
term "research' designates an activity designed to test an hypothesis, permit conclusions
to be drawn, and thereby to develop or contribute to generalizable knowledge
(expressed, for example, in theories, principles, and statements of relationships).
Research is usually described in a formal protocol that sets forth an objective and a set of
procedures designed to reach that objective.
When a clinician departs in a significant way from standard or accepted practice, the
innovation does not, in and of itself, constitute research. The fact that a procedure is
"experimental," in the sense of new, untested or different, does not automatically place it
in the category of research. Radically new procedures of this description should,
however, be made the object of formal research at an early stage in order to determine
whether they are safe and effective. Thus, it is the responsibility of medical practice
committees, for example, to insist that a major innovation be incorporated into a formal
research project.(3)
Research and practice may be carried on together when research is designed to evaluate
the safety and efficacy of a therapy. This need not cause any confusion regarding
whether or not the activity requires review; the general rule is that if there is any element
of research in an activity, that activity should undergo review for the protection of human
subjects.
Part B: Basic Ethical Principles
B. Basic Ethical Principles
The expression "basic ethical principles" refers to those general judgments that serve as
a basic justification for the many particular ethical prescriptions and evaluations of human
actions. Three basic principles, among those generally accepted in our cultural tradition,
are particularly relevant to the ethics of research involving human subjects: the principles
of respect of persons, beneficence and justice.
1. Respect for Persons. -- Respect for persons incorporates at least two ethical
convictions: first, that individuals should be treated as autonomous agents, and second,
that persons with diminished autonomy are entitled to protection. The principle of respect
for persons thus divides into two separate moral requirements: the requirement to
acknowledge autonomy and the requirement to protect those with diminished autonomy.
An autonomous person is an individual capable of deliberation about personal goals and
of acting under the direction of such deliberation. To respect autonomy is to give weight
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to autonomous persons' considered opinions and choices while refraining from
obstructing their actions unless they are clearly detrimental to others. To show lack of
respect for an autonomous agent is to repudiate that person's considered judgments, to
deny an individual the freedom to act on those considered judgments, or to withhold
information necessary to make a considered judgment, when there are no compelling
reasons to do so.
However, not every human being is capable of self-determination. The capacity for selfdetermination matures during an individual's life, and some individuals lose this capacity
wholly or in part because of illness, mental disability, or circumstances that severely
restrict liberty. Respect for the immature and the incapacitated may require protecting
them as they mature or while they are incapacitated.
Some persons are in need of extensive protection, even to the point of excluding them
from activities which may harm them; other persons require little protection beyond
making sure they undertake activities freely and with awareness of possible adverse
consequence. The extent of protection afforded should depend upon the risk of harm and
the likelihood of benefit. The judgment that any individual lacks autonomy should be
periodically reevaluated and will vary in different situations.
In most cases of research involving human subjects, respect for persons demands that
subjects enter into the research voluntarily and with adequate information. In some
situations, however, application of the principle is not obvious. The involvement of
prisoners as subjects of research provides an instructive example. On the one hand, it
would seem that the principle of respect for persons requires that prisoners not be
deprived of the opportunity to volunteer for research. On the other hand, under prison
conditions they may be subtly coerced or unduly influenced to engage in research
activities for which they would not otherwise volunteer. Respect for persons would then
dictate that prisoners be protected. Whether to allow prisoners to "volunteer" or to
"protect" them presents a dilemma. Respecting persons, in most hard cases, is often a
matter of balancing competing claims urged by the principle of respect itself.
2. Beneficence. -- Persons are treated in an ethical manner not only by respecting their
decisions and protecting them from harm, but also by making efforts to secure their wellbeing. Such treatment falls under the principle of beneficence. The term "beneficence" is
often understood to cover acts of kindness or charity that go beyond strict obligation. In
this document, beneficence is understood in a stronger sense, as an obligation. Two
general rules have been formulated as complementary expressions of beneficent actions
in this sense: (1) do not harm and (2) maximize possible benefits and minimize possible
harms.
The Hippocratic maxim "do no harm" has long been a fundamental principle of medical
ethics. Claude Bernard extended it to the realm of research, saying that one should not
injure one person regardless of the benefits that might come to others. However, even
avoiding harm requires learning what is harmful; and, in the process of obtaining this
information, persons may be exposed to risk of harm. Further, the Hippocratic
Oath requires physicians to benefit their patients "according to their best judgment."
Learning what will in fact benefit may require exposing persons to risk. The problem
posed by these imperatives is to decide when it is justifiable to seek certain benefits
despite the risks involved, and when the benefits should be foregone because of the
risks.
The obligations of beneficence affect both individual investigators and society at large,
because they extend both to particular research projects and to the entire enterprise of
research. In the case of particular projects, investigators and members of their institutions
are obliged to give forethought to the maximization of benefits and the reduction of risk
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that might occur from the research investigation. In the case of scientific research in
general, members of the larger society are obliged to recognize the longer term benefits
and risks that may result from the improvement of knowledge and from the development
of novel medical, psychotherapeutic, and social procedures.
The principle of beneficence often occupies a well-defined justifying role in many areas of
research involving human subjects. An example is found in research involving children.
Effective ways of treating childhood diseases and fostering healthy development are
benefits that serve to justify research involving children -- even when individual research
subjects are not direct beneficiaries. Research also makes it possible to avoid the harm
that may result from the application of previously accepted routine practices that on
closer investigation turn out to be dangerous. But the role of the principle of beneficence
is not always so unambiguous. A difficult ethical problem remains, for example, about
research that presents more than minimal risk without immediate prospect of direct
benefit to the children involved. Some have argued that such research is inadmissible,
while others have pointed out that this limit would rule out much research promising great
benefit to children in the future. Here again, as with all hard cases, the different claims
covered by the principle of beneficence may come into conflict and force difficult choices.
3. Justice. -- Who ought to receive the benefits of research and bear its burdens? This is
a question of justice, in the sense of "fairness in distribution" or "what is deserved." An
injustice occurs when some benefit to which a person is entitled is denied without good
reason or when some burden is imposed unduly. Another way of conceiving the principle
of justice is that equals ought to be treated equally. However, this statement requires
explication. Who is equal and who is unequal? What considerations justify departure from
equal distribution? Almost all commentators allow that distinctions based on experience,
age, deprivation, competence, merit and position do sometimes constitute criteria
justifying differential treatment for certain purposes. It is necessary, then, to explain in
what respects people should be treated equally.
There are several widely accepted formulations of just ways to distribute burdens and
benefits. Each formulation mentions some relevant property on the basis of which
burdens and benefits should be distributed. These formulations are (1) to each person an
equal share, (2) to each person according to individual need, (3) to each person
according to individual effort, (4) to each person according to societal contribution, and
(5) to each person according to merit.
Questions of justice have long been associated with social practices such as punishment,
taxation and political representation. Until recently these questions have not generally
been associated with scientific research. However, they are foreshadowed even in the
earliest reflections on the ethics of research involving human subjects. For example,
during the 19th and early 20th centuries the burdens of serving as research subjects fell
largely upon poor ward patients, while the benefits of improved medical care flowed
primarily to private patients. Subsequently, the exploitation of unwilling prisoners as
research subjects in Nazi concentration camps was condemned as a particularly flagrant
injustice. In this country, in the 1940's, the Tuskegee syphilis study used disadvantaged,
rural black men to study the untreated course of a disease that is by no means confined
to that population. These subjects were deprived of demonstrably effective treatment in
order not to interrupt the project, long after such treatment became generally available.
Against this historical background, it can be seen how conceptions of justice are relevant
to research involving human subjects. For example, the selection of research subjects
needs to be scrutinized in order to determine whether some classes (e.g., welfare
patients, particular racial and ethnic minorities, or persons confined to institutions) are
being systematically selected simply because of their easy availability, their compromised
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position, or their manipulability, rather than for reasons directly related to the problem
being studied. Finally, whenever research supported by public funds leads to the
development of therapeutic devices and procedures, justice demands both that these not
provide advantages only to those who can afford them and that such research should not
unduly involve persons from groups unlikely to be among the beneficiaries of subsequent
applications of the research.
Part C: Applications
C. Applications
Applications of the general principles to the conduct of research leads to consideration of
the following requirements: informed consent, risk/benefit assessment, and the selection
of subjects of research.
1. Informed Consent. -- Respect for persons requires that subjects, to the degree that
they are capable, be given the opportunity to choose what shall or shall not happen to
them. This opportunity is provided when adequate standards for informed consent are
satisfied.
While the importance of informed consent is unquestioned, controversy prevails over the
nature and possibility of an informed consent. Nonetheless, there is widespread
agreement that the consent process can be analyzed as containing three elements:
information, comprehension and voluntariness.
Information. Most codes of research establish specific items for disclosure intended to
assure that subjects are given sufficient information. These items generally include: the
research procedure, their purposes, risks and anticipated benefits, alternative procedures
(where therapy is involved), and a statement offering the subject the opportunity to ask
questions and to withdraw at any time from the research. Additional items have been
proposed, including how subjects are selected, the person responsible for the research,
etc.
However, a simple listing of items does not answer the question of what the standard
should be for judging how much and what sort of information should be provided. One
standard frequently invoked in medical practice, namely the information commonly
provided by practitioners in the field or in the locale, is inadequate since research takes
place precisely when a common understanding does not exist. Another standard,
currently popular in malpractice law, requires the practitioner to reveal the information
that reasonable persons would wish to know in order to make a decision regarding their
care. This, too, seems insufficient since the research subject, being in essence a
volunteer, may wish to know considerably more about risks gratuitously undertaken than
do patients who deliver themselves into the hand of a clinician for needed care. It may be
that a standard of "the reasonable volunteer" should be proposed: the extent and nature
of information should be such that persons, knowing that the procedure is neither
necessary for their care nor perhaps fully understood, can decide whether they wish to
participate in the furthering of knowledge. Even when some direct benefit to them is
anticipated, the subjects should understand clearly the range of risk and the voluntary
nature of participation.
A special problem of consent arises where informing subjects of some pertinent aspect of
the research is likely to impair the validity of the research. In many cases, it is sufficient to
indicate to subjects that they are being invited to participate in research of which some
features will not be revealed until the research is concluded. In all cases of research
involving incomplete disclosure, such research is justified only if it is clear that (1)
incomplete disclosure is truly necessary to accomplish the goals of the research, (2)
there are no undisclosed risks to subjects that are more than minimal, and (3) there is an
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adequate plan for debriefing subjects, when appropriate, and for dissemination of
research results to them. Information about risks should never be withheld for the
purpose of eliciting the cooperation of subjects, and truthful answers should always be
given to direct questions about the research. Care should be taken to distinguish cases in
which disclosure would destroy or invalidate the research from cases in which disclosure
would simply inconvenience the investigator.
Comprehension. The manner and context in which information is conveyed is as
important as the information itself. For example, presenting information in a disorganized
and rapid fashion, allowing too little time for consideration or curtailing opportunities for
questioning, all may adversely affect a subject's ability to make an informed choice.
Because the subject's ability to understand is a function of intelligence, rationality,
maturity and language, it is necessary to adapt the presentation of the information to the
subject's capacities. Investigators are responsible for ascertaining that the subject has
comprehended the information. While there is always an obligation to ascertain that the
information about risk to subjects is complete and adequately comprehended, when the
risks are more serious, that obligation increases. On occasion, it may be suitable to give
some oral or written tests of comprehension.
Special provision may need to be made when comprehension is severely limited -- for
example, by conditions of immaturity or mental disability. Each class of subjects that one
might consider as incompetent (e.g., infants and young children, mentally disable
patients, the terminally ill and the comatose) should be considered on its own terms.
Even for these persons, however, respect requires giving them the opportunity to choose
to the extent they are able, whether or not to participate in research. The objections of
these subjects to involvement should be honored, unless the research entails providing
them a therapy unavailable elsewhere. Respect for persons also requires seeking the
permission of other parties in order to protect the subjects from harm. Such persons are
thus respected both by acknowledging their own wishes and by the use of third parties to
protect them from harm.
The third parties chosen should be those who are most likely to understand the
incompetent subject's situation and to act in that person's best interest. The person
authorized to act on behalf of the subject should be given an opportunity to observe the
research as it proceeds in order to be able to withdraw the subject from the research, if
such action appears in the subject's best interest.
Voluntariness. An agreement to participate in research constitutes a valid consent only if
voluntarily given. This element of informed consent requires conditions free of coercion
and undue influence. Coercion occurs when an overt threat of harm is intentionally
presented by one person to another in order to obtain compliance. Undue influence, by
contrast, occurs through an offer of an excessive, unwarranted, inappropriate or improper
reward or other overture in order to obtain compliance. Also, inducements that would
ordinarily be acceptable may become undue influences if the subject is especially
vulnerable.
Unjustifiable pressures usually occur when persons in positions of authority or
commanding influence -- especially where possible sanctions are involved -- urge a
course of action for a subject. A continuum of such influencing factors exists, however,
and it is impossible to state precisely where justifiable persuasion ends and undue
influence begins. But undue influence would include actions such as manipulating a
person's choice through the controlling influence of a close relative and threatening to
withdraw health services to which an individual would otherwise be entitle.
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2. Assessment of Risks and Benefits. -- The assessment of risks and benefits requires a
careful arrayal of relevant data, including, in some cases, alternative ways of obtaining
the benefits sought in the research. Thus, the assessment presents both an opportunity
and a responsibility to gather systematic and comprehensive information about proposed
research. For the investigator, it is a means to examine whether the proposed research is
properly designed. For a review committee, it is a method for determining whether the
risks that will be presented to subjects are justified. For prospective subjects, the
assessment will assist the determination whether or not to participate.
The Nature and Scope of Risks and Benefits. The requirement that research be justified
on the basis of a favorable risk/benefit assessment bears a close relation to the principle
of beneficence, just as the moral requirement that informed consent be obtained is
derived primarily from the principle of respect for persons. The term "risk" refers to a
possibility that harm may occur. However, when expressions such as "small risk" or "high
risk" are used, they usually refer (often ambiguously) both to the chance (probability) of
experiencing a harm and the severity (magnitude) of the envisioned harm.
The term "benefit" is used in the research context to refer to something of positive value
related to health or welfare. Unlike, "risk," "benefit" is not a term that expresses
probabilities. Risk is properly contrasted to probability of benefits, and benefits are
properly contrasted with harms rather than risks of harm.
Accordingly, so-called risk/benefit assessments are concerned with the probabilities and
magnitudes of possible harm and anticipated benefits. Many kinds of possible harms and
benefits need to be taken into account. There are, for example, risks of psychological
harm, physical harm, legal harm, social harm and economic harm and the corresponding
benefits. While the most likely types of harms to research subjects are those of
psychological or physical pain or injury, other possible kinds should not be overlooked.
Risks and benefits of research may affect the individual subjects, the families of the
individual subjects, and society at large (or special groups of subjects in society).
Previous codes and Federal regulations have required that risks to subjects be
outweighed by the sum of both the anticipated benefit to the subject, if any, and the
anticipated benefit to society in the form of knowledge to be gained from the research. In
balancing these different elements, the risks and benefits affecting the immediate
research subject will normally carry special weight. On the other hand, interests other
than those of the subject may on some occasions be sufficient by themselves to justify
the risks involved in the research, so long as the subjects' rights have been protected.
Beneficence thus requires that we protect against risk of harm to subjects and also that
we be concerned about the loss of the substantial benefits that might be gained from
research.
The Systematic Assessment of Risks and Benefits. It is commonly said that benefits and
risks must be "balanced" and shown to be "in a favorable ratio." The metaphorical
character of these terms draws attention to the difficulty of making precise judgments.
Only on rare occasions will quantitative techniques be available for the scrutiny of
research protocols. However, the idea of systematic, nonarbitrary analysis of risks and
benefits should be emulated insofar as possible. This ideal requires those making
decisions about the justifiability of research to be thorough in the accumulation and
assessment of information about all aspects of the research, and to consider alternatives
systematically. This procedure renders the assessment of research more rigorous and
precise, while making communication between review board members and investigators
less subject to misinterpretation, misinformation and conflicting judgments. Thus, there
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should first be a determination of the validity of the presuppositions of the research; then
the nature, probability and magnitude of risk should be distinguished with as much clarity
as possible. The method of ascertaining risks should be explicit, especially where there is
no alternative to the use of such vague categories as small or slight risk. It should also be
determined whether an investigator's estimates of the probability of harm or benefits are
reasonable, as judged by known facts or other available studies.
Finally, assessment of the justifiability of research should reflect at least the following
considerations: (i) Brutal or inhumane treatment of human subjects is never morally
justified. (ii) Risks should be reduced to those necessary to achieve the research
objective. It should be determined whether it is in fact necessary to use human subjects
at all. Risk can perhaps never be entirely eliminated, but it can often be reduced by
careful attention to alternative procedures. (iii) When research involves significant risk of
serious impairment, review committees should be extraordinarily insistent on the
justification of the risk (looking usually to the likelihood of benefit to the subject -- or, in
some rare cases, to the manifest voluntariness of the participation). (iv) When vulnerable
populations are involved in research, the appropriateness of involving them should itself
be demonstrated. A number of variables go into such judgments, including the nature and
degree of risk, the condition of the particular population involved, and the nature and level
of the anticipated benefits. (v) Relevant risks and benefits must be thoroughly arrayed in
documents and procedures used in the informed consent process.
3. Selection of Subjects. -- Just as the principle of respect for persons finds expression in
the requirements for consent, and the principle of beneficence in risk/benefit assessment,
the principle of justice gives rise to moral requirements that there be fair procedures and
outcomes in the selection of research subjects.
Justice is relevant to the selection of subjects of research at two levels: the social and the
individual. Individual justice in the selection of subjects would require that researchers
exhibit fairness: thus, they should not offer potentially beneficial research only to some
patients who are in their favor or select only "undesirable" persons for risky research.
Social justice requires that distinction be drawn between classes of subjects that ought,
and ought not, to participate in any particular kind of research, based on the ability of
members of that class to bear burdens and on the appropriateness of placing further
burdens on already burdened persons. Thus, it can be considered a matter of social
justice that there is an order of preference in the selection of classes of subjects (e.g.,
adults before children) and that some classes of potential subjects (e.g., the
institutionalized mentally infirm or prisoners) may be involved as research subjects, if at
all, only on certain conditions.
Injustice may appear in the selection of subjects, even if individual subjects are selected
fairly by investigators and treated fairly in the course of research. Thus injustice arises
from social, racial, sexual and cultural biases institutionalized in society. Thus, even if
individual researchers are treating their research subjects fairly, and even if IRBs are
taking care to assure that subjects are selected fairly within a particular institution, unjust
social patterns may nevertheless appear in the overall distribution of the burdens and
benefits of research. Although individual institutions or investigators may not be able to
resolve a problem that is pervasive in their social setting, they can consider distributive
justice in selecting research subjects.
Some populations, especially institutionalized ones, are already burdened in many ways
by their infirmities and environments. When research is proposed that involves risks and
does not include a therapeutic component, other less burdened classes of persons
should be called upon first to accept these risks of research, except where the research
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is directly related to the specific conditions of the class involved. Also, even though public
funds for research may often flow in the same directions as public funds for health care, it
seems unfair that populations dependent on public health care constitute a pool of
preferred research subjects if more advantaged populations are likely to be the recipients
of the benefits.
One special instance of injustice results from the involvement of vulnerable subjects.
Certain groups, such as racial minorities, the economically disadvantaged, the very sick,
and the institutionalized may continually be sought as research subjects, owing to their
ready availability in settings where research is conducted.
Given their dependent status and their frequently compromised capacity for free consent,
they should be protected against the danger of being involved in research solely for
administrative convenience, or because they are easy to manipulate as a result of their
illness or socioeconomic condition.
(1) Since 1945, various codes for the proper and responsible conduct of human
experimentation in medical research have been adopted by different organizations. The
best known of these codes are the Nuremberg Code of 1947, the Helsinki Declaration of
1964 (revised in 1975), and the 1971 Guidelines (codified into Federal Regulations in
1974) issued by the U.S. Department of Health, Education, and Welfare Codes for the
conduct of social and behavioral research have also been adopted, the best known being
that of the American Psychological Association, published in 1973.
(2) Although practice usually involves interventions designed solely to enhance the wellbeing of a particular individual, interventions are sometimes applied to one individual for
the enhancement of the well-being of another (e.g., blood donation, skin grafts, organ
transplants) or an intervention may have the dual purpose of enhancing the well-being of
a particular individual, and, at the same time, providing some benefit to others (e.g.,
vaccination, which protects both the person who is vaccinated and society generally).
The fact that some forms of practice have elements other than immediate benefit to the
individual receiving an intervention, however, should not confuse the general distinction
between research and practice. Even when a procedure applied in practice may benefit
some other person, it remains an intervention designed to enhance the well-being of a
particular individual or groups of individuals; thus, it is practice and need not be reviewed
as research.
(3) Because the problems related to social experimentation may differ substantially from
those of biomedical and behavioral research, the Commission specifically declines to
make any policy determination regarding such research at this time. Rather, the
Commission believes that the problem ought to be addressed by one of its successor
bodies.
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Appendix L
CODE OF FEDERAL REGULATIONS
TITLE 45
PUBLIC WELFARE
DEPARTMENT OF HEALTH AND HUMAN SERVICES
PART 46
PROTECTION OF HUMAN SUBJECTS
Subparts A, B C D E
Revised January 15, 2009
Effective July 14, 2009
Basic HHS Policy for Protection of Human Research Subjects
Subpart A –
(Common
Rule)Section.
To what does this policy apply?
46.101
46.102
46.103
46.10446.106
46.107
46.108
46.109
46.110
46.111

Definitions.
Assuring compliance with this policy--research conducted or supported by any
Federal Department or Agency.
[Reserved]
IRB membership.
IRB functions and operations.
IRB review of research.
Expedited review procedures for certain kinds of research involving no more
than minimal risk, and for minor changes in approved research.
Criteria for IRB approval of research.
Review by institution.

46.112
Suspension or termination of IRB approval of research.
46.113
46.114
46.115
46.116
46.117
46.118
46.119
46.120
46.121
46.122
46.123
46.124

Cooperative research.
IRB records.
General requirements for informed consent.
Documentation of informed consent.
Applications and proposals lacking definite plans for involvement of human
subjects.
Research undertaken without the intention of involving human subjects.
Evaluation and disposition of applications and proposals for research to be
conducted or supported by a Federal Department or Agency.
[Reserved]
Use of Federal funds.
Early termination of research support: Evaluation of applications and proposals.
Conditions.
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Subpart B --

Additional Protections for Pregnant Women, Human Fetuses and Neonates
Involved in Research

Sec.
To what do these regulations apply?
46.201
46.202
46.203
46.204
46.205
46.206
46.207

Subpart C -Sec.
46.301
46.302
46.303
46.304
46.305
46.306
Subpart D -Sec.
46.401
46.402
46.403
46.404
46.405

Definitions.
Duties of IRBs in connection with research involving pregnant women, fetuses, and
neonates.
Research involving pregnant women or fetuses.
Research involving neonates.
Research involving, after delivery, the placenta, the dead fetus or fetal material.
Research not otherwise approvable which presents an opportunity to understand,
prevent, or alleviate a serious problem affecting the health or welfare of pregnant
women, fetuses, or neonates.
Additional Protections Pertaining to Biomedical and Behavioral Research
Involving Prisoners as Subjects
Applicability.
Purpose.
Definitions.
Composition of Institutional Review Boards where prisoners are involved.
Additional duties of the Institutional Review Boards where prisoners are involved.
Permitted research involving prisoners.
Additional Protections for Children Involved as Subjects in Research

To what do these regulations apply?
Definitions.
IRB duties.
Research not involving greater than minimal risk.
Research involving greater than minimal risk but presenting the prospect of direct
benefit to the individual subjects.
46.406
Research involving greater than minimal risk and no prospect of direct benefit to
individual subjects, but likely to yield generalizable knowledge about the subject's
disorder or condition.
46.407
Research not otherwise approvable which presents an opportunity to understand,
prevent, or alleviate a serious problem affecting the health or welfare of children.
46.408
Requirements for permission by parents or guardians and for assent by children.
46.409
Wards.
Subpart E -Registration of Institutional Review Boards
Sec.
46.501
What IRBs must be registered?
46.502
What information must be provided when registering an IRB?
46.503
When must an IRB be registered?
46.504
How must an IRB be registered?
46.505
When must IRB registration information be renewed or updated?
Authority: 5 U.S.C. 301, 42 U.S.C. 289(a).
Editorial Note: The Department of Health and Human Services issued a notice of waiver
regarding the requirements set forth in part 46, relating to protection of human subjects, as they
pertain to demonstration projects, approved under section 1115 of the Social Security Act, which
test the use of cost--sharing, such as deductibles, copayment and coinsurance, in the Medicaid
program. For further information see 47 FR 9208, Mar. 4, 1982.
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Subpart A

***
Basic HHS Policy for Protection of Human Research Subjects
Authority: 5 U.S.C. 301, 42 U.S.C. 289(a), 42 U.S.C. 300v-1(b).
Source: 56 FR 28012, 28022, June 18, 1991, unless otherwise noted.

§46.101 To what does this policy apply?
(a) Except as provided in paragraph (b) of this section, this policy applies to all research involving
human subjects conducted, supported or otherwise subject to regulation by any Federal
department or agency which takes appropriate administrative action to make the policy applicable
to such research. This includes research conducted by Federal civilian employees or military
personnel, except that each department or agency head may adopt such procedural
modifications as may be appropriate from an administrative standpoint. It also includes research
conducted, supported, or otherwise subject to regulation by the Federal government outside the
United States.
(1) Research that is conducted or supported by a Federal department or agency, whether or not it
is regulated as defined in §46.102(e), must comply with all sections of this policy.
(2) Research that is neither conducted nor supported by a Federal department or agency but is
subject to regulation as defined in §46.102(e) must be reviewed and approved, in compliance
with §46.101, §46.102, and §46.107 through §46.117 of this policy, by an institutional review
board (IRB) that operates in accordance with the pertinent requirements of this policy.
(b) Unless otherwise required by department or agency heads, research activities in which the
only involvement of human subjects will be in one or more of the following categories are exempt
from this policy:
(1) Research conducted in established or commonly accepted educational settings, involving
normal educational practices, such as (i) research on regular and special education instructional
strategies, or (ii) research on the effectiveness of or the comparison among instructional
techniques, curricula, or classroom management methods.
(2) Research involving the use of educational tests (cognitive, diagnostic, aptitude, achievement),
survey procedures, interview procedures or observation of public behavior, unless:
(i) information obtained is recorded in such a manner that human subjects can be identified,
directly or through identifiers linked to the subjects, and (ii) any disclosure of the human subjects'
responses outside the research could reasonably place the subjects at risk of criminal or civil
liability or be damaging to the subjects' financial standing, employability, or reputation.
(3) Research involving the use of educational tests (cognitive, diagnostic, aptitude, achievement),
survey procedures, interview procedures, or observation of public behavior that is not exempt
under paragraph (b)(2) of this section, if:
(i) the human subjects are elected or appointed public officials or candidates for public office, or
(ii) Federal statute(s) require(s) without exception that the confidentiality of the personally
identifiable information will be maintained throughout the research and thereafter.
(4) Research involving the collection or study of existing data, documents, records, pathological
specimens, or diagnostic specimens, if these sources are publicly available or if the information is
recorded by the investigator in such a manner that subjects cannot be identified, directly or
through identifiers linked to the subjects.
(5) Research and demonstration projects which are conducted by or subject to the approval of
department or agency heads, and which are designed to study, evaluate, or otherwise examine:
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(i) Public benefit or service programs, (ii) procedures for obtaining benefits or services under
those programs, (iii) possible changes in or alternatives to those programs or procedures, or (iv)
possible changes in methods or levels of payment for benefits or services under those programs.
(6) Taste and food quality evaluation and consumer acceptance studies, (i) if wholesome foods
without additives are consumed or (ii) if a food is consumed that contains a food ingredient at or
below the level and for a use found to be safe, or agricultural chemical or environmental
contaminant at or below the level found to be safe, by the Food and Drug Administration or
approved by the Environmental Protection Agency or the Food Safety and Inspection Service of
the U.S. Department of Agriculture.
(c) Department or agency heads retain final judgment as to whether a particular activity is
covered by this policy.
(d) Department or agency heads may require that specific research activities or classes of
research activities conducted, supported, or otherwise subject to regulation by the department or
agency but not otherwise covered by this policy, comply with some or all of the requirements of
this policy.
(e) Compliance with this policy requires compliance with pertinent Federal laws or regulations
which provide additional protections for human subjects.
(f) This policy does not affect any state or local laws or regulations which may otherwise be
applicable and which provide additional protections for human subjects.
(g) This policy does not affect any foreign laws or regulations which may otherwise be applicable
and which provide additional protections to human subjects of research.
(h) When research covered by this policy takes place in foreign countries, procedures normally
followed in the foreign countries to protect human subjects may differ from those set forth in this
policy. [An example is a foreign institution which complies with guidelines consistent with the
World Medical Assembly Declaration (Declaration of Helsinki amended 1989) issued either by
sovereign states or by an organization whose function for the protection of human research
subjects is internationally recognized.] In these circumstances, if a department or agency head
determines that the procedures prescribed by the institution afford protections that are at least
equivalent to those provided in this policy, the department or agency head may approve the
substitution of the foreign procedures in lieu of the procedural requirements provided in this
policy. Except when otherwise required by statute, Executive Order, or the department or agency
head, notices of these actions as they occur will be published in the FEDERAL REGISTER or will
be otherwise published as provided in department or agency procedures.
(i) Unless otherwise required by law, department or agency heads may waive the applicability of
some or all of the provisions of this policy to specific research activities or classes or research
activities otherwise covered by this policy. Except when otherwise required by statute or
Executive Order, the department or agency head shall forward advance notices of these actions
to the Office for Human Research Protections, Department of Health and Human Services (HHS),
or any successor office, and shall also publish them in the FEDERAL REGISTER or in such other
1
manner as provided in department or agency procedures.
1

Institutions with HHS-approved assurances on file will abide by provisions of Title 45 CFR part
46 subparts A-D. Some of the other departments and agencies have incorporated all provisions
of Title 45 CFR part 46 into their policies and procedures as well. However, the exemptions at 45
CFR 46.101(b) do not apply to research involving prisoners, subpart C. The exemption at 45 CFR
46.101(b)(2), for research involving survey or interview procedures or observation of public
behavior, does not apply to research with children, subpart D, except for research involving
observations of public behavior when the investigator(s) do not participate in the activities being
observed.
[56 FR 28012, 28022, June 18, 1991; 56 FR 29756, June 28, 1991, as amended at 70 FR
36328, June 23, 2005]
§46.102 Definitions.
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(a) Department or agency head means the head of any Federal department or agency and any
other officer or employee of any department or agency to whom authority has been delegated.
(b) Institution means any public or private entity or agency (including Federal, state, and other
agencies).
(c) Legally authorized representative means an individual or judicial or other body authorized
under applicable law to consent on behalf of a prospective subject to the subject's participation in
the procedure(s) involved in the research.
(d) Research means a systematic investigation, including research development, testing and
evaluation, designed to develop or contribute to generalizable knowledge. Activities which meet
this definition constitute research for purposes of this policy, whether or not they are conducted or
supported under a program which is considered research for other purposes. For example, some
demonstration and service programs may include research activities.
(e) Research subject to regulation, and similar terms are intended to encompass those research
activities for which a Federal department or agency has specific responsibility for regulating as a
research activity, (for example, Investigational New Drug requirements administered by the Food
and Drug Administration). It does not include research activities which are incidentally regulated
by a Federal department or agency solely as part of the department's or agency's broader
responsibility to regulate certain types of activities whether research or non-research in nature
(for example, Wage and Hour requirements administered by the Department of Labor).
(f) Human subject means a living individual about whom an investigator (whether professional or
student) conducting research obtains
(1) Data through intervention or interaction with the individual, or
(2) Identifiable private information.
Intervention includes both physical procedures by which data are gathered (for example,
venipuncture) and manipulations of the subject or the subject's environment that are performed
for research purposes. Interaction includes communication or interpersonal contact between
investigator and subject. Private information includes information about behavior that occurs in a
context in which an individual can reasonably expect that no observation or recording is taking
place, and information which has been provided for specific purposes by an individual and which
the individual can reasonably expect will not be made public (for example, a medical record).
Private information must be individually identifiable (i.e., the identity of the subject is or may
readily be ascertained by the investigator or associated with the information) in order for obtaining
the information to constitute research involving human subjects.
(g) IRB means an institutional review board established in accord with and for the purposes
expressed in this policy.
(h) IRB approval means the determination of the IRB that the research has been reviewed and
may be conducted at an institution within the constraints set forth by the IRB and by other
institutional and Federal requirements.
(i) Minimal risk means that the probability and magnitude of harm or discomfort anticipated in the
research are not greater in and of themselves than those ordinarily encountered in daily life or
during the performance of routine physical or psychological examinations or tests.
(j) Certification means the official notification by the institution to the supporting department or
agency, in accordance with the requirements of this policy, that a research project or activity
involving human subjects has been reviewed and approved by an IRB in accordance with an
approved assurance.
§46.103 Assuring compliance with this policy -- research conducted or supported by any Federal
Department or Agency.
(a) Each institution engaged in research which is covered by this policy and which is conducted or
supported by a Federal department or agency shall provide written assurance satisfactory to the
department or agency head that it will comply with the requirements set forth in this policy. In lieu
of requiring submission of an assurance, individual department or agency heads shall accept the
existence of a current assurance, appropriate for the research in question, on file with the Office
for Human Research Protections, HHS, or any successor office, and approved for Federalwide
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use by that office. When the existence of an HHS-approved assurance is accepted in lieu of
requiring submission of an assurance, reports (except certification) required by this policy to be
made to department and agency heads shall also be made to the Office for Human Research
Protections, HHS, or any successor office.
(b) Departments and agencies will conduct or support research covered by this policy only if the
institution has an assurance approved as provided in this section, and only if the institution has
certified to the department or agency head that the research has been reviewed and approved by
an IRB provided for in the assurance, and will be subject to continuing review by the IRB.
Assurances applicable to Federally supported or conducted research shall at a minimum include:
(1) A statement of principles governing the institution in the discharge of its responsibilities for
protecting the rights and welfare of human subjects of research conducted at or sponsored by the
institution, regardless of whether the research is subject to Federal regulation. This may include
an appropriate existing code, declaration, or statement of ethical principles, or a statement
formulated by the institution itself. This requirement does not preempt provisions of this policy
applicable to department- or agency-supported or regulated research and need not be applicable
to any research exempted or waived under §46.101(b) or (i).
(2) Designation of one or more IRBs established in accordance with the requirements of this
policy, and for which provisions are made for meeting space and sufficient staff to support the
IRB's review and recordkeeping duties.
(3) A list of IRB members identified by name, earned degrees, representative capacity,
indications of experience such as board certifications, licenses, etc., sufficient to describe each
member's chief anticipated contributions to IRB deliberations, and any employment or other
relationship between each member and the institution, for example: full-time employee, part-time
employee, member of governing panel or board, stockholder, paid or unpaid consultant. Changes
in IRB membership shall be reported to the department or agency head, unless in accord with
§46.103(a) of this policy, the existence of an HHS-approved assurance is accepted. In this case,
change in IRB membership shall be reported to the Office for Human Research Protections, HHS,
or any successor office.
(4) Written procedures which the IRB will follow (i) for conducting its initial and continuing review
of research and for reporting its findings and actions to the investigator and the institution, (ii) for
determining which projects require review more often than annually and which projects need
verification from sources other than the investigators that no material changes have occurred
since previous IRB review, and (iii) for ensuring prompt reporting to the IRB of proposed changes
in a research activity, and for ensuring that such changes in approved research, during the period
for which IRB approval has already been given, may not be initiated without IRB review and
approval except when necessary to eliminate apparent immediate hazards to the subject.
(5) Written procedures for ensuring prompt reporting to the IRB, appropriate institutional officials,
and the department or agency head of (i) any unanticipated problems involving risks to subjects
or others or any serious or continuing noncompliance with this policy or the requirements or
determinations of the IRB, and (ii) any suspension or termination of IRB approval.
(c) The assurance shall be executed by an individual authorized to act for the institution and to
assume on behalf of the institution the obligations imposed by this policy and shall be filed in such
form and manner as the department or agency head prescribes.
(d) The department or agency head will evaluate all assurances submitted in accordance with this
policy through such officers and employees of the department or agency and such experts or
consultants engaged for this purpose as the department or agency head determines to be
appropriate. The department or agency head's evaluation will take into consideration the
adequacy of the proposed IRB in light of the anticipated scope of the institution's research
activities and the types of subject populations likely to be involved, the appropriateness of the
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proposed initial and continuing review procedures in light of the probable risks, and the size and
complexity of the institution.
(e) On the basis of this evaluation, the department or agency head may approve or disapprove
the assurance, or enter into negotiations to develop an approvable one. The department or
agency head may limit the period during which any particular approved assurance or class of
approved assurances shall remain effective or otherwise condition or restrict approval.
(f) Certification is required when the research is supported by a Federal department or agency
and not otherwise exempted or waived under §46.101(b) or (i). An institution with an approved
assurance shall certify that each application or proposal for research covered by the assurance
and by §46.103 of this Policy has been reviewed and approved by the IRB. Such certification
must be submitted with the application or proposal or by such later date as may be prescribed by
the department or agency to which the application or proposal is submitted. Under no condition
shall research covered by §46.103 of the Policy be supported prior to receipt of the certification
that the research has been reviewed and approved by the IRB. Institutions without an approved
assurance covering the research shall certify within 30 days after receipt of a request for such a
certification from the department or agency, that the application or proposal has been approved
by the IRB. If the certification is not submitted within these time limits, the application or proposal
may be returned to the institution.
(Approved by the Office of Management and Budget under Control Number 0990-0260.)
[56 FR 28012, 28022, June 18, 1991; 56 FR 29756, June 28, 1991, as amended at 70 FR
36328, June 23, 2005]
§§46.104--46.106 [Reserved]
§46.107 IRB membership.
(a) Each IRB shall have at least five members, with varying backgrounds to promote complete
and adequate review of research activities commonly conducted by the institution. The IRB shall
be sufficiently qualified through the experience and expertise of its members, and the diversity of
the members, including consideration of race, gender, and cultural backgrounds and sensitivity to
such issues as community attitudes, to promote respect for its advice and counsel in
safeguarding the rights and welfare of human subjects. In addition to possessing the professional
competence necessary to review specific research activities, the IRB shall be able to ascertain
the acceptability of proposed research in terms of institutional commitments and regulations,
applicable law, and standards of professional conduct and practice. The IRB shall therefore
include persons knowledgeable in these areas. If an IRB regularly reviews research that involves
a vulnerable category of subjects, such as children, prisoners, pregnant women, or handicapped
or mentally disabled persons, consideration shall be given to the inclusion of one or more
individuals who are knowledgeable about and experienced in working with these subjects.
(b) Every nondiscriminatory effort will be made to ensure that no IRB consists entirely of men or
entirely of women, including the institution's consideration of qualified persons of both sexes, so
long as no selection is made to the IRB on the basis of gender. No IRB may consist entirely of
members of one profession.
(c) Each IRB shall include at least one member whose primary concerns are in scientific areas
and at least one member whose primary concerns are in nonscientific areas.
(d) Each IRB shall include at least one member who is not otherwise affiliated with the institution
and who is not part of the immediate family of a person who is affiliated with the institution.
(e) No IRB may have a member participate in the IRB's initial or continuing review of any project
in which the member has a conflicting interest, except to provide information requested by the
IRB.
(f) An IRB may, in its discretion, invite individuals with competence in special areas to assist in
the review of issues which require expertise beyond or in addition to that available on the IRB.
These individuals may not vote with the IRB
§46.108 IRB functions and operations.
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In order to fulfill the requirements of this policy each IRB shall:
(a) Follow written procedures in the same detail as described in §46.103(b)(4) and, to the extent
required by, §46.103(b)(5).
(b) Except when an expedited review procedure is used (see §46.110), review proposed research
at convened meetings at which a majority of the members of the IRB are present, including at
least one member whose primary concerns are in nonscientific areas. In order for the research to
be approved, it shall receive the approval of a majority of those members present at the meeting

§46.109 IRB review of research.
(a) An IRB shall review and have authority to approve, require modifications in (to secure
approval), or disapprove all research activities covered by this policy.
(b) An IRB shall require that information given to subjects as part of informed consent is in
accordance with §46.116. The IRB may require that information, in addition to that specifically
mentioned in §46.116, be given to the subjects when in the IRB's judgment the information would
meaningfully add to the protection of the rights and welfare of subjects.
(c) An IRB shall require documentation of informed consent or may waive documentation in
accordance with §46.117.
(d) An IRB shall notify investigators and the institution in writing of its decision to approve or
disapprove the proposed research activity, or of modifications required to secure IRB approval of
the research activity. If the IRB decides to disapprove a research activity, it shall include in its
written notification a statement of the reasons for its decision and give the investigator an
opportunity to respond in person or in writing.
(e) An IRB shall conduct continuing review of research covered by this policy at intervals
appropriate to the degree of risk, but not less than once per year, and shall have authority to
observe or have a third party observe the consent process and the research. High heat
[56 FR 28012, 28022, June 18, 1991; 56 FR 29756, June 28, 1991, as amended at 70 FR 36328,
June 23, 2005]
§46.110 Expedited review procedures for certain kinds of research involving no more than
minimal risk, and for minor changes in approved research.
(a) The Secretary, HHS, has established, and published as a Notice in the FEDERAL
REGISTER, a list of categories of research that may be reviewed by the IRB through an
expedited review procedure. The list will be amended, as appropriate, after consultation with
other departments and agencies, through periodic republication by the Secretary, HHS, in the
FEDERAL REGISTER. A copy of the list is available from the Office for Human Research
Protections, HHS, or any successor office.
(b) An IRB may use the expedited review procedure to review either or both of the following:
(1) some or all of the research appearing on the list and found by the reviewer(s) to involve no
more than minimal risk,
(2) minor changes in previously approved research during the period (of one year or less) for
which approval is authorized.
Under an expedited review procedure, the review may be carried out by the IRB chairperson or
by one or more experienced reviewers designated by the chairperson from among members of
the IRB. In reviewing the research, the reviewers may exercise all of the authorities of the IRB
except that the reviewers may not disapprove the research. A research activity may be
disapproved only after review in accordance with the non-expedited procedure set forth in
§46.108(b).
(c) Each IRB which uses an expedited review procedure shall adopt a method for keeping all
members advised of research proposals which have been approved under the procedure.
(d) The department or agency head may restrict, suspend, terminate, or choose not to authorize
an institution's or IRB's use of the expedited review procedure.
[56 FR 28012, 28022, June 18, 1991, as amended at 70 FR 36328, June 23, 2005]
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§46.111 Criteria for IRB approval of research.
(a) In order to approve research covered by this policy the IRB shall determine that all of the
following requirements are satisfied:
(1) Risks to subjects are minimized: (i) By using procedures which are consistent with sound
research design and which do not unnecessarily expose subjects to risk, and (ii) whenever
appropriate, by using procedures already being performed on the subjects for diagnostic or
treatment purposes.
(2) Risks to subjects are reasonable in relation to anticipated benefits, if any, to subjects, and the
importance of the knowledge that may reasonably be expected to result. In evaluating risks and
benefits, the IRB should consider only those risks and benefits that may result from the research
(as distinguished from risks and benefits of therapies subjects would receive even if not
participating in the research). The IRB should not consider possible long-range effects of applying
knowledge gained in the research (for example, the possible effects of the research on public
policy) as among those research risks that fall within the purview of its responsibility.
(3) Selection of subjects is equitable. In making this assessment the IRB should take into account
the purposes of the research and the setting in which the research will be conducted and should
be particularly cognizant of the special problems of research involving vulnerable populations,
such as children, prisoners, pregnant women, mentally disabled persons, or economically or
educationally disadvantaged persons.
(4) Informed consent will be sought from each prospective subject or the subject's legally
authorized representative, in accordance with, and to the extent required by §46.116.
(5) Informed consent will be appropriately documented, in accordance with, and to the extent
required by §46.117.
(6) When appropriate, the research plan makes adequate provision for monitoring the data
collected to ensure the safety of subjects.
(7) When appropriate, there are adequate provisions to protect the privacy of subjects and to
maintain the confidentiality of data.
(b) When some or all of the subjects are likely to be vulnerable to coercion or undue influence,
such as children, prisoners, pregnant women, mentally disabled persons, or economically or
educationally disadvantaged persons, additional safeguards have been included in the study to
protect the rights and welfare of these subjects.
§46.112 Review by institution.
Research covered by this policy that has been approved by an IRB may be subject to further
appropriate review and approval or disapproval by officials of the institution. However, those
officials may not approve the research if it has not been approved by an IRB.
§46.113 Suspension or termination of IRB approval of research.
An IRB shall have authority to suspend or terminate approval of research that is not being
conducted in accordance with the IRB's requirements or that has been associated with
unexpected serious harm to subjects. Any suspension or termination of approval shall include a
statement of the reasons for the IRB's action and shall be reported promptly to the investigator,
appropriate institutional officials, and the department or agency head.
(Approved by the Office of Management and Budget under Control Number 0990-0260.)
[56 FR 28012, 28022, June 18, 1991, as amended at 70 FR 36328, June 23, 2005]
§46.114 Cooperative research.
Cooperative research projects are those projects covered by this policy which involve more than
one institution. In the conduct of cooperative research projects, each institution is responsible for
safeguarding the rights and welfare of human subjects and for complying with this policy. With the
approval of the department or agency head, an institution participating in a cooperative project
may enter into a joint review arrangement, rely upon the review of another qualified IRB, or make
similar arrangements for avoiding duplication of effort.
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§46.115 IRB records.
(a) An institution, or when appropriate an IRB, shall prepare and maintain adequate
documentation of IRB activities, including the following:
(1) Copies of all research proposals reviewed, scientific evaluations, if any, that accompany the
proposals, approved sample consent documents, progress reports submitted by investigators,
and reports of injuries to subjects.
(2) Minutes of IRB meetings which shall be in sufficient detail to show attendance at the
meetings, actions taken by the IRB, the vote on these actions including the number of members
voting for, against, and abstaining, the basis for requiring changes in or disapproving research,
and a written summary of the discussion of controverted issues and their resolution.
(3) Records of continuing review activities.
(4) Copies of all correspondence between the IRB and the investigators.
(5) A list of IRB members in the same detail as described in §46.103(b)(3).
(6) Written procedures for the IRB in the same detail as described in §46.103(b)(4) and
§46.103(b)(5).
(7) Statements of significant new findings provided to subjects, as required by §46.116(b)(5).
(b) The records required by this policy shall be retained for at least 3 years, and records relating
to research which is conducted shall be retained for at least 3 years after completion of the
research. All records shall be accessible for inspection and copying by authorized representatives
of the department or agency at reasonable times and in a reasonable manner.
(Approved by the Office of Management and Budget under Control Number 0990-0260.)
[56 FR 28012, 28022, June 18, 1991, as amended at 70 FR 36328, June 23, 2005]
§46.116 General requirements for informed consent.
Except as provided elsewhere in this policy, no investigator may involve a human being as a
subject in research covered by this policy unless the investigator has obtained the legally
effective informed consent of the subject or the subject's legally authorized representative. An
investigator shall seek such consent only under circumstances that provide the prospective
subject or the representative sufficient opportunity to consider whether or not to participate and
that minimize the possibility of coercion or undue influence. The information that is given to the
subject or the representative shall be in language understandable to the subject or the
representative. No informed consent, whether oral or written, may include any exculpatory
language through which the subject or the representative is made to waive or appear to waive
any of the subject's legal rights, or releases or appears to release the investigator, the sponsor,
the institution or its agents from liability for negligence.
(a) Basic elements of informed consent. Except as provided in paragraph (c) or (d) of this section,
in seeking informed consent the following information shall be provided to each subject:
(1) A statement that the study involves research, an explanation of the purposes of the research
and the expected duration of the subject's participation, a description of the procedures to be
followed, and identification of any procedures which are experimental,
(2) A description of any reasonably foreseeable risks or discomforts to the subject,
(3) A description of any benefits to the subject or to others which may reasonably be expected
from the research,
(4) A disclosure of appropriate alternative procedures or courses of treatment, if any, that might
be advantageous to the subject,
(5) A statement describing the extent, if any, to which confidentiality of records identifying the
subject will be maintained,
(6) For research involving more than minimal risk, an explanation as to whether any
compensation and an explanation as to whether any medical treatments are available if injury
occurs and, if so, what they consist of, or where further information may be obtained,
(7) An explanation of whom to contact for answers to pertinent questions about the research and
research subjects' rights, and whom to contact in the event of a research-related injury to the
subject, and
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(8) A statement that participation is voluntary, refusal to participate will involve no penalty or loss
of benefits to which the subject is otherwise entitled, and the subject may discontinue
participation at any time without penalty or loss of benefits to which the subject is otherwise
entitled.
(b) Additional elements of informed consent. When appropriate, one or more of the following
elements of information shall also be provided to each subject:
(1) A statement that the particular treatment or procedure may involve risks to the subject (or to
the embryo or fetus, if the subject is or may become pregnant) which are currently unforeseeable,
(2) Anticipated circumstances under which the subject's participation may be terminated by the
investigator without regard to the subject's consent,
(3) Any additional costs to the subject that may result from participation in the research,
(4) The consequences of a subject's decision to withdraw from the research and procedures for
orderly termination of participation by the subject,
(5) A statement that significant new findings developed during the course of the research which
may relate to the subject's willingness to continue participation will be provided to the subject, and
(6) The approximate number of subjects involved in the study.
(c) An IRB may approve a consent procedure which does not include, or which alters, some or all
of the elements of informed consent set forth above, or waive the requirement to obtain informed
consent provided the IRB finds and documents that:
(1) The research or demonstration project is to be conducted by or subject to the approval of
state or local government officials and is designed to study, evaluate, or otherwise examine: (i)
public benefit or service programs, (ii) procedures for obtaining benefits or services under those
programs, (iii) possible changes in or alternatives to those programs or procedures, or (iv)
possible changes in methods or levels of payment for benefits or services under those programs,
and
(2) The research could not practicably be carried out without the waiver or alteration.
(d) An IRB may approve a consent procedure which does not include, or which alters, some or all
of the elements of informed consent set forth in this section, or waive the requirements to obtain
informed consent provided the IRB finds and documents that:
(1) The research involves no more than minimal risk to the subjects,
(2) The waiver or alteration will not adversely affect the rights and welfare of the subjects,
(3) The research could not practicably be carried out without the waiver or alteration, and
(4) Whenever appropriate, the subjects will be provided with additional pertinent information after
participation.
(e) The informed consent requirements in this policy are not intended to preempt any applicable
Federal, state, or local laws which require additional information to be disclosed in order for
informed consent to be legally effective.
(f) Nothing in this policy is intended to limit the authority of a physician to provide emergency
medical care, to the extent the physician is permitted to do so under applicable Federal, state, or
local law.
(Approved by the Office of Management and Budget under Control Number 0990-0260.)
[56 FR 28012, 28022, June 18, 1991, as amended at 70 FR 36328, June 23, 2005]
§46.117 Documentation of informed consent.
(a) Except as provided in paragraph (c) of this section, informed consent shall be documented by
the use of a written consent form approved by the IRB and signed by the subject or the subject's
legally authorized representative. A copy shall be given to the person signing the form.
(b) Except as provided in paragraph (c) of this section, the consent form may be either of the
following:
(1) A written consent document that embodies the elements of informed consent required by
§46.116. This form may be read to the subject or the subject's legally authorized representative,
but in any event, the investigator shall give either the subject or the representative adequate
opportunity to read it before it is signed, or
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(2) A short form written consent document stating that the elements of informed consent required
by §46.116 have been presented orally to the subject or the subject's legally authorized
representative. When this method is used, there shall be a witness to the oral presentation. Also,
the IRB shall approve a written summary of what is to be said to the subject or the representative.
Only the short form itself is to be signed by the subject or the representative. However, the
witness shall sign both the short form and a copy of the summary, and the person actually
obtaining consent shall sign a copy of the summary. A copy of the summary shall be given to the
subject or the representative, in addition to a copy of the short form.
(c) An IRB may waive the requirement for the investigator to obtain a signed consent form for
some or all subjects if it finds either:
(1) That the only record linking the subject and the research would be the consent document and
the principal risk would be potential harm resulting from a breach of confidentiality. Each subject
will be asked whether the subject wants documentation linking the subject with the research, and
the subject's wishes will govern, or
(2) That the research presents no more than minimal risk of harm to subjects and involves no
procedures for which written consent is normally required outside of the research context.
In cases in which the documentation requirement is waived, the IRB may require the investigator
to provide subjects with a written statement regarding the research.
(Approved by the Office of Management and Budget under Control Number 0990-0260.)
[56 FR 28012, 28022, June 18, 1991, as amended at 70 FR 36328, June 23, 2005]
§46.118 Applications and proposals lacking definite plans for involvement of human subjects.
Certain types of applications for grants, cooperative agreements, or contracts are submitted to
departments or agencies with the knowledge that subjects may be involved within the period of
support, but definite plans would not normally be set forth in the application or proposal. These
include activities such as institutional type grants when selection of specific projects is the
institution's responsibility, research training grants in which the activities involving subjects remain
to be selected, and projects in which human subjects' involvement will depend upon completion
of instruments, prior animal studies, or purification of compounds. These applications need not be
reviewed by an IRB before an award may be made. However, except for research exempted or
waived under §46.101(b) or (i), no human subjects may be involved in any project supported by
these awards until the project has been reviewed and approved by the IRB, as provided in this
policy, and certification submitted, by the institution, to the department or agency.
§46.119 Research undertaken without the intention of involving human subjects.
In the event research is undertaken without the intention of involving human subjects, but it is
later proposed to involve human subjects in the research, the research shall first be reviewed and
approved by an IRB, as provided in this policy, a certification submitted, by the institution, to the
department or agency, and final approval given to the proposed change by the department or
agency.
§46.120 Evaluation and disposition of applications and proposals for research to be conducted or
supported by a Federal Department or Agency.
(a) The department or agency head will evaluate all applications and proposals involving human
subjects submitted to the department or agency through such officers and employees of the
department or agency and such experts and consultants as the department or agency head
determines to be appropriate. This evaluation will take into consideration the risks to the subjects,
the adequacy of protection against these risks, the potential benefits of the research to the
subjects and others, and the importance of the knowledge gained or to be gained.
(b) On the basis of this evaluation, the department or agency head may approve or disapprove
the application or proposal, or enter into negotiations to develop an approvable one.
§46.121 [Reserved]

236

§46.122 Use of Federal funds.
Federal funds administered by a department or agency may not be expended for research
involving human subjects unless the requirements of this policy have been satisfied.
§46.123 Early termination of research support: Evaluation of applications and proposals.
(a) The department or agency head may require that department or agency support for any
project be terminated or suspended in the manner prescribed in applicable program
requirements, when the department or agency head finds an institution has materially failed to
comply with the terms of this policy.
(b) In making decisions about supporting or approving applications or proposals covered by this
policy the department or agency head may take into account, in addition to all other eligibility
requirements and program criteria, factors such as whether the applicant has been subject to a
termination or suspension under paragraph (a) of this section and whether the applicant or the
person or persons who would direct or has/have directed the scientific and technical aspects of
an activity has/have, in the judgment of the department or agency head, materially failed to
discharge responsibility for the protection of the rights and welfare of human subjects (whether or
not the research was subject to Federal regulation).
§46.124 Conditions.
With respect to any research project or any class of research projects the department or agency
head may impose additional conditions prior to or at the time of approval when in the judgment of
the department or agency head additional conditions are necessary for the protection of human
subjects.

237

APPENDIX M

238

239

240

241

242

243

244

245

246

247

248

249

Appendix N

250

251

252

Appendix O
Written Testimony
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on behalf of the
Consortium of Social Science Associations
in Cooperation with the American Sociological Association
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The Committee on Assessing the System for Protecting Human Research Subjects
The Institute of Medicine
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Written Testimony Felice J. Levine, PhD American Sociological Association on behalf of
the Consortium of Social Science Associations in Cooperation with the American
Sociological Association Submitted to The Committee on Assessing the System for
Protecting Human Research Subjects
The Institute of Medicine
The National Academies January 31, 2001
Dr. Federman and Members of the Committee:
Thank you very much for the opportunity to submit comments on the draft accreditation
standards regarding the protection of human participants in research. As Executive
Officer of the American Sociological Association and as a member of the Executive
Committee of the Consortium of Social Science Associations (COSSA), I am pleased to
be able to do so on behalf of COSSA. COSSA is an advocacy organization for the social
and behavioral sciences, supported by over 105 professional associations, scientific
societies, universities, and research institutes.
COSSA appreciates the opportunity to talk about some of the issues and challenges for
the social and behavioral sciences under the proposed standards of accreditation for the
protection of human subjects in research. COSSA believes in promoting sound science
with sound ethical practices. Most of our professional associations have developed
ethical guidelines for researchers to follow in conducting their studies, particularly where
human subjects are part of the research design. All embrace the Belmont Report's
admonitions of respect for persons, beneficence, and justice. We are, however,
concerned with the growing fault lines in the system that protects human subjects and by
the gap that has developed between law and policy on-the-books and in-action. For
example, researchers utilizing secondary data are being asked to seek approval by IRBs
to use these data where the information is in anonymous form and where subjects are
already protected under earlier protocols. We hope the Committee will examine such
issues closely, not only in assessing these draft standards, but also in your larger study
of the whole system of protecting human research participants.
For the social and behavioral sciences, the overall problem with the system is the attempt
to fit our research into a framework that was over specified and designed for biomedical-
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clinical research. The presence of IRBs in academic and other research organizations
dates back to 1974 when Federal guidelines were established for the protection of human
subjects. While social and behavioral science research was included from the outset,
much of the impetus for such guidelines grew out of concerns about informed consent
and risks involved in biomedical research. Despite the passage of time, this model of
science continues to color the operations of the system, the understanding of best ethical
practices, and the functioning of Institutional Review Boards (IRBs). The proposed
standards that we are here to discuss today provide further evidence of this inherent
problem. If these standards are intended to be universal and fit all research involving
human participants, then they need to be framed in a way that meaningfully includes all
research fields. Standing alone, for example, the very long mention at the beginning of
Section 3 of Henry Beecher and his 1966 article on "Ethics and Clinical Research"
focuses too exclusively on physicians and on "performing experiments" on humans. This
type of preamble sends the wrong signal. We need to take this opportunity to send
inclusive signals about a broader band of research involving humans.
Before offering our specific observations of the draft accreditation standards, we address
some general concerns about the standards and about the system for protecting human
research subjects. We have framed our observations as a series of ten
recommendations. Most are broadly applicable to accreditation and the overall system;
some deal with issues that are particularly important for improving the ethical
consideration of research in the social and behavioral sciences. We believe that these
recommendations could and should usefully guide the IOM Committee in both the
assessment of the system and the development of accreditation standards.
GENERAL RECOMMENDATIONS
1) Seize the Moment for Effective Leadership on Behalf of All Science. IOM has the
opportunity to provide guidance on an accreditation system and a human research
participant protection system that effectively reaches to all areas of scientific research
and effectively serves all Federal funding agencies engaged in the support of such
research-not just the biomedical sciences. The social and behavioral sciences have
been committed to this system and its objectives, but often, in practice, the ethical
requirements of our sciences have not been consistently and effectively understood.
2) There is Virtue to Moving Ahead, but There is Also Virtue to Slowing the "Train"
Sufficiently to Ensure We Can Turn a New Corner. If the standards for accreditation are
to be more effective than the current process for obtaining assurances of compliance
under the Common Rule, then the two important IOM studies yet to be undertaken
should logically proceed before the final crafting and finalizing of accreditation
standards. Simply put, perhaps the final accreditation standards should follow after
studies two and three and not before.
3) Where's the Fit? The proposed accreditation standards integrate many pieces of the
Common Rule but use these regulations in a different context and often coupled with
other ideas. Accreditation standards should accredit to the regulations in place; the goal
of accreditation is to ensure that the regulations are followed, not to produce additional
regulations. The disjuncture between the Common Rule and the accreditation standards
needs careful analysis. It may be wisest to have accreditation standards that ensure the
effective implementation of the Common Rule guidelines. Then, perhaps as part of
introducing accreditation standards, an evaluation could be undertaken to assess
whether the system is working effectively and what gaps exist. The problem in the past
has been less the actual rules governing the human research protection system than
implementation of them.
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4) The Devil is in the Details. The proposed accreditation standards are not per se
couched in the language of any one science or arena of research, but, when coupled
with the Commentary, these standards are quite biomedical and heavily clinical and pay
only lip service to other substantive arenas of work. This is especially problematic for the
social and behavioral sciences. Will the Commentary be presented? If so, the role of the
Commentary needs to be clear, and the examples across areas of research need to be
specified.
5) While Good Ethics Makes for Good Research, Judgments of Best Ethical Practices are
Distinct from Judgments about the Quality of the Research. The proposed accreditation
standards overreach to what constitutes quality science and do not sufficiently distinguish
between those judgments and what constitutes ethical practices in science. Standards
shift from the criteria for the accreditation of IRBs to the assessment of the research and
the researcher. The standards need to emphasize accrediting the structure put in place
and the procedures to be followed for the
protection of human participants in research.
6) Clarity, Simplicity, and Transparency are Fundamental to Accreditation Standards of
Excellence. Many of the standards require judgments that are impossible to make. The
standards should not tell an institution how it should achieve its goals, but should set
forth what the standards or goals are. The standards should focus on the actual facts of
what is required and not engage in standard setting or determinations that are highly
subjective or elusive. The Commentary is often so detailed that, by omission, it is limiting
in its scope; at other points, the standards are so vague as to be subject to widely
different interpretations. Ironically, the movement to accreditation in large part aims to
transcend such problems-with the promulgation of reproducible standards intended to be
the backbone.
http://www.cossa.org/humanparticipants.html
7) The Educative Role of Accreditation Standards Can be More Powerful than its
Regulatory or Enforcement Functions. We know from research on compliance and noncompliance, that the primary power of a rule system is in its moral persuasion and
educative effects. Yet, the proposed accreditation standards, especially the Commentary,
provide little education for IRBs regarding how the human research protection system
should operate-especially for the social and behavioral sciences.
8) Less Can be More: Accreditation Standards Should Ensure that the Human Research
Protection System Does Not Overreach Its Role and that it Stays on Task. The human
research protection system needs to ensure that research proceeds and knowledge is
advanced in accordance with the highest standards of ethical practice with respect to
human subjects protection. The system needs also to ensure that work that comports to
ethical standards is facilitated and not impeded by the process. For example, research
involves risk at various levels-standards should hold IRBs to the task of effectively
implementing what was intended to be exempt or expedited and what requires full review.
Consent is another area where IRBs need to have knowledge about how to undertake
research ethically. Studies of runaway youth, for example, raise different issues about
parental consent than do observational studies of
preschoolers in a classroom.
9) Human Research Participants Refer to Actual Participation in a Study Underway or
Being Proposed. The accreditation standards need to make clear to IRBs what the scope
of the human research protection system is and is not. The analysis, for example, of
public use data or public use files where information is maintained in anonymous form
and without personal identifiers is research about people but not on people. The definition
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of human subjects under the Common Rule defines the scope of its purview as research
on living individuals when an investigator obtains data through an intervention or
interaction or obtains identifiable private information. For a human research protection
system to focus on this domain and to do it well-with appropriate attention to level of riskis to achieve an important goal.
10) Focus on the Ethical Considerations regarding Human Research Participants in
Various Types of Research. The answer to concerns in the social and behavioral
sciences is not to create a dual human research protection system but to ensure a
system that is more sophisticated about ethical practices across fields of science. Social
and behavioral science research is increasingly interdisciplinary within fields and across
especially biomedical, environmental, public health, and engineering fields. Separation
of the review by field could create redundancy and limit researchers mutually benefiting
from the ethical expertise of each other. But, this puts a burden on ensuring that an
altered human research protection system includes the necessary and appropriate
expertise on ethical practices in the social and behavioral sciences. The composition of
IRBs is very important; other parts of the system also need to be savvy about ethical
practices in the social and behavioral sciences.
SPECIFIC ILLU.S.TRATIVE CONCERNS
Our general recommendations raise questions that speak to the overall thrust, tone,
scope, and reach-if not overreaching-of the accreditation standards as currently crafted.
They also speak to how and when the IOM might be best situated to develop and
recommend accreditation standards for Institutional Review Boards. Because our general
concerns speak to each of the standards, we offer below some illustration of the type of
revisions and development work that would be required in any revision process.
Section on Principles Underlying . . . . should be expanded to set the tone of what is
meant to be included within the scope of the Belmont Report and the Common Rule (45
CFR Part 26). Note, for example, the reference in paragraph two to only "experimental
subjects." This should be changed to "who agree to be research participants (subjects)"
or similar language.
Definitions should explicitly include "colleges and universities" not just "universities."
Proposed Standard 1.7 calls for the review of the policies and procedures of the Human
Research Protection Plan. We suggest that it include a clause that periodic review must
include input from the scientific community and researchers as to whether the policies
and procedures are effectively protecting research participants and enabling the progress
of
research.
Proposed Standard 1.9 would benefit from explicit recognition of the social and
behavioral sciences. The language and Commentary of 1.9 should be appropriately
amended. Such a modification would make clear that the social and behavioral sciences
are different from the biomedical/clinical sciences and that, in a meaningful protection of
research participants, ethical principles need to be applied and implemented appropriate
to the substance and methodologies of the work. We urge that the Human Research
Protection Plan recognize that research in the social and behavioral sciences often
involves different situations (from clinical experiments) regarding the protection of human
subjects. The Plan could allows for specialty IRBs or certainly IRBs with appropriate
expertise in the social and behavioral sciences and ethical practices therein.
Proposed Standard 1.11 should make clear that expertise for the chair needs to include
expertise regarding ethical issues as they pertain to human participants in social and
behavioral science research. Language could be added to the effect of "across all fields
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of science germane to the work of the IRB." As in the Commentary, perhaps the
proposed standard should refer to both the chair and the members. The Commentary can
make clear that every chair cannot be expert in the specifics of all arenas of inquiry, but
that chairs need to display a breadth of interest and exposure that signals knowledge and
openness across fields. Also, the reference to "organization culture" seems superfluous
to an accreditation standard. It is not clear how one would measure "their [IRB chairs]
contribution to the organization's culture." It is also unclear why this determination is
included in the Commentary and the fit between this language and requirements for
assurances under the Common Rule.
Proposed Standard 1.14 focuses on the performance of an organization's HRPPemphasizing the importance of assessment and evaluation. The Commentary, however,
should refer only to the HRPP overall and the IRBs, not to the investigator. The
evaluation, of course, focuses on whether the HRPP is effectively performing its functions
of protecting human participants in research and thus necessarily examines how the
system identifies and deals with problems. The Commentary, however, should not imply
that there is a further assessment of the performance of investigators beyond examining
how the system operates with respect to the ethical monitoring of investigations. Also, the
Commentary should not explicitly cite any group like PRIM&R and what roles it might
perform because such roles are not mandated by the accreditation process. Also, the
Commentary should allow for successful assessments
and how they will be duly recorded and reported.
Proposed Standard 1.15 does not recognize the breadth and nature of communities of
research when it charges this function to the "organization." As currently written, the
proposed standard seems also to confuse an implied "local" community with populations
at risk and groups requiring special sensitivity because of their vulnerabilities. If it is to be
retained as a standard, it needs to be clear how community is defined. Does it include
international communities in multi-national research? Unlike in clinical trials where the
subject population might be drawn from the proximal community, in the social and
behavioral sciences, the sites for research and the locations of relevant research
participants and research communities can be geographically wide ranging. Typically
samples are drawn not based on geographic convenience to the investigator, but on the
substantive ideas motivating the research. Researchers need to demonstrate sensitivity
to relevant research communities, but it is unclear how or why the "organization" would
be charged with doing so. Therefore, as an accreditation standard for HRPP, this should
be deleted.
Proposed Standard 2.3 has examples in the Commentary that could usefully be
broadened. The Commentary should also use explicit language that signals the social
and behavioral sciences. Here and throughout "i.e." is used when it seems that "e.g." is
meant.
Proposed Standard 2.4 seems to focus on traits beyond substantive expertise in relevant
ethical areas embraced by the IRB. Why is this section necessary as an accreditation
standard, how does it link to the assurances specified in the Common Rule, and what
does it add beyond Proposed Standard 1.11? Especially in the Commentary, it reads far
too much like a job description. The accreditation standards need to focus on required
structures and processes; it seems unnecessary and unwise to frame the standards in
terms of personality attributes of those who serve. The Standard itself talks about
"sufficient respect" and other elusive traits which we believe are far too subjective and not
very
useful. Therefore, we recommend that this whole section should be eliminated.
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Proposed Standard 2.5 and the Commentary could usefully signal the breadth of
research involving human subjects. The text should read: The IRB administrator, staff,
chair(s), and Board members must possess and maintain knowledge, skills and abilities
appropriate to the actual conduct of research across all areas of study with human
subjects. IRB chairs and members should be encouraged to attend scientific society
meetings and their ethics workshops so that they understand the ethical requirements
put on the researcher by his/her professional community. Language in Commentary
should not explicitly privilege-even by example-any one certification process like CCIP.
Standards should be neutral on their face and should not promote any specific
programs.
Proposed Standards 2.8 and 2.9 should be in reverse order. The appropriateness of the
consent process should take precedence over the legibility of the consent documents.
Proposed Standard 2.10 needs clarification. The Commentary is misguided. The IRB
should not be determining who should serve as principal investigator and whether that
person is qualified to lead a research project. That should be left to peer review of the
substance of the research itself. The IRBs' attention should be directed to the processes
and procedures to be followed for the protection of human research participants. The
language could usefully be modified from "to be responsible for the research" to "to be
responsible for the protection of human subjects involved in the conduct of the
research." This standard is a further location where the breadth of the fields could be
signaled and the
social and behavioral sciences more explicitly included.
Proposed Standard 2.11 and specifically its opening Commentary should include a wide
array of examples that go beyond health and visibly include examples from the social
and behavioral sciences on health and other issues. For example, written specific
guidelines for IRBs would be useful in the area of survey research (including with
respect to different populations), and IRBs would benefit from being better informed (and
having greater expertise) regarding how risk or adverse circumstances may be different
in survey research. As elsewhere, the current examples (after the "i.e.," are essentially
all clinical or biomedical.)
Proposed Standard 2.11 (E) (F) essentially has no Commentary. This is an area where
the accreditation standards can ensure that the HRPP system and the operations of IRBs
reach-not overreach-to what is meant to be included. The specification of Commentary
here could usefully educate IRBs about human subjects protection with respect to a
considerable amount of work in the social and behavioral sciences. Research qualified
for exemption or expedited review needs to be explicitly stipulated and reference made to
the Common Rule.
Proposed Standard 2.12 and 2.13 could usefully be aligned with the Common Rule; in
their present form, they are too prescriptive. They should be simplified so that the goals
and purposes of the IRB record keeping are clear and so that someone not party to the
process or the meeting could be expected to understand what has happened and why.
Proposed Standard 3, as noted above, needs to have the General Commentary recast
to explicit capture all fields of research, not just the biomedical and clinical fields. In
Commentary about investigators, all researchers and all IRBs need to see that these
accreditation standards includes social and behavioral science research and other
germane fields.
Proposed Standard 3.4 needs to explicitly account for exempt research and the
alignment between the responsibility of the IRBs and the investigators. Also, the
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Commentary gives final authority to the IRBs. We recommend that the IRB should not
have the sole authority in the organization to determine what constitutes protection of
human participants in research. There should be some avenue of appeal of IRB
decisions. Thus, if an IRB determined that a given project, such as secondary analysis
of data, should not be exempt, there needs to be another body where the researcher
can make his/her case and which is charged with determining if the IRB operated
consistent with regulations.
Proposed Standard 3.5 substantially overlaps Standard 2.10, which, as noted earlier,
needs clarification. The one difference is the emphasis on "delegation." Were this
Standard to be retained, it should read: "Principal Investigators (PIs) may delegate
responsibility for aspects of human subjects protection only to individuals who are
qualified through training and experience for this role."
Proposed Standard 3.7 is vague and unclear as to its purpose and intent. It sounds
almost like a "litmus test" that goes well beyond the high level of ethical practices
that an investigator may set for his or her own research. Furthermore, it is unclear
how it would be measured. We recommend that it be eliminated.
CONCLU.S.ION
In addressing both our general recommendations and specific concerns, we in the social
and behavioral sciences and in the scientific societies can be very useful. We stand
ready to do so under the auspices of COSSA. Other key agencies outside of the health
sciences that fund and support research with human participants can also help to bring
appropriate knowledge to bear. The National Science Foundation is key in that regard.
We believe that such guidance can help structure the next round of revisions for a final
set of "testable" accreditation standards. We at COSSA as well as many, many top
quality researchers behind us are eager to help in any way we can. Thank you for the
opportunity to present our views.

http://www.cossa.org/humanparticipants.html
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Appendix P

Office for Human Research Protections (OHRP)
Determination Letters 2000 – 2010

1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
21.
22.
23.
24.
25.
26.
27.
28.
29.
30.
31.
32.
33.
34.
35.
36.
37.
38.
39.
40.

12/04/2000
12/11/2000
12/11/2000
12/11/2000
12/12/2000
12/12/2000
12/12/2000
12/15/2000
12/15/2000
12/18/2000
12/20/2000
12/20/2000
12/22/2000
12/22/2000
11/03/2000
11/06/2000
11/08/2000
11/13/2000
11/22/2000
11/17/2000
11/27/2000
11/27/2000
11/27/2000
11/27/2000
11/27/2000
11/27/2000
11/29/2000
11/30/2000
10/03/2000
10/03/2000
10/03/2000
10/04/2000
10/11/2000
10/11/2000
10/11/2000
10/19/2000
10/19/2000
10/19/2000
10/19/2000
10/23/2000

University of South Florida
Louisiana State University Medical Center of New Orleans
The University of Alabama at Birmingham
University of Wisconsin - Madison
Yale University
National Institutes of Health
State University of New York
Massachusetts Eye and Ear Infirmary
Virginia Commonwealth University
Vanderbilt University
Yale University
Washington University School of Medicine
Wake Forest University
The University of North Carolina at Chapel Hill
National Institutes of Health
University of Arkansas for Medical Sciences
Yale University
University of Florida
University of Missouri - Columbia
University of South Florida
University of Rochester
RAND
Evanston Northwestern Healthcare Corporation
Case Western Reserve University
Raritan Bay Medical Center
Brown University
Temple University
Charles R. Drew University of Medicine and Science
The Johns Hopkins University
State University of New York at Binghamton
Brooke Army Medical Center
Georgetown University
Northeast Georgia Health Services
Evanston Northwestern Healthcare Corporation
St. Francis Health System
University of Maryland
Research Foundation for Mental Hygiene, Inc.
East Tennessee State University
The University of Oklahoma Health Sciences Center
Kaiser Foundation Hospitals
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41.
42.
43.
44.
45.
46.
47.
48.
49.
50.
51.
52.
53.
54.
55.
56.
57.
58.
59.
60.
61.
62.
63.
64.
65.
66.
67.
68.
69.
70.
71.
72.
73.
74.
75.
76.
77.
78.
79.
80.
81.
82.
83.
84.
85.
86.
87.
88.
89.
90.
91.
92.
93.
94.

10/24/2000
10/26/2000
10/26/2000
10/27/2000
10/27/2000
10/27/2000
09/07/2000
09/14/2000
09/21/2000
09/22/2000
09/26/2000
09/28/2000
08/02/2000
08/04/2000
08/07/2000
08/07/2000
08/07/2000
08/07/2000
08/11/2000
08/23/2000
08/25/2000
08/28/2000
08/28/2000
08/28/2000
08/28/2000
07/07/2000
07/10/2000
07/10/2000
07/12/2000
07/13/2000
07/13/2000
07/17/2000
07/18/2000
07/21/2000
07/27/2000
07/28/2000
07/31/2000
07/31/2000
12/05/2001
12/11/2001
12/14/2001
12/14/2001
12/14/2001
12/20/2001
12/21/2001
12/21/2001
11/16/2001
11/21/2001
11/26/2001
11/29/2001
11/30/2001
11/30/2001
10/03/2001
10/03/2001

University of South Florida
University of Colorado Health Sciences Center
Toxicology Associates
Louisiana State University Medical Center
The Pennsylvania State University
George Mason University
University of Florida
University of Texas Medical Branch at Galveston
University of Tennessee, Memphis
Virginia Commonwealth University
University of Texas Medical Branch at Galveston
University of South Florida
The University of Alabama at Birmingham
Northeast Georgia Health Services
Good Samaritan Regional Medical Center
INOVA Institute of Research and Education, Fairfax Hospital
Morehouse School of Medicine
University of Cincinnati
University of Wisconsin - Madison
University of Pennsylvania
The Cleveland Clinic Foundation
The University of Alabama at Birmingham
Memorial Health University Medical Center
St. Francis Health System
The Miriam Hospital
University of Oklahoma Health Sciences Center
University of Nebraska Medical Center
University of Texas Medical Branch at Galveston
University at Buffalo, State University of New York
University of Oklahoma Health Sciences Center
University of Illinois at Chicago
State University of New York
University of Illinois at Chicago
Encino-Tarzana Regional Medical Center
Yale University
University of Miami
University of Miami
University at Buffalo, State University of New York
Brooke Army Medical Center
Thomas Jefferson University/Wills Eye Hospital
John Hopkins University School of Medicine
Memorial Medical Center, New Orleans
University of Texas Health Science Center, Houston
University of Cincinnati
Columbia University
Columbia University Health Sciences Division
Brookhaven Science Associates, LLC
Children's National Medical Center
The Johns Hopkins University School of Medicine
Virginia Mason Research Center
Eastern Virginia Medical School
Case Western Reserve University
The Johns Hopkins University School of Medicine
Suburban Hospital
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95.
10/10/2001 Beth Israel Deaconess Medical Center
96.
10/15/2001 The Johns Hopkins University School of Medicine and
National Institute on Aging
97.
10/15/2001 Thomas Jefferson University/Wills Eye Hospital
98.
10/17/2001 Georgetown University
99.
10/23/2001 St. Elizabeth's Medical Center of Boston
100.
10/23/2001 The University of Texas Health Center - San Antonio
101.
10/24/2001 Sturdy Memorial Hospital
102.
10/24/2001 University of California - Los Angeles
103.
10/24/2001 University of California - San Francisco
104.
10/25/2001 National Institute on Drug Abuse (NIDA)
105.
10/29/2001 Georgetown University
106.
10/30/2001 Brown University
107.
10/30/2001 State University of New York at Stony Brook
108.
09/04/2001 Memorial Medical Center, New Orleans
109.
09/21/2001 University of South Florida/Tampa General Healthcare
110.
09/21/2001 Aaron Diamond AIDS Research Center
111.
09/26/2001 University of Pennsylvania
112.
08/01/2001 Thomas Jefferson University/Wills Eye Hospital
113.
08/06/2001 Georgetown University
114.
08/15/2001 Georgetown University
115.
08/15/2001 National Institutes of Health
116.
08/16/2001 University of Miami
117.
08/17/2001 Michael Reese Hospital
118.
08/17/2001 Rosewell Park Cancer Institute
119.
08/17/2001 University of California, Irvine
120.
08/17/2001 University of Michigan
121.
08/17/2001 University of Washington
122.
08/20/2001 University of Pennsylvania
123.
08/21/2001 University of Iowa
124.
08/21/2001 Okanagan Similkameen Health Region-Corporate
125.
08/21/2001 South Georgia Medical Center
126.
08/22/2001 St. Jude Children's Research Hospital
127.
08/22/2001 National Institutes of Health
128.
08/27/2001 University of California, San Francisco
129.
08/28/2001 The University of Texas Health Science Center at San
Antonio
130.
08/29/2001 National Institutes of Health
131.
08/29/2001 University of California, Davis
132.
08/29/2001 Minnesota Department of Health
133.
08/29/2001 State University of New York at Stony Brook
134.
08/31/2001 Childrens Hospital Los Angeles
135.
07/11/2001 University of Missouri - Columbia
136.
07/12/2001 St. Elizabeth's Medical Center of Boston
137.
07/12/2001 The University of Texas M.D. Anderson Cancer Center
138.
07/13/2001 St. Judes Children's Research Hospital
139.
07/19/2001 Johns Hopkins University School of Medicine/The Johns
Hopkins Bayview Medical Center
140.
07/20/2001 University of South Florida
141.
07/22/2001 Johns Hopkins University School of Medicine/The Johns
Hopkins Bayview Medical Center
142.
06/01/2001 Florida Department of Children and Families
143.
06/01/2001 Michael Reese Hospital
144.
06/05/2001 Roswell Park Cancer Institute
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145.
06/05/2001 Sturdy Memorial Hospital
146.
06/06/2001 University of Pennsylvania
147.
06/11/2001 Cleveland Clinic Foundation
148.
06/11/2001 Scientific Analysis Corporation
149.
06/11/2001 University of California, Irvine
150.
06/11/2001 University of Michigan
151.
06/14/2001 University of Arkansas for Medical Sciences & Arkansas
Children's Hospital
152.
05/03/2001 University of Colorado Health Sciences Center
153.
05/07/2001 University of Pennsylvania
154.
05/10/2001 University of Missouri-Columbia
155.
05/29/2001 University of Colorado Health Sciences Center
156.
05/31/2001 University of Texas M.D. Anderson Cancer Center
157.
05/31/2001 Georgetoown University
158.
04/13/2001 Mary Bridge Children's Hospital & Health Center
159.
04/17/2001 University of Texas - Houston Health Science Center
160.
04/19/2001 University of South Florida
161.
04/20/2001 University of Washington
162.
04/23/2001 Wills Eye Hospital - Thomas Jefferson University
163.
04/30/2001 University of Cincinnati, Department of Veterans Affairs
Medical Center and Shriners Burns Institute
164.
04/30/2001 University of Cincinnati, Department of Veterans Affairs
Medical Center and Shriners Burns Institute
165.
04/30/2001 University of Cincinnati, Department of Veterans Affairs
Medical Center and Shriners Burns Institute
166.
04/30/2001 NIH Cancer Therapy Evaluation Program - Eastern
Cooperative Oncology Group
167.
03/26/2001 University of Southern California Health Sciences
168.
03/27/2001 Indiana University
169.
03/28/2001 Department of Veterans Affairs Medical Center, Philadelphia
170.
03/28/2001 The University of Texas Southwestern Medical Center
171.
03/29/2001 RAND
172.
03/29/2001 Garden State Cancer Center
173.
03/29/2001 St. Jude Children's Research Hospital
174.
03/30/2001 St. Jude Children's Research Hospital
175.
03/30/2001 University of Utah
176.
03/30/2001 University of Illinois at Chicago
177.
02/08/2001 Children's Hospital, Boston
178.
02/12/2001 Louisiana State University Medical Center
179.
02/15/2001 Baylor College of Medicine
180.
02/15/2001 University of Cincinnati
181.
02/15/2001 Department of Veterans Affairs Medical Center, Philadelphia
182.
02/16/2001 Florida Dept. of Health/FDCF
183.
02/22/2001 Yale University
184.
02/28/2001 Raritan Bay Medical Center
185.
02/28/2001 Brown University Graduate School
186.
01/12/2001 Mary Bridge Children's Hospital & Health Center
187.
01/17/2001 National Institutes of Health
188.
01/17/2001 University of Texas Medical Branch at Galveston
189.
01/19/2001 University of Miami
190.
01/22/2001 The John Hopkins University School of Medicine
191.
01/22/2001 McMaster University
192.
01/22/2001 University of Pennsylvania
193.
01/22/2001 National Institutes of Health
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194.
01/23/2001 The University of Texas Southwestern Medical Center
195.
01/23/2001 National Institutes of Health
196.
01/24/2001 Garden State Cancer Center
197.
01/24/2001 National Institutes of Health
198.
01/25/2001 University of South Florida
199.
01/25/2001 Cook Children's Medical Center
200.
01/25/2001 St. Francis Health System
201.
01/26/2001 University of South Florida
202.
01/31/2001 Morehouse School of Medicine
203.
01/31/2001 St. Luke's Medical Center
204.
01/31/2001 The University of Memphis
205.
12/03/2002 Columbia University Health Sciences
206.
12/03/2002 Lawrence Berkeley National Laboratory/University of
California, Berkeley
207.
12/03/2002 National Institutes of Health
208.
12/04/2002 Ohio State University
209.
12/04/2002 University of Miami
210.
12/10/2002 Oregon Health & Science University
211.
12/20/2002 Lankenau Medical Research Center
212.
12/27/2002 Wake Forest University School of Medicine
213.
11/13/2002 Johns Hopkins University
214.
11/14/2002 Lankenau Medical Research Center
215.
11/14/2002 Loma Linda University
216.
11/21/2002 New York City Department of Health and Mental Hygiene
217.
11/21/2002 New York Hospital Medical Center of Queens
218.
11/21/2002 University of Cincinnati
219.
11/27/2002 University of Michigan, Ann Arbor
220.
10/04/2002 Oregon Health & Science University
221.
10/07/2002 Vanderbilt University
222.
10/10/2002 New York City Department of Health and Mental Hygiene
223.
10/24/2002 Oregon Health & Science University
224.
10/28/2002 Uganda National Council of Science and Technology
225.
10/28/2002 University of Louisville
226.
10/30/2002 National Institutes of Health
227.
09/04/2002 Beth Israel Deaconess Medical Center
228.
09/04/2002 University of Florida
229.
09/05/2002 Loyola University Chicago
230.
09/16/2002 University of Michigan
231.
09/24/2002 University of Louisville
232.
08/05/2002 University of Hawaii
233.
08/05/2002 University of Miami
234.
08/19/2002 Johns Hopkins University School of Medicine/Kennedy
Krieger Institute
235.
08/19/2002 University of Chicago
236.
08/19/2002 University of Utah
237.
08/20/2002 Hawaii State Department of Health
238.
08/23/2002 Johns Hopkins University School of Medicine
239.
08/26/2002 University of Michigan
240.
07/01/2002 Boston University Medical Center
241.
07/01/2002 New York City Department of Health
242.
07/11/2002 Walter Reed Army Medical Center
243.
07/16/2002 National Institutes of Health
244.
07/16/2002 Uganda National Council of Science and Technology
245.
07/17/2002 Johns Hopkins University School of Medicine
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246.
07/24/2002 Beijing Medical University
247.
07/24/2002 Brigham & Women's Hospital
248.
07/24/2002 Harvard School of Public Health
249.
07/24/2002 Massachusetts Mental Health Center/Massachusetts
Mental Health Research Corporation
250.
07/24/2002 Shanghai No. 1 Textile Hospital
251.
07/24/2002 Sun Yat-sen University of Medical Sciences
252.
07/24/2002 Yunnan Institute for Drug Abuse
253.
07/29/2002 Lankenau Hospital
254.
07/29/2002 St. Louis University
255.
07/31/2002 Duke University Health System, Inc.
256.
07/31/2002 University of Washington
257.
06/10/2002 Thomas Jefferson University
258.
06/10/2002 University of Pennsylvania
259.
06/18/2002 Johns Hopkins University
260.
06/18/2002 New York University School of Medicine
261.
06/26/2002 Vanderbilt University/Nashville Veterans Affairs Medical
Center
262.
06/27/2002 Columbia University, Health Sciences
263.
05/07/2002 Mount Sinai School of Medicine
264.
05/08/2002 New York University School of Medicine
265.
05/09/2002 Columbia University College of Physicians and
Surgeons/New York-Presbyterian Hospital
266.
05/09/2002 Beth Israel Deaconess Medical Center
267.
05/13/2002 Children's Hospital of Pittsburgh
268.
05/13/2002 Ochsner Clinical Foundation
269.
05/16/2002 Parker Hughes Institute
270.
05/23/2002 University of California, San Francisco
271.
05/31/2002 Johns Hopkins University School of Medicine
272.
05/31/2002 State University of New York Downstate Medical Center
273.
05/31/2002 Winifred Masterson Burke Medical Research Institute
274.
04/02/2002 Indiana University
275.
04/02/2002 Mayo Foundation
276.
04/02/2002 Memorial Hospital of Rhode Island
277.
04/02/2002 University of Kansas Medical Center
278.
04/03/2002 LDS Hospital
279.
04/03/2002 Massachusetts General Hospital
280.
04/03/2002 Rush-Presbyterian-St. Luke's Medical Center
281.
04/03/2002 Washington University School of Medicine
282.
04/03/2002 University of Colorado Health Sciences Center
283.
04/03/2002 University of Minnesota
284.
04/04/2002 Baylor College of Medicine
285.
04/04/2002 Cornell University Medical Center
286.
04/04/2002 University of Texas Southwestern Medical Center
287.
04/10/2002 Boston University Medical Center
288.
04/11/2002 Cleveland Clinic Foundation
289.
04/11/2002 University of California, San Francisco
290.
04/12/2002 State University of New York at Stony Brook
291.
04/17/2002 State University of New York Health Sciences Center at
Brooklyn/Downstate Medical Center
292.
04/17/2002 Walter Reed Army Medical Center
293.
04/23/2002 Case Western Reserve University
294.
04/23/2002 University of Chicago
295.
04/25/2002 University of California, Davis
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296.
04/29/2002 Johns Hopkins University, School of Medicine
297.
04/29/2002 University of California, Irvine
298.
04/29/2002 University of California, San Diego
299.
04/29/2002 University of Michigan Ann Arbor
300.
04/30/2002 Beth Israel Deaconess Medical Center
301.
04/30/2002 Cleveland Clinic Foundation
302.
04/30/2002 McLean Hospital
303.
04/30/2002 University of Pennsylvania
304.
03/12/2002 National Institutes of Health
305.
03/18/2002 Suburban Hospital
306.
03/19/2002 University of California, Los Angeles
307.
03/21/2002 Duke University Health System, Inc.
308.
03/25/2002 Emory University
309.
03/25/2002 Southern Illinois University
310.
03/25/2002 University of Kentucky
311.
03/25/2002 University of Maryland, Baltimore
312.
03/25/2002 University of Pittsburgh
313.
03/25/2002 University of South Florida
314.
03/25/2002 Walter Reed Army Medical Center
315.
03/25/2002 Yale University
316.
03/26/2002 Case Western Reserve University
317.
03/27/2002 University of California, San Diego
318.
03/28/2002 Brigham and Women's Hospital
319.
03/28/2002 Harvard School of Public Health
320.
03/28/2002 Massachusetts Mental Health Center
321.
02/01/2002 Duke University Health System, Inc.
322.
02/02/2002 Brookhaven Science Associates, LLC
323.
02/04/2002 John Hopkins University School of Medicine
324.
02/04/2002 LDS Hospital
325.
02/04/2002 University of Maryland, Baltimore
326.
02/04/2002 University of Washington
327.
02/04/2002 Vanderbilt University/Nashville Veterans Affairs Medical
Center
328.
02/05/2002 University of Cincinnati
329.
02/05/2002 Yale University
330.
02/07/2002 Cleveland Clinic Foundation
331.
02/08/2002 University of California, San Francisco
332.
02/11/2002 University of California, San Diego
333.
02/11/2002 University of Michigan, Ann Arbor
334.
02/26/2002 University of Arkansas for Medical Sciences
335.
02/27/2002 National Institutes of Health
336.
01/07/2002 Beth Israel Deaconess Medical Center
337.
01/07/2002 University of Colorado Health Sciences Center
338.
01/08/2002 University of California, San Diego
339.
01/10/2002 Baylor College of Medicine
340.
01/11/2002 Thomas Jefferson University
341.
01/14/2002 North Shore University Hospital
342.
01/18/2002 Duke University Health System, Inc.
343.
01/18/2002 John Hopkins University School of Medicine/Kennedy
Krieger Institute
344.
01/22/2002 Beth Israel Deaconess Medical Center
345.
01/24/2002 John Hopkins University School of Medicine
346.
01/29/2002 Children's National Medical Center
347.
01/29/2002 Massachusetts General Hospital
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348.
01/30/2002 Thomas Jefferson University
349.
01/30/2002 University of Pennsylvania
350.
01/31/2002 University of Colorado Health Sciences Center
351.
12/01/2003 Columbia University Health Sciences
352.
11/03/2003 Baystate Medical Center
353.
11/03/2003 University of Maryland at Baltimore/Baltimore Veterans
Affairs Medical Center
354.
11/05/2003 Center for Molecular Medicine and Immunology
355.
11/05/2003 Moses Cone Health System
356.
11/10/2003 Duke University Health System
357.
11/10/2003 Wake Forest University School of Medicine
358.
11/17/2003 Louisiana State University Health Sciences Center
359.
11/17/2003 Thomas Jefferson University
360.
11/17/2003 University of Virginia
361.
11/17/2003 Vanderbilt University
362.
11/19/2003 University of California, San Francisco
363.
10/01/2003 Ochsner Clinic Foundation
364.
10/06/2003 Boston University Medical Center
365.
10/06/2003 National Institutes of Health
366.
10/06/2003 University of South Florida
367.
10/20/2003 Cleveland Clinic Foundation
368.
10/20/2003 University of Maryland
369.
10/21/2003 The Cleveland Clinic Foundation
370.
10/23/2003 Johns Hopkins University School of Medicine
371.
10/30/2003 Parma Community General Hospital
372.
09/03/2003 University of Rochester
373.
09/05/2003 Parma Community General Hospital
374.
09/15/2003 University of Michigan
375.
09/29/2003 Ohio State University
376.
8/07/2003 University of South Florida
377.
8/21/2003 National Institutes of Health
378.
8/28/2003 Garden State Cancer Center
379.
07/01/2003 University of Florida
380.
07/01/2003 University of Maryland
381.
07/02/2003 University of Texas - Austin
382.
07/03/2003 ARDS Network
383.
07/15/2003 The University of Alabama at Birmingham
384.
07/25/2003 Baystate Medical Center
385.
07/25/2003 Case Western Reserve University
386.
07/25/2003 The Cleveland Clinic Foundation
387.
07/25/2003 Department of Veterans Affairs - New Orleans
388.
07/25/2003 Duke University Health System, Inc
389.
07/25/2003 Harris County Hospital District
390.
07/25/2003 Intermountain Health Care - McKay-Dee Hospital Center
391.
07/25/2003 Intermountain Health Care - Utah Valley Regional Medical
Center
392.
07/25/2003 Johns Hopkins University School of Medicine
393.
07/25/2003 LDS Hospital
394.
07/25/2003 Louisiana State University Health Sciences Center
395.
07/25/2003 Moses Cone Health System
396.
07/25/2003 Northwestern University
397.
07/25/2003 Ochsner Clinic Foundation
398.
07/25/2003 St. Anthony Central Hospital
399.
07/25/2003 Thomas Jefferson University
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400.
07/25/2003 Tulane University Hospital
401.
07/25/2003 The University of British Columbia
402.
07/25/2003 University of California, San Francisco
403.
07/25/2003 The University of Chicago
404.
07/25/2003 University of Colorado Health Sciences Center
405.
07/25/2003 University of Maryland at Baltimore
406.
07/25/2003 University of Michigan
407.
07/25/2003 University of Pennsylvania
408.
07/25/2003 University of Pittsburgh
409.
07/25/2003 University of Texas Health Science Center at San Antonio
410.
07/25/2003 University of Virginia
411.
07/25/2003 University of Washington
412.
07/25/2003 Vanderbilt University
413.
07/25/2003 Veterans Affairs Medical Center - Denver
414.
07/25/2003 Wake Forest University School of Medicine
415.
06/02/2003 University of Arizona
416.
06/04/2003 University of Texas - Austin
417.
05/02/2003 Harvard School of Public Health
418.
05/13/2003 Columbia University Health Sciences
419.
05/15/2003 National Institutes of Health
420.
05/30/2003 City of Hope National Medical Center
421.
04/02/2003 Beth Israel Deaconess Medical Center
422.
04/08/2003 Virginia Commonwealth University
423.
04/17/2003 Oregon Health & Science University
424.
04/21/2003 University of Cincinnati Medical Center
425.
04/29/2003 Saint Joseph‘s University
426.
03/17/2003 National Institutes of Health
427.
03/21/2003 University of Washington
428.
03/24/2003 Duke University Health Systems, Inc.
429.
03/24/2003 Mary Imogene Bassett Hospital
430.
03/24/2003 Uganda National Council of Science & Technology
431.
03/26/2003 New York University School of Medicine
432.
02/06/2003 University of California San Francisco
433.
02/12/2003 Mount Sinai School of Medicine
434.
02/12/2003 University of Colorado Health Sciences Center
435.
02/12/2003 University of Michigan
436.
02/13/2003 The Children‘s Hospital of Philadelphia
437.
02/22/2003 University of California - Los Angeles
438.
02/25/2003 Saint Joseph‘s University
439.
01/07/2003 Washington University School of Medicine
440.
01/13/2003 University of California, San Francisco
441.
01/23/2003 Loma Linda University
442.
01/29/2003 Saint Louis University Health Sciences Center
443.
12/02/2004 Colorado Cancer Research Program, Inc.
444.
12/06/2004 Evanston Northwestern Healthcare
445.
12/06/2004 St. John's Health System
446.
12/07/2004 M. D. Anderson Cancer Center
447.
12/15/2004 University of Colorado Health Sciences Center
448.
12/22/2004 Baptist Hospital of Miami, Inc.
449.
11/03/2004 City of Hope National Medical Center and Beckman
Research Institute
450.
11/03/2004 University of Maryland Baltimore Professional Schools
451.
11/04/2004 Baptist Hospital of Miami
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452.
11/05/2004 University of Southern California - Health Science/Charles
R. Drew University
453.
11/22/2004 University of Arizona
454.
10/13/2004 Florida Department of Health
455.
10/15/2004 National Institutes of Health
456.
10/15/2004 Virginia Commonwealth University
457.
09/09/2004 Columbia University Health Sciences
458.
09/16/2004 Scott & White Memorial Hospital
459.
08/02/2004 Columbia University Health Sciences
460.
08/03/2004 Association of American Medical Colleges
461.
08/03/2004 Finch University Health Sciences/Chicago Medical School
462.
08/03/2004 George Washington University
463.
08/03/2004 University of California, Los Angeles
464.
08/03/2004 University of Massachusetts Medical School
465.
08/03/2004 University of Medicine & Dentistry of New Jersey - Newark
Campus/New Brunswick Campus
466.
08/03/2004 University of Miami
467.
08/12/2004 Community Hospital of the Monterey Peninsula
468.
08/19/2004 Tufts-New England Medical Center
469.
08/20/2004 Virginia Commonwealth University
470.
08/23/2004 City of Hope National Medical Center
471.
08/26/2004 AIDS Research Alliance-Chicago/Saint Joseph Hospital
472.
08/31/2004 Florida Department of Health
473.
07/01/2004 Fred Hutchinson Cancer Research Center
474.
07/06/2004 Evanston Northwestern Healthcare Research Institute
475.
07/06/2004 Medical University of South Carolina
476.
07/06/2004 Ohio State University
477.
07/08/2004 Tufts-New England Medical Center
478.
07/21/2004 Joan and Sanford I. Weill College of Medicine of Cornell
University
479.
07/22/2004 Texas Tech University Health Sciences Center
480.
06/29/2004 Johns Hopkins University School of Medicine
481.
06/29/2004 M. D. Anderson Cancer Center
482.
06/29/2004 University of Michigan
483.
05/03/2004 University of Pittsburgh/Carnegie Mellon University
484.
05/10/2004 University of Colorado Health Sciences Center
485.
05/24/2004 Joan and Sanford I. Weill College of Medicine of Cornell
University
486.
05/26/2004 Harvard Medical School
487.
05/28/2004 Oregon Health & Science University
488.
04/05/2004 AIDS Research Alliance-Chicago
489.
04/05/2004 University of Cincinnati
490.
04/15/2004 Intermountain Health Care/McKay-Dee Hospital Center
491.
04/15/2004 Thomas Jefferson University
492.
04/15/2004 University of Alabama - Birmingham
493.
04/16/2004 Northwestern University
494.
04/20/2004 Evanston Northwestern Healthcare Research Institute
495.
04/21/2004 Medical University of South Carolina
496.
04/23/2004 Baptist Hospital of Miami
497.
03/10/2004 University of Alabama, Birmingham
498.
03/26/2004 Harvard Medical School
499.
02/13/2004 Denver Veterans Affairs Medical Center
500.
02/13/2004 University of Texas Health Science Center at San Antonio
501.
02/26/2004 University of California, San Francisco
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502.
01/06/2004 Harris County Hospital District
503.
01/06/2004 University of California, San Francisco
504.
01/06/2004 University of Colorado Health Sciences Center
505.
01/06/2004 University of Michigan
506.
01/06/2004 University of Pennsylvania
507.
01/07/2004 Children's Hospital and Regional Medical Center
508.
01/12/2004 Ohio State University
509.
01/15/2004 Oregon Health & Sciences University
510.
01/20/2004 Johns Hopkins University School of Medicine
511.
01/20/2004 University of Chicago
512.
01/20/2004 University of Pittsburgh
513.
01/21/2004 University of Pittsburgh
514.
01/28/2004 Tulane University Hospital
515.
01/30/2004 University of Washington
516.
December 13, 2005 Mid-Delta Family Practice Clinic
517.
November 22, 2005 Gothenburg University
518.
October 3, 2005 Gothenburg University
519.
October 19, 2005 National Institutes of Health
520.
October 20, 2005 University of South Florida/ All Children‘s Health
System
521.
October 24, 2005 University of Washington
522.
October 27, 2005 Drexel University College of Medicine
523.
October 31, 2005 Gothenburg University
524.
October 31, 2005 Louisiana State University Health Science Center
Shreveport
525.
September 9, 2005 University of Washington
526.
August 5, 2005 University of Miami
527.
August 18, 2005 University of Illinois at Urbana-Champaign
528.
August 18, 2005 University of Minnesota
529.
August 25, 2005 National Institutes of Health
530.
August 26, 2005 University of South Florida
531.
August 30, 2005 Northwestern University
532.
July 19, 2005 St. Joseph‘s Hospital Atlanta
533.
July 28, 2005 Oregon Health and Science University
534.
June 29, 2005 Northwestern University
535.
May 2, 2005 University of Maryland Baltimore Professional Schools
536.
May 19, 2005 St. Joseph‘s Hospital Atlanta, Inc.
537.
May 23, 2005 Columbia University Medical Center / New York
Presbyterian Hospital
538.
April 1, 2005 University of Washington
539.
April 15, 2005 Joan and Sanford I. Weill College of Medicine of Cornell
University
540.
April 27, 2005 University of Colorado Health Sciences Center
541.
April 28, 2005 National Jewish Medical and Research Center
542.
April 29, 2005 National Institutes of Health
543.
March 1, 2005 University of Colorado Health Sciences Center
544.
March 7, 2005 National Institutes of Health
545.
March 8, 2005 University Hospitals of Cleveland
546.
March 14, 2005 University of Illinois at Urbana-Champaign
547.
March 30, 2005 National Institutes of Health
548.
February 24, 2005 University of Maryland Baltimore Professional
Schools
549.
February 25, 2005 St. John's Health System
550.
February 28, 2005 National Jewish Medical and Research Center
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551.
January 5, 2005 Saint Joseph Hospital
552.
January 6, 2005 Joan and Sanford I. Weill College of Medicine of Cornell
University
553.
January 7, 2005 University Hospitals of Cleveland
554.
January 10, 2005 National Institutes of Health
555.
December 7, 2006 Medical College of Wisconsin
556.
December 13, 2006 New England Research Institute
557.
December 13, 2006 University of Washington
558.
December 20, 2006 University of Illinois at Urbana-Champaign
559.
December 21, 2006 Children's Hospital Oakland
560.
December 22, 2006 Anne Arundel Medical Center
561.
November 8, 2006 Lenox Hill Hospital
562.
November 17, 2006 San Antonio Metropolitan Health District
563.
November 22, 2006 Women & Infants Hospital of Rhode Island
564.
October 11, 2006 University of Utah
565.
October 12, 2006 University of Illinois at Urbana-Champaign
566.
October 19, 2006 Main Line Health Systems
567.
October 24, 2006 Scripps Health
568.
October 25, 2006 Illinois Institute of Technology
569.
September 6, 2006 Illinois Institute of Technology
570.
September 25, 2006 Women & Infants Hospital of Rhode Island
571.
August 15, 2006 Children‘s Hospital of Philadelphia
572.
August 16, 2006 University of Miami
573.
August 21, 2006 Main Line Health Systems
574.
August 24, 2006 Scripps Health
575.
August 28, 2006 Cook County Bureau of Health Services
576.
August 28, 2006 Drexel University College of Medicine
577.
August 29, 2006 New England Research Institutes, Inc.
578.
August 29, 2006 University of Washington
579.
July 6, 2006 University of Colorado at Boulder
580.
July 21, 2006 Custom Kynetics/Cardinal Hill Rehab
581.
July 21, 2006 San Juan City Hospital
582.
June 15, 2006 Eastern Virginia Medical School
583.
June 19, 2006 Bronx-Lebanon Hospital Center
584.
June 19, 2006 Universidad Central del Caribe
585.
June 19, 2006 Children's Hospital of the King's Daughters
586.
June 19, 2006 Children's Hospital and Research Center at Oakland
587.
June 19, 2006 University of Medicine and Dentistry of New Jersey
588.
June 19, 2006 Bellevue Hospital Center
589.
June 19, 2006 Children's Hospital and Regional Medical Center
590.
June 19, 2006 SUNY Upstate Medical University
591.
June 19, 2006 Drexel University College of Medicine
592.
June 19, 2006 Cook County Bureau of Health Services
593.
June 19, 2006 Children's Hospital of Philadelphia
594.
June 19, 2006 Duke University School of Medicine
595.
June 19, 2006 University of Miami
596.
June 19, 2006 University of Chicago
597.
June 19, 2006 Children's Hospital of Orange County
598.
June 19, 2006 Children's Memorial Hospital
599.
June 19, 2006 San Juan City Hospital
600.
June 19, 2006 University of California, San Francisco
601.
June 21, 2006 University of Miami
602.
June 26, 2006 University of Maryland Baltimore School of Medicine
603.
June 27, 2006 Scripps Health
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604.
June 28, 2006 University of Tennessee Health Science Center
605.
May 5, 2006 Research Foundation for Mental Hygiene, Inc
606.
May 17, 2006 The University of Tennessee Health Science Center
607.
May 23, 2006 University of California, Los Angeles
608.
April 10, 2006 Scripps Health
609.
April 11, 2006 Research Foundation for Mental Hygiene, Inc.
610.
April 11, 2006 University of Colorado at Boulder
611.
April 12, 2006 Delta Health Center
612.
April 26, 2006 Philadelphia Health and Education Corporation (Drexel
University College of Medicine)
613.
March 3, 2006 State University of New York at Stony Brook
614.
March 27, 2006 University of Houston
615.
February 14, 2006 Delta Health Center
616.
February 14, 2006 Mid-Delta Family Practice Clinic
617.
February 14, 2006 University of California, Los Angeles
618.
February 17, 2006 Bellevue Hospital Center
619.
February 17, 2006 Bronx-Lebanon Hospital Center
620.
February 17, 2006 Children‘s Hospital - Denver
621.
February 17, 2006 Children's Hospital - Oakland
622.
February 17, 2006 Children's Hospital - Philadelphia
623.
February 17, 2006 Children's Hospital & Regional Medical Center
624.
February 17, 2006 Columbia University Medical Center/New York
Presbyterian Hospital
625.
February 17, 2006 Cook County Bureau of Health Services
626.
February 17, 2006 H. Lee Moffitt Cancer Center and Research Institute
627.
February 17, 2006 Harbor-UCLA Medical Center
628.
February 17, 2006 Johns Hopkins Health System
629.
February 17, 2006 North Shore-Long Island Jewish Health System
630.
February 17, 2006 SUNY Stony Brook
631.
February 17, 2006 SUNY Upstate Medical University
632.
February 17, 2006 University of Chicago
633.
February 17, 2006 University of Maryland Baltimore Professional
Schools
634.
February 17, 2006 University of Medicine and Dentistry New Jersey/New
Brunswick
635.
February 17, 2006 University of Miami
636.
February 24, 2006 Philadelphia Health and Education Corporation
(Drexel University College of Medicine)
637.
February 27, 2006 Gothenburg University
638.
January 25, 2006 Louisiana State University Health Science Center
Shreveport
639.
January 25, 2006December 17, 2007 The J. David Gladstone Institutes/
University of California, San Francisco/San Francisco General Hospital Medical
Center
640.
January 26, 2006 University of Tennessee Health Science Center
641.
December 17, 2007 University of Connecticut Health Center
642.
December 18, 2007 Interior Health Authority
643.
December 19, 2007 University of Arizona
644.
December 19, 2007 Carondelet Health Network
645.
December 20, 2007 New York University School of Medicine
646.
November 1, 2007 New Mexico State University
647.
November 6, 2007 Michigan Health & Hospital Association
648.
November 6, 2007 John Hopkins University School of Medicine/ Johns
Hopkins Bloomberg School of Public Health/ Johns Hopkins University
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649.
November 28, 2007 Saint John's Health System
650.
October 15, 2007 Bridge Back Recovery Homes, Inc.
651.
September 14, 2007 Saint John's Health System
652.
September 14, 2007 University of Miami
653.
September 17, 2007 Bluefield State College
654.
September 24, 2007 Hawaii State Department of Health/ University of
Hawaii
655.
August 9, 2007 University of Connecticut Health Center
656.
August 27, 2007 New Mexico State University
657.
July 9, 2007 Bluefield State College
658.
July 18, 2007 University of Miami
659.
July 19, 2007 Johns Hopkins
660.
July 24, 2007 Arizona State University
661.
June 22, 2007 University of Arizona
662.
June 25, 2007 Hawaii State Department of Health/ University of Hawaii
663.
June 29, 2007 University of California at Berkeley
664.
May 2, 2007 University of Florida/ Malcom Randall VA Medical Center
665.
May 15, 2007 Arizona State University
666.
May 16, 2007 University of Texas Health Science Center at Houston
667.
May 30, 2007 University of Florida
668.
April 10, 2007 University of Miami
669.
April 23, 2007 University of Washington
670.
March 7, 2007 New Mexico State University
671.
March 20, 2007 Bluefield State College
672.
February 5, 2007 Anne Arundel Medical Center
673.
February 6, 2007 Washington University School of Medicine
674.
February 13, 2007 HCA-HEALTHONE LLC
675.
January 3, 2007 University of Utah
676.
January 4, 2007 Cleveland Clinic Foundation/Case Western Reserve
University
677.
University of Houston
678.
December 1, 2008 YRG CARE India
679.
December 4, 2008 Mayo Clinic
680.
December 16, 2008 University of KwaZulu-Natal
681.
December 30, 2008 University of Puerto Rico
682.
November 24, 2008 Haverford College
683.
October 3, 2008 George Washington University
684.
September 15, 2008 YR Gaitonde Center for AIDS Research and
Education
685.
September 15, 2008 Haverford College
686.
September 26, 2008 Interior Health Authority
687.
August 1, 2008 University of Washington
688.
August 13, 2008 University of KwaZulu-Natal
689.
August 21, 2008 Cook County Bureau of Health Services/ Rush
University Medical Center
690.
July 3, 2008 The J. David Gladstone Institutes/ University of California,
San Francisco
691.
July 17, 2008 Lehigh Valley Hospital & Health Network
692.
July 23, 2008 Mayo Clinic
693.
June 2, 2008 Columbia University Health Sciences
694.
May 1, 2008 Lehigh Valley Hospital & Health Network
695.
May 2, 2008 University of Arizona
696.
May 6, 2008 George Washington University
697.
May 13, 2008 Carondelet Health Network
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698.
May 19, 2008 The J. David Gladstone Institutes/ University of California,
San Francisco
699.
April 21, 2008 University of California at Berkley
700.
April 28, 2008 University of Connecticut Health Center
701.
April 28, 2008 Saint John's Health System
702.
March 3, 2008 University of Connecticut Health Center
703.
March 5, 2008 New York University
704.
February 11, 2008 Charles R. Drew University of Medicine & Science
705.
February 14, 2008 John Hopkins University School of Medicine /Johns
Hopkins Bloomberg School of Public Health /Johns Hopkins University
706.
February 14, 2008 Michigan Health & Hospital Association
707.
February 21, 2008 Bluefield State College
708.
February 25, 2008 Columbia University Medical Center
709.
February 25, 2008 Gothenburg University
710.
February 27, 2008 University of Washington
711.
January 2, 2008 Mount Sinai School of Medicine
712.
December 8, 2009 - Northern Arizona University
713.
December 16, 2009 - Carle Clinic Association/ Carle Foundation Hospital
714.
November 9, 2009 - University of California, San Francisco
715.
November 9, 2009 - Children's Hospital of Philadelphia
716.
November 9, 2009 - Cincinnati Children's Hospital Medical Center
717.
October 30, 2009 - Mt. Sinai Medical Center
718.
September 2, 2009 - The University of Iowa
719.
September 16, 2009 - Northern Arizona University
720.
September 21, 2009 - Carle Clinic Association/ Carle Foundation
Hospital
721.
July 31, 2009 Howard University
722.
June 4, 2009 Weizmann Institute of Science
723.
June 5, 2009 Board of Regents of the University of Oklahoma Health
Sciences Center
724.
June 9, 2009 Carle Clinic Association / Carle Foundation Hospital
725.
May 26, 2009 Scottsdale Healthcare
726.
May 27, 2009 Mount Sinai Medical Center/ Duke University Health
System, Inc./ University of Miami
727.
April 15, 2009 University of Washington
728.
April 15, 2009 Northern Virginia Pelvic Surgery
729.
April 29, 2009 Duke University Health System, Inc.
730.
April 30, 2009 Weizmann Institute of Science
731.
March 2, 2009 Board of Regents of the University of Oklahoma Health
Sciences Center
732.
March 17, 2009 Children's Hospital of Philadelphia
733.
March 17, 2009 University of California, San Francisco
734.
March 17, 2009 Cincinnati Children's Hospital Medical Center
735.
March 19, 2009 Cook County Bureau of Health
736.
March 25, 2009 Native American Cancer Research/ University of
Colorado Denver
737.
March 30, 2009 Children's Hospital Oakland Research Institute
738.
March 30, 2009 Scottsdale Healthcare
739.
February 3, 2009 University of KwaZulu-Natal
740.
February 11, 2009 Indiana University
741.
February 17, 2009 Duke University Health System, Inc.
742.
February 19, 2009 Children's Hospital Oakland Research Institute
743.
February 19, 2009 Northern Virginia Pelvic Surgery Associate
744.
February 25, 2009 Rush University Medical Center
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745.
January 29, 2009 Mayo Clinic
746.
November 24, 2010 Drexel University/Philadelphia Health & Education
Corp.
747.
October 4, 2010 University of California, Berkeley
748.
October 26, 2010 Drexel University/Philadelphia Health & Education
Corp.
749.
September 2, 2010 Weill Cornell Medical Center and Mount Sinai
School of Medicine
750.
September 6, 2010 Massachusetts General Hospital
751.
June 3, 2010 Board of Regents of the University of Oklahoma Health
Sciences Center
752.
May 10, 2010 North Shore-Long Island Jewish Health System
753.
April 8, 2010 University at Buffalo - State University of New York
754.
April 8, 2010 University of California, San Francisco
755.
April 16, 2010 University of British Columbia
756.
April 30, 2010 Howard University
757.
March 29, 2010 University of California, San Francisco
758.
March 29, 2010 Intermountain Health Care
759.
February 25, 2010 Research Triangle Institute International/ University
of Rochester
760.
February 25, 2010 University at Buffalo - State University of New York
761.
January 11, 2010 East Carolina University
762.
January 28, 2010 Intermountain Health Care
763.
January 29, 2010 Howard University
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Appendix Q
Determination Letter

DEPARTMENT OF HEALTH & HUMAN SERVICES
Office of the Secretary
Office of Public Health and Science
___________________________________________________________________________
Office for Human Research Protections
The Tower Building
1101 Wootton Parkway, Suite 200
Rockville, Maryland 20852
Telephone: 240 453-8297
FAX: 240 453-6909
March 27, 2006
Arthur C. Vailas, Ph.D.
Vice President for Research
University of Houston
4800 Calhoun 316 East Cullen
Houston, TX 77204-2015
RE: Human Research Subject Protections Under Federalwide Assurance FWA-5994
(1) Research Project: Investigation of Variables Involved in the Behavioral Treatment of
Children with Autism
Project Number: 03-097
Principal Investigator: Gerald Harris, Ph.D.
(2) TYAP Project: Acquisition of ABA Treatment Skills: In-Vivo vs. Video Modeling
(3) Research Project: Generalization of Parent Training: A Comparison Study
Principal Investigator: Gerald Harris, Ph.D.
(4) Research Project: Training and Generalizing Interaction Skills with Siblings of Children
with Autism
Principal Investigator: Gerald Harris, Ph.D.
(5) Research Project: The Relationship of Parental Stress to Autism Treatment Type and
Duration Principal Investigator: Gerald Harris, Ph.D.
Dear Dr. Vailas:
The Office of Human Research Protections has reviewed the University of Houston‘s
(UH) March 2, 2006 and January 27, 2005 reports regarding the above referenced
research and OHRP‘s inquiry regarding allegations of noncompliance with Department
of Health and Human Services (HHS) regulations for the protection of human research
subjects involving the above-referenced research.
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(1) In its January 25, 2006 letter, OHRP made the following determination:
HHS regulations at 45 CFR 46.103(a), 46.103(b)(4)(ii) and 46.103(b)(5) require that
institutions have written institutional review board (IRB) procedures that adequately
describe IRB operations with respect to:
(a) determining which projects require review more often than annually and which need
verification from sources other than the investigators that no material changes have occurred
since previous IRB review, and
(b) ensuring prompt reporting to the IRB, appropriate institutional officials, any Department or
Agency head, and OHRP of (a) any unanticipated problems involving risks to subjects or others;
(b) any serious or continuing noncompliance with 45 CFR Part 46 or the requirements or
determinations of the IRB; and (c) any suspension or termination of IRB approval.
OHRP found that the UH IRB Policies and Procedures supplied to OHRP do not contain
specific procedures for how the IRB conducts these activities.
Corrective Action: OHRP acknowledges that UH‘s IRB Policies and Procedures have
now been revised to describe IRB operations adequately with respect to the above
requirements under HHS regulations at 45 CFR 46.103(a), 46.103(b)(4)(ii), and
46.103(b)(5).
OHRP makes the following additional findings about the above-referenced research and
projects:
(2) HHS regulations at 45 CFR 46.109(a) require institutional review boards (IRBs) to review and
have authority to approve, require modifications in (to secure approval), or disapprove all
research activities covered by the HHS regulations. With respect to allegations that research was
conducted without IRB review and approval and without legally effective informed consent, OHRP
finds that this allegation cannot be substantiated. OHRP acknowledges UH‘s statements that (a)
the IRB-approved study # 03-097 titled ―Investigation of Variables Involved in the Behavioral
Treatment of Children with Autism‖ involves the collection of data from the clinical files of the
investigator‘s private clients at the Texas Young Autism Project; (b) the second referenced project
(hereinafter referred to as ―TYAP Project‖) is a presentation of activities conducted by TYAP and
was not subject to UH IRB review or approval, and (c) the last three projects (two presentations
and one poster) were not based on independent research, but utilized a subset of the research
database created under the first, IRB-approved research project.
(3) HHS regulations at 45 CFR 46.116 require investigators to obtain legally effective informed
consent prior to the initiation of research. For research involving children, HHS regulations at 45
CFR 46.408 require IRBs to determine that adequate provisions are made for soliciting the assent
of children and the permission of each child‘s parents or
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guardian. OHRP finds that when the UH IRB approved study #03-097, it reviewed and
approved a parental permission form which contained all of the required elements of
informed consent set forth under 45 CFR 46.116. OHRP notes that there is no evidence in
the IRB file to determine whether the UH IRB considered, as required by 45 CFR
46.408(a), whether the child subjects involved in study #03-097 were capable of providing
assent; however, OHRP acknowledges that UH IRB Policies and Procedures require
assent from children capable of providing it, and describe appropriate criteria to include in
assent forms.
(4) HHS regulations at 45 CFR 46.111(a)(1)(i) state that, in order to approve research covered by
the regulations, the IRB shall determine that risks to subjects are minimized by using procedures
which are consistent with sound research design and which do not unnecessarily expose subjects
to risk. OHRP questioned whether the UH IRB, in reviewing project #03-097, obtained sufficient
information from the investigator regarding data recording technique and statistical method to
determine that these regulatory requirements were satisfied.
Corrective Action: OHRP acknowledges that IRB project #03-097 involved only the collection of
pre-existing data from TYAP files, and that the UH IRB identified the only significant risk of this
research to be the possible loss of confidentiality. OHRP further acknowledges that UH modified
its ―IRB Application To Conduct Research Using Human Subjects‖ form to request that
investigators include a description of date recording techniques and/or statistical methods to be
employed in the research.
(5) HHS regulations at 45 CFR 46.110(c) require IRBs that use expedited review procedures to
keep all IRB members advised of research proposals which have been approved via expedited
review.
OHRP finds that the UH IRB did not keep all IRB members advised of the approval of
project # 03-097, as required by 45 CFR 46.110.
Corrective Action: The UH IRB has modified its reporting procedures to ensure that the
minutes for the expedited review subcommittee reflect subcommittee decisions
regarding the research proposals it reviews under an expedited review procedure, and
that these minutes are presented to the full IRB by one of the reviewing subcommittee
members.
(6) HHS regulations at 45 CFR 46.404-407 (subpart D) require specific findings on the part
of the IRB for approval of research involving children. OHRP expressed concern that the
UH IRB file for project #03-097 provides no evidence that the IRB made the required
Subpart D findings.
Corrective Action: OHRP acknowledges UH‘s statement that, as a matter of policy and
practice, the IRB reviews the requirements of subpart D for all research activities
involving children. OHRP notes that UH initiated the following changes to
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address OHRP‘s concern in this and future research activities: (a) the IRB application
form now
requires investigators seeking approval for research involving children to designate what
they believe to be the category of the research under HHS regulations (45 CFR 46.404,
46.405, or 46.406) and to explain how the regulatory criteria are met by the study; (b) a
new reviewer‘s worksheet has been developed to require reviewers to identify the
appropriate regulatory category for involvement of children in research and to ensure that
child assent is obtained if appropriate, and (c) the regulatory category for involvement of
children in research will now be noted in IRB meeting minutes.
OHRP finds that the above corrective actions are adequate and appropriate under UH‘s FWA. As
a result, there should be no need for further OHRP involvement in this matter, although you
should notify OHRP if new information becomes available which might alter this determination.
OHRP appreciates the continued commitment of your institution to the protection of human
research subjects. Please do not hesitate to contact me should you have any questions.
Sincerely,
Carol J. Weil, J.D. Compliance Oversight
Coordinator Division of Compliance Oversight

cc: Ms. Debra Comeaux, Research Compliance Specialist,
U Houston Dr. Merrill Hiscock, IRB Chair,
U Houston IRB #2A and 2B
Dr. Gerald Harris, U Houston
Dr. Bernard Schwetz, OHRP
Dr. Melody H. Lin, OHRP
Dr. Michael Carome, OHRP
Dr. Kristina Borror, OHRP
Ms. Shirley Hicks, OHRP
Dr. Irene Stith-Coleman, OHRP
Ms. Pat El-Hinnawy, OHRP
Ms. Janet Fant, OHRP
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Appendix R
List of Acronyms
CARMA
CRS
DHHS
DL
FDA
FWA
HHS
HRPP
IRB
NBAC
NCJJ
NIH
OHRP
OPRR
SACHRP
SSR

Complementary Analysis Research Method Application
Congress of Research Service
Department of Health and Human Services
Determination Letters
Food and Drug Administration
Federalwide Assurance
Health and Human Services
Human Research Protection Program
Institutional Review Board
National Bioethics Advisory Commission
National Center for Juvenile Justice
National Institutes of Health
Office of Human Research Protections
Office for the Protection of Research Risks
Secretary's Advisory Committee on Human Research
Protections
Social Science Research
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APPENDIX S

Social/Behavioral IRB – Expedited Review
Approval Notice
NOTICE TO ALL RESEARCHERS:
Please be aware that a protocol violation (e.g., failure to submit a modification for
any change) of an IRB approved protocol may result in mandatory remedial
education, additional audits, re-consenting subjects, researcher probation,
suspension of any research protocol at issue, suspension of additional existing
research protocols, invalidation of all research conducted under the research
protocol at issue, and further appropriate consequences as determined by the IRB
and the Institutional Officer.

DATE: March 24, 2011
TO:

Dr. LeAnn Putney, Educational Psychology

FROM: Office of Research Integrity - Human Subjects
RE:

Notification of IRB Action by Charles Rasmussen Chair
Protocol Title: The Impact of Regulating Social Science Research with
Biomedical Regulations
Protocol #: 1103-3762M
Expiration Date: March 23, 2012
This memorandum is notification that the project referenced above has been reviewed and approved by the
UNLV Social/Behavioral Institutional Review Board (IRB) as indicated in Federal regulatory statutes 45
CFR 46 and UNLV Human Research Policies and Procedures.
The protocol is approved for a period of one year and expires March 23, 2012. If the above-referenced
project has not been completed by this date you must request renewal by submitting a Continuing Review
Request form 30 days before the expiration date.
PLEASE NOTE:
Upon approval, the research team is responsible for conducting the research as stated in the protocol most
recently reviewed and approved by the IRB, which shall include using the most recently submitted
Informed Consent/Assent forms and recruitment materials. The official versions of these forms are
indicated by footer which contains approval and expiration dates.
Should there be any change to the protocol, it will be necessary to submit a Modification Form through
ORI - Human Subjects. No changes may be made to the existing protocol until modifications have been
approved by the IRB. Modified versions of protocol materials must be used upon review and approval.
Unanticipated problems, deficiencies to protocols, and adverse events must be reported to the ORI – HS
within 10 days of occurrence.
If you have questions or require any assistance, please contact the Office of Research Integrity - Human
Subjects at IRB@unlv.edu or call 895-2794.
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